≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Cystic kidney disease, including avohilmo

Endpoint Browser PheWeb

Q17_CYSTIC_KIDNEY_DISEA_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 — Q61
  • Hospital discharge: ICD-10 — Q61
  • Cause of death: ICD-10 — Q61

3 out of 7 registries used, show all original rules.

1374

4. Check minimum number of events

None

1374

5. Include endpoints

None

1374

6. Filter based on genotype QC (FinnGen only)

1312

Control definitions (FinnGen only)

Control exclude
Q17_CONGEN_MALFO_URINARY_SYSTEM

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF13
Parent code in ICD-10
Q6[0-4]
Name in latin
Morbus cysticus renalis

Similar endpoints

↥

List of similar endpoints to Cystic kidney disease, including avohilmo based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 1312 679 633
Unadjusted period prevalence (%) 0.26 0.24 0.29
Median age at first event (years) 51.58 48.89 54.47

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1374
Matched controls
13740
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
V03AE01
ATC
polystyrene sulfonate; oral
42.7
320.2
195
53
L04AD02
ATC
tacrolimus; systemic
68.6
307.7
297
55
L04AA06
ATC
mycophenolic acid; systemic
66.7
307.7
439
96
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
+∞
307.7
615
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
145.8
307.7
357
33
KA1AE
NOMESCO Finland
Kidney ultrasound examination
22.1
307.7
252
138
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
91.7
307.7
575
107
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.6
307.7
424
438
Z94.0
ICD-10 Finland
Kidney transplant status
181.7
307.7
484
41
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
82.7
307.7
522
101
N18.8
ICD-10 Finland
Other chronic renal failure
39.6
307.7
307
99
A12AA04
ATC
calcium carbonate; oral
86.3
307.7
404
66
127
Kela drug reimbursment
Transplant complication
95.6
307.7
473
75
TK800
NOMESCO Finland
Hemodialysis
60.3
307.7
421
100
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
203.2
307.7
403
28
A11CC03
ATC
alfacalcidol; systemic
72.5
307.7
530
118
L04AD01
ATC
ciclosporin; systemic
30.9
307.7
241
94
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
154.3
307.7
311
26
V03AE02
ATC
sevelamer; oral
121.1
307.7
170
16
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
104.3
307.7
368
48
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
+∞
307.7
843
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
16.9
307.7
429
360
N18.0
ICD-10 Finland
End-stage renal disease
89.7
307.7
268
37
Z49.0
ICD-10 Finland
Preparatory care for dialysis
103.0
307.7
273
33
Z49.1
ICD-10 Finland
Extracorporeal dialysis
89.7
307.7
339
50
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
91.0
307.7
259
35
B03XA02
ATC
darbepoetin alfa; parenteral
35.3
307.7
324
119
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
9.0
307.7
614
1136
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
140.5
307.7
262
23
137
Kela drug reimbursment
Uraemia requiring dialysis
58.9
307.7
206
41
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
72.8
296.6
161
25
H02AB04
ATC
methylprednisolone; systemic
7.7
287.6
553
1110
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
155.8
281.9
140
10
205
Kela drug reimbursment
Chronic hypertension
6.7
275.3
753
2114
B05DA
ATC
Isotonic solutions
49.1
267.9
157
36
Z49.2
ICD-10 Finland
Other dialysis
47.4
264.1
156
37
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
65.9
257.4
142
24
196
Kela drug reimbursment
Paricalcitol and cinacalcet
102.5
251.3
130
14
B05DB
ATC
Hypertonic solutions
53.5
250.7
144
30
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
59.8
249.3
140
26
Q61.99
ICD-10 Finland
Cystic kidney disease, unspecified
+∞
232.0
216
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
10.9
229.3
272
304
B03XA01
ATC
erythropoietin; parenteral
45.9
223.9
133
32
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
10.0
223.2
285
351
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
76.5
221.2
119
17
V03AE03
ATC
lanthanum carbonate; oral
93.7
214.1
112
13
KBV00
NOMESCO Finland
Insertion of stent into ureter
56.0
207.7
118
23
H05BX01
ATC
cinacalcet; oral
62.7
206.8
115
20
TK820
NOMESCO Finland
Peritoneal dialysis
48.2
196.1
115
26
C03CA01
ATC
furosemide; systemic
4.9
189.7
711
2450
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
8.1
188.2
285
428
L04AA01
ATC
[U] ciclosporin
29.9
183.4
123
45
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
38.5
177.4
110
31
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
20.5
171.9
134
72
Q61.0
ICD-10 Finland
Congenital single renal cyst
+∞
165.0
155
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
5.4
160.5
396
954
JN3AD
NOMESCO Finland
Abdominal CT examination
5.1
150.5
402
1031
N28.1
ICD-10 Finland
Cyst of kidney
18.1
146.7
121
73
C08CA01
ATC
amlodipine; oral
4.1
143.8
806
3548
U14
ICPC
Kidney symptom/complaint
16.6
141.7
122
80
C07AG02
ATC
carvedilol; oral
7.1
136.6
229
379
3025
Kela drug reimbursment
Calcium carbonate
38.8
136.1
84
23
321
Kela drug reimbursment
Paricalcitol and cinacalcet
36.2
135.0
85
25
TK810
NOMESCO Finland
Hemofiltration
32.7
132.6
86
28
C02AC05
ATC
moxonidine; oral
7.9
131.4
195
282
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
33.5
127.4
82
26
C09AA02
ATC
enalapril; systemic
4.1
123.3
455
1473
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
20.4
116.3
90
47
C08CA02
ATC
felodipine; oral
5.2
115.3
278
644
3AC01, ,
NOMESCO Finland
21.0
108.7
83
42
KAC00
NOMESCO Finland
Nephrectomy
174.0
108.0
112
7
M04AA01
ATC
allopurinol; systemic
4.4
107.7
332
933
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.5
106.3
311
839
R4110
NOMESCO Finland
Physiotherapy
3.4
105.9
610
2605
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
5.7
105.5
218
439
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
9.6
103.0
126
143
K76.80
ICD-10 Finland
Hepatic cyst
24.8
102.5
73
31
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
8.3
100.9
140
186
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.4
95.8
281
756
N19
ICD-10 Finland
Unspecified kidney failure
7.6
95.1
143
208
WX610
NOMESCO Finland
Patient controlled analgesia
23.4
94.8
69
31
WX202
NOMESCO Finland
Supraclavicular plexus blockade
14.7
94.5
86
62
7531A
ICD-9 Finland
Congenital anomalies of urinary system, Cystic kidney disease
972.3
94.0
91
*
Q61.1
ICD-10 Finland
Polycystic kidney, autosomal recessive
+∞
92.8
88
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
24.7
92.6
66
28
RD210, ,
NOMESCO Finland
9.9
89.4
106
115
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.3
88.8
267
729
C08CA13
ATC
lercanidipine; oral
3.7
87.9
343
1126
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
109.5
85.1
92
9
WX203
NOMESCO Finland
Infraclavicular plexus blockade
9.3
84.9
106
123
J01MA02
ATC
ciprofloxacin; systemic
3.0
84.3
708
3636
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.6
84.1
125
179
Q44.6
ICD-10 Finland
Cystic disease of liver
156.5
84.1
88
6
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
120.3
84.0
90
8
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
83.4
858
4905
Z2446
NOMESCO Finland
Social worker
4.6
82.7
220
545
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
5.9
80.3
154
287
XPX08
NOMESCO Finland
Intraoperative flow measurement
17.7
80.3
66
39
ZXE20
NOMESCO Finland
More than three and less than five hours
3.6
79.8
323
1080
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
78.3
379
1417
C02CA01
ATC
prazosin; oral
14.0
78.1
73
55
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.8
78.0
153
291
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
77.9
531
2414
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
77.2
660
3379
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
9.6
75.3
91
101
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
195.3
71.9
74
*
R50.9
ICD-10 Finland
Fever, unspecified
3.2
71.4
358
1359
C07AB02
ATC
metoprolol; systemic
3.1
71.2
382
1508
K65.0
ICD-10 Finland
Acute peritonitis
15.4
70.3
62
42
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
23.5
69.0
50
22
RS220, ,
NOMESCO Finland
11.1
68.6
74
70
Q61.8
ICD-10 Finland
Other cystic kidney diseases
+∞
67.2
64
*
R4190
NOMESCO Finland
Nutritional therapy
5.1
67.1
151
324
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
23.1
64.4
47
21
Q61.5
ICD-10 Finland
Medullary cystic kidney
+∞
64.1
61
*
C02EA02, ,
ATC
5.9
61.4
116
212
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
8.0
61.2
85
112
L04AX01
ATC
azathioprine; systemic
5.4
60.8
126
251
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.7
60.7
216
656
ZX120
NOMESCO Finland
Intravenous
3.7
60.6
221
682
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
113.6
60.4
65
6
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.9
60.3
369
1551
R31
ICD-10 Finland
Unspecified haematuria
3.4
58.3
237
784
A12AA12
ATC
[U] calcium acetate
125.4
56.3
60
5
I10
ICD-10 Finland
Essential (primary) hypertension
2.5
56.2
929
6198
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
55.7
553
2932
Z94.4
ICD-10 Finland
Liver transplant status
25.1
55.1
39
16
M10.3
ICD-10 Finland
Gout due to impairment of renal function
22.9
54.6
40
18
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
18.1
54.3
44
25
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.1
53.5
83
124
Z3226
NOMESCO Finland
Physiotherapist
2.7
53.1
361
1591
ZXA00
NOMESCO Finland
Right side
2.5
52.9
457
2263
A07AA09
ATC
vancomycin; oral
10.4
52.5
59
59
A41.9
ICD-10 Finland
Sepsis, unspecified
5.5
52.2
106
207
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
12.2
51.7
52
44
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.0
51.3
80
120
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
51.3
413
1973
WX402
NOMESCO Finland
General anaesthesia
2.5
51.3
435
2130
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
14.8
51.2
46
32
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.1
50.4
91
159
Z3231
NOMESCO Finland
Registered nurse
2.4
49.8
491
2569
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
16.6
49.7
42
26
KBV10
NOMESCO Finland
Removal of stent from ureter
15.1
49.5
44
30
M10.9
ICD-10 Finland
Gout, unspecified
3.9
49.5
161
457
J01MA12
ATC
levofloxacin; systemic
2.7
48.8
340
1509
C10AA05
ATC
atorvastatin; oral
2.3
48.5
664
3989
WW200
NOMESCO Finland
Immunization
6.0
48.4
89
158
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
+∞
48.2
46
*
A12BA01
ATC
potassium chloride; oral
5.3
47.4
99
198
WX204
NOMESCO Finland
Axillary plexus blockaced
5.1
47.2
103
214
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
14.4
46.1
42
30
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
14.5
45.2
41
29
Q61
ICD-10 Finland
Cystic kidney disease
+∞
45.0
43
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
8.2
44.6
60
76
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.4
44.3
119
293
Z99.2
ICD-10 Finland
Dependence on renal dialysis
121.6
44.0
47
*
ZXD05
NOMESCO Finland
Urgent procedure
2.3
43.8
505
2795
UKC02
NOMESCO Finland
Cystoscopy
2.7
43.7
289
1243
C08CA05
ATC
nifedipine; systemic
4.0
41.2
125
337
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.4
40.9
108
262
N25.0
ICD-10 Finland
Renal osteodystrophy
60.7
40.5
47
8
H26.3
ICD-10 Finland
Drug-induced cataract
12.5
40.3
40
33
A41.8
ICD-10 Finland
Other specified sepsis
6.6
40.0
66
105
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
8.1
39.8
54
69
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
54.0
39.7
47
9
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
8.4
39.5
52
64
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
205.8
39.0
40
*
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
108.3
38.9
42
*
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
108.3
38.9
42
*
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
8.4
38.6
51
63
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
12.6
38.5
38
31
C09CA01
ATC
losartan; oral
2.2
38.5
418
2237
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.9
38.4
70
123
C09CA06
ATC
candesartan; oral
2.2
38.0
411
2193
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.4
37.7
99
239
B01AB10
ATC
tinzaparin; parenteral
2.8
37.4
214
850
M01AE01
ATC
ibuprofen; systemic, rectal
0.5
37.2
896
11011
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.4
37.1
305
1445
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
11.1
36.5
39
36
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
36.0
574
3543
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
82.4
36.0
40
5
N02AX02
ATC
tramadol; systemic, rectal
2.0
35.7
654
4242
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
35.6
217
890
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
35.5
460
2626
Z2221
NOMESCO Finland
Medical doctor
2.1
35.4
449
2541
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
35.3
333
1672
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.5
35.2
130
400
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
35.1
402
2185
N18
ICD-10 Finland
Chronic kidney disease
8.7
34.5
44
52
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
34.4
265
1215
C08CA03
ATC
isradipine; systemic
10.3
33.7
38
38
Q61.40
ICD-10 Finland
Renal dysplasia of a kidney (multicystic)
+∞
33.5
32
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
5.9
33.2
61
108
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
33.2
575
3629
Z31.5
ICD-10 Finland
Genetic counselling
3.5
33.2
122
374
ZXE00
NOMESCO Finland
One hour or less
2.0
33.1
599
3838
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.8
32.9
61
109
TQW99
NOMESCO Finland
Other minor procedure on skin
3.6
32.9
114
336
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
92.4
32.9
36
*
ZXA05
NOMESCO Finland
Left side
2.2
32.5
375
2036
RS222, ,
NOMESCO Finland
7.9
32.4
45
59
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
89.8
31.9
35
*
A10BH05
ATC
linagliptin; oral
3.6
31.5
108
316
JAF10
NOMESCO Finland
Repair of umbilical hernia
4.7
30.6
73
163
WX002
NOMESCO Finland
Sedation and analgesia
2.2
30.6
313
1614
EB1WA, ,
NOMESCO Finland
10.9
30.5
33
31
5AB14, ,
NOMESCO Finland
39.0
30.4
38
10
PBM09
NOMESCO Finland
Closure of arteriovenous fistula of brachial artery
+∞
30.3
29
*
C09BA02
ATC
enalapril and diuretics; systemic
3.1
30.1
138
483
Z3229
NOMESCO Finland
Other healthcare associate professional
2.9
30.0
157
592
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
3.4
29.6
113
354
602
Kela drug reimbursment
Children's severe malnutrition
10.9
29.6
32
30
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
9.9
29.5
34
35
L57.0
ICD-10 Finland
Actinic keratosis
2.6
28.4
183
767
WX892
NOMESCO Finland
Monitored bed care
2.9
28.4
149
562
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
6.9
28.2
44
66
XF602
NOMESCO Finland
Bloodpressure monitoring
7.4
28.1
41
57
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.9
28.0
142
526
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
8.2
27.8
37
46
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
11.4
27.6
29
26
ZXC50
NOMESCO Finland
Cryotherapy
4.5
27.6
68
156
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
4.5
27.4
69
161
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
8.1
27.3
37
47
Q61.48
ICD-10 Finland
Nonspecified renal dysplasia
+∞
27.2
26
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
9.6
27.1
32
34
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
24.4
27.1
38
16
XF612
NOMESCO Finland
Measurement of central venous pressure
63.4
27.0
31
5
H05BX02
ATC
paricalcitol; systemic
76.7
26.9
30
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
142.8
26.7
28
*
7151
FHL
Kidney transplantation
142.8
26.7
28
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.4
26.5
99
306
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
5.9
26.4
48
84
WW500
NOMESCO Finland
Blood transfusion
3.6
26.1
88
254
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.2
26.0
54
107
C10AA04
ATC
fluvastatin; oral
2.7
25.9
148
583
C03AA03
ATC
hydrochlorothiazide; oral
2.8
25.9
143
554
WX882
NOMESCO Finland
High dependency care
3.9
25.7
77
205
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.3
25.5
102
329
A02BC01
ATC
omeprazole; systemic
1.9
24.8
390
2333
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
21.7
24.8
36
17
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
7.6
24.7
35
47
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.5
24.7
87
259
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.9
24.3
121
443
JN4AD
NOMESCO Finland
Body CT examination
2.3
24.2
195
904
3008
Kela drug reimbursment
Tolvaptan
+∞
24.0
23
*
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
9.2
23.9
29
32
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
34.0
23.4
30
9
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
8.1
23.1
31
39
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
4.6
23.1
56
127
Q61.41
ICD-10 Finland
Renal dysplasia of both kidneys (multicystic)
+∞
23.0
22
*
5901A
ICD-9 Finland
Infections of kidney, Acute pyelonephritis
8.7
22.8
29
34
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
22.8
618
4349
C08CA10
ATC
nilvadipine; oral
5.3
22.8
46
89
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
22.6
172
776
JAF30
NOMESCO Finland
Repair of umbilical hernia using prosthetic material
4.6
22.6
54
121
XF600
NOMESCO Finland
Bloodpressure measurement
2.8
22.1
121
466
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
6.5
21.9
36
57
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
21.9
246
1302
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.5
21.8
143
603
RS221, ,
NOMESCO Finland
5.3
21.4
43
83
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
23.6
21.3
30
13
UJF32
NOMESCO Finland
Coloscopy
1.9
21.3
369
2262
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
21.2
107
394
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
21.1
544
3752
N04BC05
ATC
pramipexole; oral
2.6
21.0
127
514
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
20.8
262
1442
KH1AD
NOMESCO Finland
CT of urinary organs
3.5
20.7
74
222
212
Kela drug reimbursment
Gout
5.1
20.5
43
86
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
20.4
152
679
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
33.1
20.2
26
8
204
Kela drug reimbursment
Leukemia lymphatica
3.8
20.2
62
168
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
5.6
19.7
37
67
L04AA05
ATC
[U] tacrolimus
29.4
19.7
26
9
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.4
19.7
142
625
KA5AT
NOMESCO Finland
Puncture of kidney cyst with ultrasound guidance
106.6
19.6
21
*
SPAT1255
SPAT
Intravenous administration of medicine
2.7
19.6
108
417
R11
ICD-10 Finland
Nausea and vomiting
2.3
19.3
150
682
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
31.8
19.3
25
8
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
19.2
367
2309
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
7.6
19.1
27
36
I15.0
ICD-10 Finland
Renovascular hypertension
16.1
18.8
30
19
C07AB07
ATC
bisoprolol; oral
1.7
18.8
639
4704
Q61.90
ICD-10 Finland
Meckel-Gruber syndrome
+∞
18.8
18
*
M01AH05
ATC
etoricoxib; oral
0.6
18.4
499
6731
G04CA02
ATC
tamsulosin; oral
1.8
18.4
326
2001
J01DB01
ATC
cefalexin; oral
1.9
18.3
1140
9849
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
44.6
18.3
22
5
J01EA01
ATC
trimethoprim; systemic
1.8
18.1
334
2075
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
33.4
18.0
23
7
U70
ICPC
Pyelonephritis/pyelitis
5.6
18.0
34
62
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
17.6
173
865
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.5
17.6
43
98
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
5.2
17.5
36
71
K65.9
ICD-10 Finland
Peritonitis, unspecified
42.6
17.3
21
5
B01AB04
ATC
dalteparin; parenteral
2.9
17.2
82
293
J01CA04
ATC
amoxicillin; systemic
1.9
17.2
1137
9874
N30.0
ICD-10 Finland
Acute cystitis
1.9
17.1
240
1364
J01FF01
ATC
clindamycin; systemic
1.7
17.0
377
2461
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
7.6
17.0
24
32
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
2.5
16.9
107
442
M10
ICD-10 Finland
Gout
3.0
16.8
76
264
KAS40
NOMESCO Finland
Excision of transplanted kidney
+∞
16.7
16
*
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
12.9
16.7
29
23
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.7
16.6
53
148
A02BC02
ATC
pantoprazole; systemic
1.6
16.5
907
7430
B07.9
ICD-10 Finland
Verruca simplex
3.0
16.5
72
245
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
16.4
171
875
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.6
16.4
54
154
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
40.6
16.4
20
5
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
16.3
184
969
ZX108
NOMESCO Finland
Inhalation
6.6
16.2
26
40
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.3
16.2
124
559
E21.2
ICD-10 Finland
Other hyperparathyroidism
15.6
16.2
26
17
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
4.7
16.2
37
80
I77.0
ICD-10 Finland
Arteriovenous fistula, acquired
30.4
16.1
21
7
WW400
NOMESCO Finland
Plasmaferesis
48.1
16.0
19
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
21.2
16.0
23
11
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.4
16.0
110
473
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.0
15.9
45
115
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.3
15.9
60
187
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.2
15.8
64
208
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.5
15.7
38
86
K06.18
ICD-10 Finland
Another gingival hyperplasia
13.1
15.7
27
21
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.8
15.6
81
303
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.4
15.6
57
174
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.1
15.5
66
221
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
15.5
290
1800
N20.0
ICD-10 Finland
Calculus of kidney
3.8
15.3
46
123
V03AG01
ATC
sodium cellulose phosphate; systemic
45.5
15.1
18
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
6.3
15.0
25
40
C02DE10, ,
ATC
5.8
15.0
27
47
Z94.1
ICD-10 Finland
Heart transplant status
15.2
14.9
24
16
J01MA14
ATC
moxifloxacin; systemic
2.2
14.8
136
661
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
14.7
133
643
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
25.3
14.7
20
8
H02AB09
ATC
hydrocortisone; systemic
3.6
14.7
48
136
PC6DE, ,
NOMESCO Finland
+∞
14.6
14
*
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
+∞
14.6
14
*
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
12.0
14.6
26
22
RS321, ,
NOMESCO Finland
81.0
14.6
16
*
4AA09, ,
NOMESCO Finland
81.0
14.6
16
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
14.5
149
757
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.5
14.4
96
407
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
3.4
14.2
51
154
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
14.0
142
717
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
5.1
13.9
29
58
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
17.8
13.8
21
12
WZC30
NOMESCO Finland
Teaching
1.8
13.8
230
1374
C02DE02, ,
ATC
5.8
13.7
25
44
PA2AG
NOMESCO Finland
Restrected MRI examination of vessels in the head with high intensity magnet
12.2
13.6
24
20
G63.8*N18.8
ICD-10 Finland
Uraemic neuropathy
75.9
13.6
15
*
L01BB01, ,
ATC
75.9
13.6
15
*
Q62.7
ICD-10 Finland
Congenital vesico-uretero-renal reflux
+∞
13.6
13
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.6
13.6
77
302
D638, N189,
ICD-10 Finland
34.4
13.5
17
5
J01MA06
ATC
norfloxacin; oral
2.0
13.5
169
921
RJ411, ,
NOMESCO Finland
10.2
13.5
26
26
Q62.10
ICD-10 Finland
Congenital unilateral occlusion of the pelvic ureteral junction
141.4
13.5
14
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
4.3
13.4
34
80
B01AA03
ATC
warfarin; systemic
1.8
13.3
225
1351
KA3EB
NOMESCO Finland
Antegrade pyelography
14.0
13.3
22
16
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
13.2
373
2571
GD1UN
NOMESCO Finland
Lung circulation SPECT
12.3
13.1
23
19
C09AA01
ATC
captopril; oral
5.3
13.0
26
50
AA1AD
NOMESCO Finland
CT of head and brain
1.6
13.0
380
2640
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.6
12.9
401
2824
C02DE04, ,
ATC
4.1
12.9
35
87
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
4.8
12.6
28
59
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
15.6
12.6
20
13
D638, N180,
ICD-10 Finland
70.5
12.6
14
*
N15.1
ICD-10 Finland
Renal and perinephric abscess
32.3
12.6
16
5
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.7
12.5
39
107
C03XA01
ATC
tolvaptan; oral
+∞
12.5
12
*
U99
ICPC
Urinary disease other
6.3
12.5
21
34
N15.9
ICD-10 Finland
Renal tubulo-interstitial disease, unspecified
131.2
12.5
13
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
5.7
12.4
23
41
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.9
12.4
59
211
L82
ICD-10 Finland
Seborrhoeic keratosis
1.7
12.3
250
1579
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.9
12.2
58
207
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
12.2
978
8417
I51.1
ICD-10 Finland
Rupture of chordae tendineae, not elsewhere classified
37.9
12.2
15
*
40399
ICD-8 Finland
Hypertensive renal disease
37.9
12.2
15
*
1530
FHL
Urethrocystoscopy
4.4
12.2
30
69
B01AC04
ATC
clopidogrel; oral
1.8
12.1
214
1298
M01AC06
ATC
meloxicam; systemic, rectal
0.6
12.1
215
3337
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
12.1
550
4204
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
12.0
129
666
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
13.5
12.0
20
15
RJ425, ,
NOMESCO Finland
47.1
11.9
14
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
4.1
11.9
32
79
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
5.9
11.8
21
36
C02LM02, ,
ATC
5.2
11.8
24
47
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.5
11.7
28
63
M10.0
ICD-10 Finland
Idiopathic gout
2.8
11.7
57
207
KB1BG
NOMESCO Finland
MRI examination of urinary tract with high intensity magnet
65.5
11.6
13
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
19.1
11.6
17
9
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
8.7
11.5
24
28
Q60.2
ICD-10 Finland
Renal agenesis, unspecified
+∞
11.5
11
*
Q62.2
ICD-10 Finland
Congenital megaloureter
+∞
11.5
11
*
T82.4
ICD-10 Finland
Mechanical complication of vascular dialysis catheter
+∞
11.5
11
*
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
3.5
11.4
39
114
5850B
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]
121.0
11.4
12
*
KA2DE, ,
NOMESCO Finland
121.0
11.4
12
*
C08DB01
ATC
diltiazem; oral
2.6
11.4
67
268
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
11.4
95
445
R60.0
ICD-10 Finland
Localized oedema
1.8
11.3
168
966
N02BE01
ATC
paracetamol; systemic, rectal
1.7
11.3
1185
10751
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
17.2
11.2
17
10
L04AA10
ATC
[U] sirolimus
25.2
11.1
15
6
XX3ZW, ,
NOMESCO Finland
25.2
11.1
15
6
JAD10
NOMESCO Finland
Repair of incisional hernia
8.6
11.0
23
27
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
10.1
11.0
21
21
PB1AE
NOMESCO Finland
Ultrasound examination of arteries of upper extremity
43.7
10.9
13
*
DHB00
NOMESCO Finland
Excision of lesion of external nose
5.5
10.9
21
39
K05.31
ICD-10 Finland
Periodontitis pronounced
1.8
10.8
157
896
GD2SN
NOMESCO Finland
Lung ventilation SPECT
8.3
10.8
23
28
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.9
10.8
144
801
C07AG01
ATC
labetalol; systemic
4.8
10.7
24
51
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
28.3
10.7
14
5
C10AA01
ATC
simvastatin; oral
1.5
10.7
494
3762
ZX197, ,
NOMESCO Finland
21.6
10.7
15
7
K05.30
ICD-10 Finland
Periodontitis complex
1.7
10.7
205
1272
59321
ICD-8 Finland
Other diseases of kidney and ureter, Cysta (cystis) renis (non congenita)
60.5
10.6
12
*
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
5.1
10.5
22
44
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.1
10.5
43
141
RJ420, ,
NOMESCO Finland
10.1
10.5
20
20
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
4.9
10.5
23
48
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.1
10.4
28
69
WX199
NOMESCO Finland
Other local analgesia
2.8
10.4
52
191
RJ530, ,
NOMESCO Finland
110.8
10.4
11
*
NFA20
NOMESCO Finland
Exploration of hip joint or femur
110.8
10.4
11
*
C02DB01
ATC
dihydralazine; systemic
+∞
10.4
10
*
KAS96
NOMESCO Finland
Other transplantation of kidney or related procedure
+∞
10.4
10
*
Q64.2
ICD-10 Finland
Congenital posterior urethral valves
+∞
10.4
10
*
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
3.9
10.4
30
78
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.6
10.4
34
97
N28.8
ICD-10 Finland
Other specified disorders of kidney and ureter
16.2
10.4
16
10
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
10.3
96
469
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.8
10.3
52
192
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
5.2
10.3
21
41
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
5.2
10.3
21
41
C09CA03
ATC
valsartan; oral
1.9
10.3
127
688
Y83.0
ICD-10 Finland
Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
18.9
10.3
15
8
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.8
10.2
175
1050
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
10.2
143
808
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
13.2
10.2
17
13
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.5
10.1
65
271
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.3
10.1
75
334
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
10.1
296
2040
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.7
10.1
222
1427
40199
ICD-8 Finland
Essential benign hypertension
4.0
10.1
28
71
C10AX09
ATC
ezetimibe; oral
1.7
10.0
226
1461
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.6
10.0
59
236
J01CA08
ATC
pivmecillinam; oral
1.5
9.9
460
3494
C10AA03
ATC
pravastatin; oral
2.1
9.9
95
470
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
20.2
9.8
14
7
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
4.9
9.8
21
43
K83.0
ICD-10 Finland
Cholangitis
4.0
9.8
27
68
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
4.6
9.8
23
51
XFE00
NOMESCO Finland
Epicardial ultrasonography
3.5
9.8
33
96
N43.3
ICD-10 Finland
Hydrocele, unspecified
3.3
9.8
37
116
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
9.8
214
1374
KC1JB
NOMESCO Finland
Miktiocystography with X-ray
55.4
9.7
11
*
A05AA02
ATC
ursodeoxycholic acid; oral
3.7
9.6
30
83
M05BA04
ATC
alendronic acid; oral
2.0
9.6
101
518
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
3.6
9.5
31
88
TPX15
NOMESCO Finland
Removal of vascular injection port
10.1
9.5
18
18
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.4
9.5
64
273
C09CA07
ATC
telmisartan; oral
2.0
9.5
98
499
N20.1
ICD-10 Finland
Calculus of ureter
2.5
9.5
58
237
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
100.7
9.4
10
*
TJA30
NOMESCO Finland
Peritoneal dialysis
100.7
9.4
10
*
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.6
9.4
30
84
Q62.0
ICD-10 Finland
Congenital hydronephrosis
+∞
9.4
9
*
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
+∞
9.4
9
*
PG5ST
NOMESCO Finland
Endovascular thrombolysis of arterio-venous shunt for dialysis with radiological guidance
+∞
9.4
9
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.4
9.3
33
99
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
4.0
9.3
26
66
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
7.0
9.3
22
32
R10.0
ICD-10 Finland
Acute abdomen
2.8
9.3
47
174
XQ848
NOMESCO Finland
Dermatological photography
2.7
9.3
48
180
N18.2
ICD-10 Finland
Chronic kidney disease, stage 2
9.6
9.3
18
19
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
3.9
9.3
27
71
XKD00
NOMESCO Finland
Uroflowmetry
1.7
9.2
190
1199
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
9.2
85
415
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.4
9.2
60
253
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.9
9.2
26
67
TQW80
NOMESCO Finland
Local dermatologic skincare
3.0
9.1
40
137
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.0
9.1
94
478
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
2.1
9.1
86
423
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
9.1
176
1092
ZXC20
NOMESCO Finland
Use of chemical agents
3.5
9.1
31
91
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
8.4
9.1
19
23
SDA03
NOMESCO Finland
Periodontal treatment
1.4
9.0
522
4116
K65.8
ICD-10 Finland
Other peritonitis
15.7
9.0
14
9
A12AA06
ATC
calcium lactate gluconate; oral
36.9
9.0
11
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.9
8.9
42
150
UJK02
NOMESCO Finland
ERCP
3.0
8.9
39
134
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
6.9
8.8
21
31
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.0
8.8
102
540
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
4.7
8.8
20
43
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.2
8.8
35
113
A03
ICPC
Fever
1.6
8.8
237
1597
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.4
8.8
62
270
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.7
8.8
45
168
M01AB05
ATC
diclofenac; systemic, rectal
0.7
8.8
592
7097
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
9.5
8.8
17
18
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
8.8
236
1591
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.6
8.7
255
1751
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
3.7
8.7
27
74
I50.1
ICD-10 Finland
Left ventricular failure
2.3
8.7
66
297
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
8.7
692
5760
RJ412, ,
NOMESCO Finland
14.1
8.7
14
10
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.1
8.7
86
431
B05D
ATC
PERITONEAL DIALYTICS
50.3
8.7
10
*
5602
FHL
Internal fistula (eg Cimino)
50.3
8.7
10
*
ED1AA
NOMESCO Finland
Mandibular X-ray examination
6.6
8.7
21
32
E87.5
ICD-10 Finland
Hyperkalaemia
3.4
8.7
30
89
HA1AA
NOMESCO Finland
X-ray mammography
2.0
8.6
98
516
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
4.8
8.6
19
40
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
3.7
8.6
27
75
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.0
8.6
92
475
JX1XB
NOMESCO Finland
Other X-ray examination of alimentary tract with contrast
20.2
8.5
12
6
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.7
8.5
43
160
B03XA05
ATC
roxadustat; oral
90.6
8.4
9
*
4059B
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]
90.6
8.4
9
*
5850A
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA SINE URAEMIA]
90.6
8.4
9
*
K03.64
ICD-10 Finland
Dental calculus supragingival
1.4
8.4
431
3316
XF402
NOMESCO Finland
ECG with work load test
1.8
8.4
132
773
Q60.4
ICD-10 Finland
Renal hypoplasia, bilateral
+∞
8.3
8
*
Q63.1
ICD-10 Finland
Lobulated, fused and horseshoe kidney
+∞
8.3
8
*
PA2AM
NOMESCO Finland
Simple MRI examination of vessels in the head with 3 Tesla magnet
+∞
8.3
8
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
8.3
288
2052
N17.8
ICD-10 Finland
Other acute renal failure
4.1
8.3
22
54
NHQ40
NOMESCO Finland
Amputation of toe
3.6
8.3
27
77
C10AA07
ATC
rosuvastatin; oral
0.6
8.3
226
3216
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.5
8.2
28
82
C07AB03
ATC
atenolol; systemic
2.1
8.2
73
351
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
8.2
87
447
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
8.2
231
1572
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
4.4
8.2
20
46
C09AA03
ATC
lisinopril; oral
2.3
8.1
60
268
BBA50
NOMESCO Finland
Total parathyroidectomy
33.6
8.1
10
*
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.7
8.0
164
1032
ZXA10
NOMESCO Finland
Bilateral
1.6
8.0
223
1513
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.8
8.0
126
737
-, ,
ICD-10 Finland
3.0
8.0
35
120
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
3.9
8.0
23
60
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
3.9
8.0
23
60
C07FB02
ATC
metoprolol and felodipine; systemic
2.8
7.9
38
137
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
7.9
82
418
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
4.5
7.9
19
43
S37.0
ICD-10 Finland
Injury of kidney
13.1
7.9
13
10
NF1AA
NOMESCO Finland
Hip X-ray examination
1.8
7.9
113
643
4019X
ICD-9 Finland
Essential hypertension, Unspecified
3.0
7.8
34
116
N13.0
ICD-10 Finland
Hydronephrosis with ureteropelvic junction obstruction
8.5
7.8
16
19
KA1AE, ,
SPAT
10.9
7.8
14
13
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
10.9
7.8
14
13
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.7
7.8
40
150
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.1
7.7
31
101
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
6.4
7.7
19
30
SPAT1164
SPAT
Haemodialysis
45.2
7.7
9
*
RJ129, ,
NOMESCO Finland
45.2
7.7
9
*
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
3.2
7.7
30
96
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
7.7
71
347
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.0
7.7
33
112
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
7.7
371
2817
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
4.0
7.6
21
53
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
18.5
7.6
11
6
D638, N188,
ICD-10 Finland
25.2
7.6
10
*
K06.10
ICD-10 Finland
Gingival fibromatosis
25.2
7.6
10
*
RJ120, ,
NOMESCO Finland
25.2
7.6
10
*
ZX100
NOMESCO Finland
Oral
3.5
7.6
25
72
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
8.9
7.5
15
17
E0000UV, ,
ATC
1.4
7.5
520
4197
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
2.6
7.5
42
165
6123
FHL
Radical surgery
2.5
7.5
44
177
XX1VW
NOMESCO Finland
Written report from radiologist
4.4
7.4
18
41
H26.02
ICD-10 Finland
Presenil cataract
2.7
7.4
39
148
PBL11
NOMESCO Finland
Construction of arteriovenous fistula from ulnar artery
80.5
7.4
8
*
KA6KT
NOMESCO Finland
Sclerotherapy of kidney cyst
80.5
7.4
8
*
JAH00
NOMESCO Finland
Laparotomy
2.5
7.4
43
172
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.5
7.4
43
172
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.0
7.3
73
367
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.1
7.3
30
99
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
2.7
7.3
39
149
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
8.4
7.3
15
18
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.5
7.3
44
179
TK822
NOMESCO Finland
Assessment of adequacy of peritoneal dialysis
+∞
7.3
7
*
PB1BT
NOMESCO Finland
Extensive upper extremity artery PTA
+∞
7.3
7
*
PBU99
NOMESCO Finland
Other repair after previous reconstruction of arteries of upper extremity
+∞
7.3
7
*
Q61.4
ICD-10 Finland
Renal dysplasia
+∞
7.3
7
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
7.3
535
4354
N03AX16
ATC
[U] pregabalin
1.5
7.3
269
1938
J34.1
ICD-10 Finland
Cyst and mucocele of nose and nasal sinus
3.3
7.3
26
79
C07AB05
ATC
betaxolol; oral
2.8
7.2
34
122
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
7.2
125
754
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
30.2
7.2
9
*
59010
ICD-8 Finland
Infections of kidney, Pyelonephritis
3.4
7.1
25
75
I15.8
ICD-10 Finland
Other secondary hypertension
8.0
7.1
15
19
H26.2
ICD-10 Finland
Complicated cataract
3.6
7.0
22
61
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
10.1
7.0
13
13
P01AB01
ATC
metronidazole; oral, rectal
1.4
7.0
476
3818
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
3.2
7.0
27
86
SDA05
NOMESCO Finland
Very demanding periodontal treatment
1.8
7.0
98
555
X57
ICD-10 Finland
Unspecified privation
2.7
6.9
36
136
WX213
NOMESCO Finland
Lower leg blockade
5.5
6.9
19
35
N05CF01
ATC
zopiclone; oral
1.4
6.9
374
2888
A10BH02
ATC
vildagliptin; oral
3.1
6.9
28
92
ZQZ00
NOMESCO Finland
Treatment of several skin areas
7.6
6.9
15
20
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
4.0
6.9
19
48
Z01.2
ICD-10 Finland
Dental examination
1.4
6.8
603
5036
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
3.0
6.8
29
98
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
8.3
6.8
14
17
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
3.8
6.8
20
53
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
6.7
6.8
16
24
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.7
6.8
35
132
PBC09
NOMESCO Finland
Suture of brachial artery
40.3
6.8
8
*
A02BA02
ATC
ranitidine; systemic
1.5
6.8
216
1509
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
16.8
6.7
10
6
O35.2
ICD-10 Finland
Maternal care for (suspected) hereditary disease in fetus
16.8
6.7
10
6
RJ511, ,
NOMESCO Finland
16.8
6.7
10
6
K02.9
ICD-10 Finland
Dental caries, unspecified
2.9
6.7
31
110
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
3.4
6.7
23
68
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
3.3
6.7
24
73
A46
ICD-10 Finland
Erysipelas
1.6
6.7
175
1169
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
2.0
6.7
68
345
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
6.7
111
660
PB1AT
NOMESCO Finland
Upper extremity artery PTA
22.6
6.7
9
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
6.7
249
1795
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
6.6
155
1008
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.7
6.6
20
54
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
6.6
265
1935
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
6.6
122
747
KA1FN
NOMESCO Finland
Isotope renography
5.9
6.6
17
29
PEN23
NOMESCO Finland
Plastic repair of femoral artery
5.9
6.6
17
29
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.8
6.6
98
564
C03BA11
ATC
indapamide; oral
2.7
6.6
35
134
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.5
6.6
22
64
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
3.8
6.5
19
50
C09DA01
ATC
losartan and diuretics; oral
1.7
6.5
126
781
EBA10
NOMESCO Finland
Operative extraction of tooth
1.6
6.5
173
1160
S18
ICPC
Laceration/cut
1.3
6.5
593
4966
H25.1
ICD-10 Finland
Senile nuclear cataract
1.4
6.5
288
2145
H01AC01
ATC
somatropin; parenteral
5.4
6.5
18
34
WX872
NOMESCO Finland
Intensive care
2.0
6.5
65
329
D638, N185,
ICD-10 Finland
70.2
6.4
7
*
7155
FHL
Exploration of the graft
70.2
6.4
7
*
KAS61
NOMESCO Finland
Percutaneous endoscopic operation for lymphocele of transplanted kidney
70.2
6.4
7
*
AB18W, ,
NOMESCO Finland
70.2
6.4
7
*
ZY010
NOMESCO Finland
Hospital outpatient
1.9
6.4
73
386
C09DA07
ATC
telmisartan and diuretics; oral
2.2
6.4
50
229
58209
ICD-8 Finland
Chronic nephritis, Unspecified
14.4
6.4
10
7
C02CB01, ,
ATC
14.4
6.4
10
7
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
14.4
6.4
10
7
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
14.4
6.4
10
7
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
14.4
6.4
10
7
XW000
NOMESCO Finland
Bone marrow biopsy
2.2
6.4
53
249
I50.0
ICD-10 Finland
Congestive heart failure
1.9
6.3
80
438
J01XX08
ATC
linezolid; systemic
6.0
6.3
16
27
C07AB04
ATC
acebutolol; systemic
3.5
6.3
21
61
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
6.3
181
1236
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
18.1
6.3
9
5
N92.4
ICD-10 Finland
Excessive bleeding in the premenopausal period
2.4
6.3
41
174
Q63.9
ICD-10 Finland
Congenital malformation of kidney, unspecified
+∞
6.3
6
*
Q60.0
ICD-10 Finland
Renal agenesis, unilateral
+∞
6.3
6
*
TKA05
NOMESCO Finland
Aspiration cytology of kidney
+∞
6.3
6
*
PBU81
NOMESCO Finland
Thrombectomy in arteriovenous fistula from artery of upper extremity
+∞
6.3
6
*
Q60.3
ICD-10 Finland
Renal hypoplasia, unilateral
+∞
6.3
6
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.0
6.2
66
340
T92
ICPC
Gout
2.8
6.2
30
109
JA3FT
NOMESCO Finland
Exchange abdominal catheter with radiological guidance
26.8
6.2
8
*
D64.8
ICD-10 Finland
Other specified anaemias
2.9
6.2
28
98
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
2.2
6.2
50
232
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.6
6.2
143
927
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.7
6.2
19
52
WX730
NOMESCO Finland
Conventional respirator
3.2
6.2
23
72
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
6.2
133
849
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
3.3
6.1
22
67
RJ421, ,
NOMESCO Finland
7.7
6.1
13
17
A28
ICPC
Limited function/disability NOS
1.5
6.1
201
1411
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
6.1
489
4006
M25.0
ICD-10 Finland
Haemarthrosis
4.1
6.1
16
39
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.6
6.1
153
1013
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.5
6.1
187
1295
J01CF02
ATC
cloxacillin; systemic
2.8
6.1
29
105
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
6.1
93
541
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
6.0
139
2070
2161
FHL
Neck ligation, big brain
10.1
6.0
11
11
SCD02
NOMESCO Finland
Removal of biofilm and/or supragingival calculus
5.2
6.0
17
33
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
3.3
6.0
22
68
ZXC15
NOMESCO Finland
Use of photodynamic technique
3.4
6.0
21
63

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Nephrology
39 [38004479]
2.7e+00
3.2e+00
3.2e+00
6.5e+00
4.0e+00
4.5e+00
4.5e+00
cases:7.81%
controls:0.58%
cases:9.54%
controls:0.44%
cases:4.84%
controls:0.21%
cases:26.12%
controls:0.05%
cases:10.45%
controls:0.22%
cases:28.59%
controls:0.46%
cases:41.65%
controls:0.82%
103
77
1216
13087
126
58
1195
13121
64
28
1257
13151
345
7
976
13172
137
29
1174
13136
366
59
914
12807
484
95
678
11540
alfacalcidol; oral, parenteral
A11CC03 [21600818]
3.0e+00
3.0e+00
3.4e+00
1.0e+50
4.0e+00
3.9e+00
4.6e+00
cases:4.70%
controls:0.24%
cases:4.39%
controls:0.24%
cases:1.29%
controls:0.05%
cases:0.53%
controls:0.00%
cases:1.98%
controls:0.04%
cases:9.14%
controls:0.20%
cases:19.54%
controls:0.23%
62
32
1257
13132
58
31
1263
13148
17
6
1304
13173
7
0
1314
13179
26
5
1285
13160
117
26
1163
12840
227
27
935
11608
calcium carbonate
A02AC01 [21600065]
3.1e+00
3.3e+00
3.4e+00
—
3.6e+00
4.2e+00
4.1e+00
cases:4.47%
controls:0.21%
cases:4.54%
controls:0.18%
cases:1.29%
controls:0.05%
—
—
cases:1.60%
controls:0.05%
cases:7.50%
controls:0.12%
cases:15.23%
controls:0.30%
59
28
1260
13136
60
24
1261
13155
17
6
1304
13173
—
21
6
1290
13159
96
16
1184
12850
177
35
985
11600
calcium carbonate; oral
A12AA04 [21600863]
3.1e+00
3.3e+00
3.4e+00
—
3.6e+00
4.2e+00
4.1e+00
cases:4.47%
controls:0.21%
cases:4.54%
controls:0.18%
cases:1.29%
controls:0.05%
—
—
cases:1.60%
controls:0.05%
cases:7.50%
controls:0.12%
cases:15.23%
controls:0.30%
59
28
1260
13136
60
24
1261
13155
17
6
1304
13173
—
21
6
1290
13159
96
16
1184
12850
177
35
985
11600
Kidney transplant status
Z94.0 [45566477]
2.8e+00
2.8e+00
2.8e+00
1.0e+50
2.4e+00
3.6e+00
4.5e+00
cases:1.59%
controls:0.10%
cases:1.67%
controls:0.10%
cases:0.83%
controls:0.05%
cases:1.44%
controls:0.00%
cases:0.76%
controls:0.07%
cases:4.30%
controls:0.12%
cases:13.94%
controls:0.17%
21
13
1298
13151
22
13
1299
13166
11
7
1310
13172
19
0
1302
13179
10
9
1301
13156
55
15
1225
12851
162
20
1000
11615
Chronic kidney disease, unspecified
N18.9 [45553438]
2.5e+00
3.0e+00
2.8e+00
—
3.3e+00
3.2e+00
3.4e+00
cases:4.62%
controls:0.40%
cases:5.15%
controls:0.27%
cases:1.82%
controls:0.11%
—
—
cases:2.36%
controls:0.09%
cases:5.70%
controls:0.24%
cases:14.29%
controls:0.55%
61
53
1258
13111
68
35
1253
13144
24
15
1297
13164
—
31
12
1280
13153
73
31
1207
12835
166
64
996
11571
ciclosporin; oral, parenteral
L04AD01 [21603924]
2.4e+00
2.9e+00
2.5e+00
—
2.9e+00
3.2e+00
3.9e+00
cases:2.43%
controls:0.22%
cases:2.57%
controls:0.15%
cases:1.14%
controls:0.09%
—
—
cases:1.22%
controls:0.07%
cases:4.45%
controls:0.19%
cases:10.41%
controls:0.23%
32
29
1287
13135
34
20
1287
13159
15
12
1306
13167
—
16
9
1295
13156
57
25
1223
12841
121
27
1041
11608
darbepoetin alfa; parenteral
B03XA02 [21601134]
3.2e+00
3.5e+00
—
—
2.6e+00
3.3e+00
4.3e+00
cases:2.43%
controls:0.10%
cases:2.80%
controls:0.08%
—
—
—
—
cases:0.84%
controls:0.06%
cases:3.13%
controls:0.12%
cases:7.57%
controls:0.11%
32
13
1287
13151
37
11
1284
13168
—
—
11
8
1300
13157
40
16
1240
12850
88
13
1074
11622
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
3.4e+00
3.6e+00
1.0e+50
—
—
4.3e+00
4.8e+00
cases:3.94%
controls:0.14%
cases:4.16%
controls:0.11%
cases:0.38%
controls:0.00%
—
—
—
—
cases:6.33%
controls:0.09%
cases:17.56%
controls:0.17%
52
18
1267
13146
55
15
1266
13164
5
0
1316
13179
—
—
81
12
1199
12854
204
20
958
11615
Hypertension secondary to other renal disorders
I15.1 [45557535]
3.0e+00
2.8e+00
—
—
—
5.1e+00
4.7e+00
cases:1.52%
controls:0.08%
cases:0.83%
controls:0.05%
—
—
—
—
—
—
cases:6.88%
controls:0.05%
cases:11.27%
controls:0.11%
20
10
1299
13154
11
7
1310
13172
—
—
—
88
6
1192
12860
131
13
1031
11622
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
1.2e+00
1.7e+00
3.9e+00
—
2.9e+00
2.9e+00
2.7e+00
cases:2.65%
controls:0.81%
cases:3.10%
controls:0.59%
cases:4.69%
controls:0.10%
—
—
cases:0.84%
controls:0.05%
cases:7.03%
controls:0.44%
cases:15.15%
controls:1.13%
35
107
1284
13057
41
78
1280
13101
62
13
1259
13166
—
11
6
1300
13159
90
56
1190
12810
176
132
986
11503
Hemodialysis
TK800 [2001305768]
2.6e+00
4.0e+00
—
—
—
3.9e+00
4.6e+00
cases:1.36%
controls:0.11%
cases:2.12%
controls:0.04%
—
—
—
—
—
—
cases:3.75%
controls:0.08%
cases:10.24%
controls:0.11%
18
14
1301
13150
28
5
1293
13174
—
—
—
48
10
1232
12856
119
13
1043
11622
AZATHIOPRINE - yes
AZATHIOPRINE-1 [2002330220]
3.5e+00
3.4e+00
—
—
—
3.6e+00
4.5e+00
cases:1.82%
controls:0.05%
cases:1.51%
controls:0.05%
—
—
—
—
—
—
cases:2.03%
controls:0.05%
cases:4.56%
controls:0.05%
24
7
1295
13157
20
7
1301
13172
—
—
—
26
7
1254
12859
53
6
1109
11629
Internal Medicine
11 [38004456]
4.5e-01
9.0e-01
1.5e+00
6.9e+00
2.0e+00
1.9e+00
1.4e+00
cases:26.16%
controls:18.37%
cases:17.41%
controls:7.91%
cases:5.53%
controls:1.31%
cases:31.87%
controls:0.05%
cases:9.15%
controls:1.33%
cases:34.92%
controls:7.59%
cases:50.34%
controls:19.88%
345
2418
974
10746
230
1042
1091
12137
73
173
1248
13006
421
6
900
13173
120
175
1191
12990
447
976
833
11890
585
2313
577
9322
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E11.2 [2000503133]
2.5e+00
2.5e+00
3.1e+00
—
2.2e+00
2.4e+00
2.4e+00
cases:1.06%
controls:0.09%
cases:0.98%
controls:0.08%
cases:0.83%
controls:0.04%
—
—
cases:0.46%
controls:0.05%
cases:1.25%
controls:0.12%
cases:1.89%
controls:0.18%
14
12
1305
13152
13
11
1308
13168
11
5
1310
13174
—
6
7
1305
13158
16
15
1264
12851
22
21
1140
11614
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
9.4e-01
1.9e+00
3.7e+00
1.0e+50
2.5e+00
2.9e+00
2.8e+00
cases:2.35%
controls:0.93%
cases:3.33%
controls:0.53%
cases:5.00%
controls:0.13%
cases:0.45%
controls:0.00%
cases:1.68%
controls:0.14%
cases:8.44%
controls:0.51%
cases:17.64%
controls:1.27%
31
123
1288
13041
44
70
1277
13109
66
17
1255
13162
6
0
1315
13179
22
18
1289
13147
108
66
1172
12800
205
148
957
11487
erythropoietin; parenteral
B03XA01 [21601133]
3.4e+00
3.5e+00
—
—
—
3.7e+00
4.0e+00
cases:1.74%
controls:0.06%
cases:1.89%
controls:0.06%
—
—
—
—
—
—
cases:2.66%
controls:0.07%
cases:5.42%
controls:0.10%
23
8
1296
13156
25
8
1296
13171
—
—
—
34
9
1246
12857
63
12
1099
11623
Unspecified kidney failure
N19 [45601718]
2.8e+00
3.1e+00
3.0e+00
—
—
3.4e+00
2.2e+00
cases:1.14%
controls:0.07%
cases:1.14%
controls:0.05%
cases:0.76%
controls:0.04%
—
—
—
—
cases:1.80%
controls:0.06%
cases:2.24%
controls:0.25%
15
9
1304
13155
15
7
1306
13172
10
5
1311
13174
—
—
23
8
1257
12858
26
29
1136
11606
prazosin; oral
C02CA01 [21600411]
2.3e+00
2.5e+00
—
—
3.2e+00
3.2e+00
3.0e+00
cases:2.12%
controls:0.22%
cases:1.51%
controls:0.12%
—
—
—
—
cases:0.92%
controls:0.04%
cases:2.42%
controls:0.10%
cases:4.65%
controls:0.24%
28
29
1291
13135
20
16
1301
13163
—
—
12
5
1299
13160
31
13
1249
12853
54
28
1108
11607
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
8.4e-01
1.9e+00
3.8e+00
1.0e+50
2.3e+00
2.6e+00
2.5e+00
cases:3.34%
controls:1.47%
cases:5.15%
controls:0.82%
cases:6.66%
controls:0.15%
cases:0.38%
controls:0.00%
cases:1.60%
controls:0.17%
cases:10.23%
controls:0.82%
cases:19.97%
controls:1.96%
44
193
1275
12971
68
108
1253
13071
88
20
1233
13159
5
0
1316
13179
21
22
1290
13143
131
106
1149
12760
232
228
930
11407
Other chronic renal failure
N18.8 [45534123]
2.2e+00
2.7e+00
—
1.0e+50
—
3.6e+00
3.7e+00
cases:1.52%
controls:0.17%
cases:1.82%
controls:0.13%
—
—
cases:1.82%
controls:0.00%
—
—
cases:4.14%
controls:0.12%
cases:9.04%
controls:0.25%
20
22
1299
13142
24
17
1297
13162
—
24
0
1297
13179
—
53
15
1227
12851
105
29
1057
11606
methylprednisolone; oral, parenteral
H02AB04 [21602732]
1.0e+00
1.6e+00
2.4e+00
—
2.4e+00
2.4e+00
2.4e+00
cases:4.70%
controls:1.75%
cases:3.48%
controls:0.74%
cases:0.76%
controls:0.07%
—
—
cases:1.14%
controls:0.11%
cases:5.47%
controls:0.54%
cases:14.37%
controls:1.56%
62
230
1257
12934
46
97
1275
13082
10
9
1311
13170
—
15
14
1296
13151
70
70
1210
12796
167
182
995
11453
Outpatient Visit
OP [9202]
3.7e-01
5.9e-01
8.5e-01
5.6e+00
1.3e+00
1.5e+00
1.6e+00
cases:67.02%
controls:58.38%
cases:54.66%
controls:40.09%
cases:18.93%
controls:9.08%
cases:56.02%
controls:0.46%
cases:25.78%
controls:8.74%
cases:76.09%
controls:41.22%
cases:92.51%
controls:70.72%
884
7685
435
5479
722
5283
599
7896
250
1197
1071
11982
740
61
581
13118
338
1151
973
12014
974
5303
306
7563
1075
8228
87
3407
Kidney ultrasound examination
KA1AE [2001305627]
2.1e+00
2.5e+00
—
1.0e+50
1.0e+50
3.2e+00
4.0e+00
cases:1.21%
controls:0.14%
cases:0.45%
controls:0.04%
—
—
cases:1.29%
controls:0.00%
cases:0.38%
controls:0.00%
cases:1.17%
controls:0.05%
cases:4.39%
controls:0.09%
16
19
1303
13145
6
5
1315
13174
—
17
0
1304
13179
5
0
1306
13165
15
6
1265
12860
51
10
1111
11625
Extracorporeal dialysis
Z49.1 [45537649]
3.5e+00
—
—
—
—
3.8e+00
4.5e+00
cases:1.29%
controls:0.04%
—
—
—
—
—
—
—
—
cases:2.03%
controls:0.05%
cases:7.75%
controls:0.09%
17
5
1302
13159
—
—
—
—
26
6
1254
12860
90
11
1072
11624
Gas panel - Venous blood
24339-4 [3000991]
1.5e-01
1.3e+00
3.0e+00
1.0e+50
3.1e+00
2.2e+00
2.2e+00
cases:0.99%
controls:0.85%
cases:1.89%
controls:0.53%
cases:1.21%
controls:0.06%
cases:0.61%
controls:0.00%
cases:0.84%
controls:0.04%
cases:3.44%
controls:0.41%
cases:8.86%
controls:1.12%
13
112
1306
13052
25
70
1296
13109
16
8
1305
13171
8
0
1313
13179
11
5
1300
13160
44
53
1236
12813
103
130
1059
11505
Construction of arteriovenous fistula from radial artery
PBL10 [2001308892]
2.9e+00
—
—
1.0e+50
1.0e+50
4.2e+00
4.6e+00
cases:1.06%
controls:0.06%
—
—
—
—
cases:0.45%
controls:0.00%
cases:0.38%
controls:0.00%
cases:2.42%
controls:0.04%
cases:6.45%
controls:0.07%
14
8
1305
13156
—
—
6
0
1315
13179
5
0
1306
13165
31
5
1249
12861
75
8
1087
11627
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
1.9e-01
1.2e+00
3.6e+00
—
2.5e+00
2.3e+00
1.8e+00
cases:0.76%
controls:0.63%
cases:1.06%
controls:0.32%
cases:1.36%
controls:0.04%
—
—
cases:0.76%
controls:0.06%
cases:2.66%
controls:0.26%
cases:5.85%
controls:1.03%
10
83
1309
13081
14
42
1307
13137
18
5
1303
13174
—
10
8
1301
13157
34
34
1246
12832
68
120
1094
11515
End-stage renal disease
N18.0 [45601717]
3.4e+00
3.7e+00
1.0e+50
1.0e+50
1.0e+50
—
4.3e+00
cases:1.74%
controls:0.06%
cases:1.82%
controls:0.05%
cases:0.53%
controls:0.00%
cases:0.53%
controls:0.00%
cases:0.69%
controls:0.00%
—
—
cases:6.20%
controls:0.09%
23
8
1296
13156
24
6
1297
13173
7
0
1314
13179
7
0
1314
13179
9
0
1302
13165
—
72
10
1090
11625
pH of Capillary blood
2745-8 [3009343]
1.9e-01
1.1e+00
3.5e+00
—
2.5e+00
2.3e+00
1.8e+00
cases:0.76%
controls:0.63%
cases:0.98%
controls:0.32%
cases:1.29%
controls:0.04%
—
—
cases:0.76%
controls:0.06%
cases:2.50%
controls:0.26%
cases:5.77%
controls:1.01%
10
83
1309
13081
13
42
1308
13137
17
5
1304
13174
—
10
8
1301
13157
32
34
1248
12832
67
118
1095
11517
moxonidine; oral
C02AC05 [21600401]
1.7e+00
1.8e+00
1.6e+00
—
1.9e+00
2.0e+00
2.1e+00
cases:2.43%
controls:0.45%
cases:1.97%
controls:0.34%
cases:0.68%
controls:0.14%
—
—
cases:0.69%
controls:0.10%
cases:2.42%
controls:0.33%
cases:4.82%
controls:0.60%
32
59
1287
13105
26
45
1295
13134
9
19
1312
13160
—
9
13
1302
13152
31
42
1249
12824
56
70
1106
11565
Essential (primary) hypertension
I10 [45591453]
7.0e-01
8.6e-01
1.2e+00
4.9e+00
1.3e+00
1.2e+00
9.3e-01
cases:19.79%
controls:10.90%
cases:12.87%
controls:5.88%
cases:3.10%
controls:0.96%
cases:10.67%
controls:0.09%
cases:3.74%
controls:1.04%
cases:17.66%
controls:6.16%
cases:32.01%
controls:15.70%
261
1435
1058
11729
170
775
1151
12404
41
126
1280
13053
141
12
1180
13167
49
137
1262
13028
226
793
1054
12073
372
1827
790
9808
carvedilol; oral
C07AG02 [21601700]
1.5e+00
1.5e+00
1.8e+00
—
2.1e+00
2.0e+00
2.2e+00
cases:3.94%
controls:0.89%
cases:3.26%
controls:0.75%
cases:1.21%
controls:0.20%
—
—
cases:1.68%
controls:0.21%
cases:5.16%
controls:0.76%
cases:7.75%
controls:0.94%
52
117
1267
13047
43
99
1278
13080
16
27
1305
13152
—
22
28
1289
13137
66
98
1214
12768
90
109
1072
11526
Inpatient Hospital
21 [8717]
2.5e-01
7.0e-01
1.1e+00
5.3e+00
1.7e+00
1.1e+00
8.5e-01
cases:36.54%
controls:30.92%
cases:18.47%
controls:10.09%
cases:3.86%
controls:1.37%
cases:13.70%
controls:0.08%
cases:6.71%
controls:1.26%
cases:23.52%
controls:9.57%
cases:45.35%
controls:26.14%
482
4070
837
9094
244
1330
1077
11849
51
181
1270
12998
181
10
1140
13169
88
166
1223
12999
301
1231
979
11635
527
3041
635
8594
Physiotherapist
Z3226 [2001311560]
8.5e-01
1.6e+00
2.1e+00
—
2.8e+00
1.9e+00
1.7e+00
cases:4.47%
controls:1.97%
cases:2.80%
controls:0.57%
cases:0.83%
controls:0.10%
—
—
cases:1.22%
controls:0.08%
cases:3.75%
controls:0.61%
cases:8.18%
controls:1.65%
59
259
1260
12905
37
75
1284
13104
11
13
1310
13166
—
16
10
1295
13155
48
78
1232
12788
95
192
1067
11443
pH of Venous blood
2746-6 [3012544]
2.2e-01
1.2e+00
3.1e+00
1.0e+50
2.7e+00
2.1e+00
1.9e+00
cases:1.21%
controls:0.97%
cases:1.89%
controls:0.61%
cases:1.44%
controls:0.07%
cases:0.68%
controls:0.00%
cases:0.92%
controls:0.06%
cases:3.98%
controls:0.52%
cases:9.72%
controls:1.56%
16
128
1303
13036
25
80
1296
13099
19
9
1302
13170
9
0
1312
13179
12
8
1299
13157
51
67
1229
12799
113
182
1049
11453
Social worker
Z2446 [2001311559]
1.1e+00
2.5e+00
2.5e+00
—
—
2.3e+00
2.5e+00
cases:1.74%
controls:0.61%
cases:1.89%
controls:0.15%
cases:0.45%
controls:0.04%
—
—
—
—
cases:1.64%
controls:0.16%
cases:4.65%
controls:0.40%
23
80
1296
13084
25
20
1296
13159
6
5
1315
13174
—
—
21
21
1259
12845
54
47
1108
11588
Base excess in Venous blood by calculation
1927-3 [3002032]
2.6e-01
1.2e+00
3.0e+00
1.0e+50
2.6e+00
2.1e+00
2.0e+00
cases:1.21%
controls:0.94%
cases:1.89%
controls:0.57%
cases:1.44%
controls:0.08%
cases:0.68%
controls:0.00%
cases:0.92%
controls:0.07%
cases:3.91%
controls:0.48%
cases:9.64%
controls:1.49%
16
124
1303
13040
25
75
1296
13104
19
10
1302
13169
9
0
1312
13179
12
9
1299
13156
50
62
1230
12804
112
173
1050
11462
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.1e-01
8.6e-01
2.7e+00
3.3e+00
1.6e+00
1.2e+00
8.8e-01
cases:12.05%
controls:9.12%
cases:10.37%
controls:4.69%
cases:7.95%
controls:0.59%
cases:1.44%
controls:0.05%
cases:3.13%
controls:0.65%
cases:13.98%
controls:4.86%
cases:26.94%
controls:13.25%
159
1201
1160
11963
137
618
1184
12561
105
78
1216
13101
19
7
1302
13172
41
85
1270
13080
179
625
1101
12241
313
1542
849
10093
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
2.0e+00
2.3e+00
2.0e+00
—
1.8e+00
2.7e+00
3.8e+00
cases:0.91%
controls:0.12%
cases:1.29%
controls:0.14%
cases:0.38%
controls:0.05%
—
—
cases:0.38%
controls:0.06%
cases:2.19%
controls:0.16%
cases:9.90%
controls:0.24%
12
16
1307
13148
17
18
1304
13161
5
7
1316
13172
—
5
8
1306
13157
28
20
1252
12846
115
28
1047
11607
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
4.3e-01
9.7e-01
2.5e+00
3.6e+00
1.4e+00
1.1e+00
6.4e-01
cases:8.34%
controls:5.57%
cases:8.02%
controls:3.21%
cases:5.22%
controls:0.43%
cases:1.36%
controls:0.04%
cases:1.75%
controls:0.43%
cases:9.84%
controls:3.39%
cases:17.90%
controls:10.29%
110
733
1209
12431
106
423
1215
12756
69
57
1252
13122
18
5
1303
13174
23
56
1288
13109
126
436
1154
12430
208
1197
954
10438
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
4.1e-01
9.4e-01
2.6e+00
3.6e+00
1.4e+00
1.1e+00
6.7e-01
cases:8.49%
controls:5.78%
cases:8.18%
controls:3.35%
cases:5.37%
controls:0.43%
cases:1.36%
controls:0.04%
cases:1.83%
controls:0.44%
cases:9.92%
controls:3.53%
cases:18.67%
controls:10.49%
112
761
1207
12403
108
441
1213
12738
71
57
1250
13122
18
5
1303
13174
24
58
1287
13107
127
454
1153
12412
217
1221
945
10414
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2.5e-01
1.2e+00
2.9e+00
1.0e+50
2.6e+00
2.1e+00
1.9e+00
cases:1.21%
controls:0.95%
cases:1.89%
controls:0.60%
cases:1.36%
controls:0.08%
cases:0.68%
controls:0.00%
cases:0.92%
controls:0.07%
cases:3.83%
controls:0.47%
cases:9.72%
controls:1.52%
16
125
1303
13039
25
79
1296
13100
18
10
1303
13169
9
0
1312
13179
12
9
1299
13156
49
61
1231
12805
113
177
1049
11458
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
4.2e-01
9.5e-01
2.6e+00
3.5e+00
1.4e+00
1.1e+00
6.5e-01
cases:8.49%
controls:5.73%
cases:8.18%
controls:3.32%
cases:5.37%
controls:0.43%
cases:1.29%
controls:0.04%
cases:1.75%
controls:0.44%
cases:9.92%
controls:3.46%
cases:18.33%
controls:10.49%
112
754
1207
12410
108
438
1213
12741
71
57
1250
13122
17
5
1304
13174
23
58
1288
13107
127
445
1153
12421
213
1221
949
10414
isradipine; oral, parenteral
C08CA03 [21601749]
1.9e+00
2.6e+00
—
—
—
3.0e+00
3.0e+00
cases:0.99%
controls:0.14%
cases:0.91%
controls:0.07%
—
—
—
—
—
—
cases:1.09%
controls:0.05%
cases:1.38%
controls:0.07%
13
19
1306
13145
12
9
1309
13170
—
—
—
14
7
1266
12859
16
8
1146
11627
Osmolality of Urine
2695-5 [3026782]
2.9e-01
7.9e-01
3.8e+00
1.0e+50
2.5e+00
1.9e+00
1.5e+00
cases:3.03%
controls:2.29%
cases:2.12%
controls:0.97%
cases:2.88%
controls:0.07%
cases:0.91%
controls:0.00%
cases:1.22%
controls:0.11%
cases:5.47%
controls:0.89%
cases:10.93%
controls:2.72%
40
301
1279
12863
28
128
1293
13051
38
9
1283
13170
12
0
1309
13179
16
14
1295
13151
70
115
1210
12751
127
317
1035
11318
Measurement of heart muscle perfusion with exercise
XF655 [2001303392]
1.4e+00
3.0e+00
—
—
—
2.7e+00
3.0e+00
cases:0.83%
controls:0.20%
cases:0.76%
controls:0.04%
—
—
—
—
—
—
cases:0.70%
controls:0.05%
cases:3.27%
controls:0.17%
11
26
1308
13138
10
5
1311
13174
—
—
—
9
6
1271
12860
38
20
1124
11615
Emergency Room Visit
ER [9203]
2.0e-01
6.7e-01
1.5e+00
5.0e+00
1.4e+00
7.8e-01
8.3e-01
cases:31.24%
controls:27.03%
cases:16.96%
controls:9.42%
cases:5.07%
controls:1.22%
cases:8.33%
controls:0.06%
cases:4.58%
controls:1.20%
cases:20.08%
controls:10.31%
cases:49.83%
controls:30.22%
412
3558
907
9606
224
1242
1097
11937
67
161
1254
13018
110
8
1211
13171
60
158
1251
13007
257
1327
1023
11539
579
3516
583
8119
azathioprine; oral, parenteral
L04AX01 [21603927]
1.5e+00
1.7e+00
1.2e+00
—
2.5e+00
2.1e+00
2.2e+00
cases:2.50%
controls:0.59%
cases:2.35%
controls:0.42%
cases:0.38%
controls:0.11%
—
—
cases:1.07%
controls:0.09%
cases:3.67%
controls:0.46%
cases:5.51%
controls:0.62%
33
78
1286
13086
31
55
1290
13124
5
15
1316
13164
—
14
12
1297
13153
47
59
1233
12807
64
72
1098
11563
Other extensive ultrasound examination of artery
PG1DE [2001309713]
1.6e+00
2.6e+00
—
—
—
2.6e+00
3.2e+00
cases:1.21%
controls:0.24%
cases:1.06%
controls:0.08%
—
—
—
—
—
—
cases:1.72%
controls:0.12%
cases:5.85%
controls:0.26%
16
32
1303
13132
14
11
1307
13168
—
—
—
22
16
1258
12850
68
30
1094
11605
felodipine; oral
C08CA02 [21601748]
1.7e+00
1.6e+00
1.6e+00
1.0e+50
1.4e+00
1.7e+00
1.9e+00
cases:7.66%
controls:1.53%
cases:6.13%
controls:1.27%
cases:1.59%
controls:0.34%
cases:0.38%
controls:0.00%
cases:1.60%
controls:0.39%
cases:6.88%
controls:1.31%
cases:10.93%
controls:1.77%
101
202
1218
12962
81
167
1240
13012
21
45
1300
13134
5
0
1316
13179
21
51
1290
13114
88
168
1192
12698
127
206
1035
11429
Bacteria [Presence] in Urine
87829-8 [36304419]
3.4e-01
1.0e+00
3.4e+00
1.0e+50
2.3e+00
1.8e+00
1.5e+00
cases:3.94%
controls:2.85%
cases:3.79%
controls:1.42%
cases:4.47%
controls:0.16%
cases:1.14%
controls:0.00%
cases:1.53%
controls:0.15%
cases:6.80%
controls:1.24%
cases:14.80%
controls:3.90%
52
375
1267
12789
50
187
1271
12992
59
21
1262
13158
15
0
1306
13179
20
20
1291
13145
87
160
1193
12706
172
454
990
11181
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.8e-01
1.0e+00
3.4e+00
1.0e+50
2.3e+00
1.8e+00
1.4e+00
cases:5.53%
controls:3.87%
cases:5.30%
controls:1.97%
cases:6.81%
controls:0.24%
cases:1.59%
controls:0.00%
cases:2.21%
controls:0.24%
cases:9.69%
controls:1.81%
cases:20.31%
controls:5.74%
73
509
1246
12655
70
260
1251
12919
90
31
1231
13148
21
0
1300
13179
29
31
1282
13134
124
233
1156
12633
236
668
926
10967
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.0e-01
1.0e+00
3.3e+00
1.0e+50
2.3e+00
1.7e+00
1.4e+00
cases:3.87%
controls:2.90%
cases:4.01%
controls:1.44%
cases:5.00%
controls:0.19%
cases:1.36%
controls:0.00%
cases:1.68%
controls:0.17%
cases:7.42%
controls:1.38%
cases:15.06%
controls:4.07%
51
382
1268
12782
53
190
1268
12989
66
25
1255
13154
18
0
1303
13179
22
23
1289
13142
95
178
1185
12688
175
474
987
11161
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
4.5e-01
1.6e+00
3.4e+00
1.0e+50
—
2.4e+00
2.5e+00
cases:0.99%
controls:0.63%
cases:1.67%
controls:0.36%
cases:1.29%
controls:0.05%
cases:0.45%
controls:0.00%
—
—
cases:3.05%
controls:0.29%
cases:7.66%
controls:0.66%
13
83
1306
13081
22
47
1299
13132
17
6
1304
13173
6
0
1315
13179
—
39
37
1241
12829
89
77
1073
11558
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
2.1e-01
8.5e-01
3.5e+00
1.0e+50
2.1e+00
1.8e+00
1.6e+00
cases:2.81%
controls:2.29%
cases:2.42%
controls:1.05%
cases:3.10%
controls:0.10%
cases:0.91%
controls:0.00%
cases:1.07%
controls:0.14%
cases:5.78%
controls:0.99%
cases:11.96%
controls:2.79%
37
302
1282
12862
32
139
1289
13040
41
13
1280
13166
12
0
1309
13179
14
18
1297
13147
74
127
1206
12739
139
325
1023
11310
pH of Urine
2756-5 [3015736]
3.7e-01
1.0e+00
2.7e+00
3.0e+00
1.2e+00
1.1e+00
7.0e-01
cases:6.44%
controls:4.55%
cases:6.51%
controls:2.39%
cases:4.24%
controls:0.29%
cases:0.76%
controls:0.04%
cases:1.07%
controls:0.33%
cases:6.88%
controls:2.42%
cases:15.15%
controls:8.16%
85
599
1234
12565
86
315
1235
12864
56
38
1265
13141
10
5
1311
13174
14
43
1297
13122
88
312
1192
12554
176
949
986
10686
Chronic hypertension
205 [2001600203]
1.2e+00
1.6e+00
3.1e+00
—
—
2.5e+00
1.4e+00
cases:5.23%
controls:1.66%
cases:1.67%
controls:0.34%
cases:0.98%
controls:0.05%
—
—
—
—
cases:3.83%
controls:0.34%
cases:5.85%
controls:1.47%
69
219
1250
12945
22
45
1299
13134
13
6
1308
13173
—
—
49
44
1231
12822
68
171
1094
11464
amlodipine; oral
C08CA01 [21601747]
9.3e-01
1.1e+00
1.1e+00
2.8e+00
1.1e+00
1.2e+00
1.4e+00
cases:15.01%
controls:6.53%
cases:14.38%
controls:5.32%
cases:4.09%
controls:1.39%
cases:0.98%
controls:0.06%
cases:4.96%
controls:1.66%
cases:17.19%
controls:5.63%
cases:28.74%
controls:8.96%
198
859
1121
12305
190
701
1131
12478
54
183
1267
12996
13
8
1308
13171
65
219
1246
12946
220
724
1060
12142
334
1043
828
10592
nifedipine; oral, parenteral
C08CA05 [21601751]
1.5e+00
1.6e+00
1.6e+00
—
1.8e+00
1.5e+00
1.6e+00
cases:3.41%
controls:0.77%
cases:2.42%
controls:0.52%
cases:0.76%
controls:0.15%
—
—
cases:1.07%
controls:0.18%
cases:2.19%
controls:0.48%
cases:2.93%
controls:0.63%
45
102
1274
13062
32
68
1289
13111
10
20
1311
13159
—
14
24
1297
13141
28
62
1252
12804
34
73
1128
11562
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
1.3e-01
6.2e-01
1.8e+00
3.8e+00
1.4e+00
9.0e-01
7.9e-01
cases:9.78%
controls:8.73%
cases:7.72%
controls:4.30%
cases:3.63%
controls:0.59%
cases:2.04%
controls:0.05%
cases:2.75%
controls:0.71%
cases:9.84%
controls:4.27%
cases:23.84%
controls:12.44%
129
1149
1190
12015
102
567
1219
12612
48
78
1273
13101
27
6
1294
13173
36
93
1275
13072
126
549
1154
12317
277
1447
885
10188
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
2.8e-01
1.0e+00
3.2e+00
—
2.1e+00
1.6e+00
1.4e+00
cases:4.40%
controls:3.37%
cases:4.39%
controls:1.66%
cases:5.37%
controls:0.24%
—
—
cases:1.83%
controls:0.22%
cases:8.28%
controls:1.71%
cases:17.38%
controls:4.97%
58
444
1261
12720
58
219
1263
12960
71
31
1250
13148
—
24
29
1287
13136
106
220
1174
12646
202
578
960
11057
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
4.3e-01
1.2e+00
3.2e+00
1.0e+50
2.3e+00
1.4e+00
1.2e+00
cases:2.05%
controls:1.34%
cases:2.20%
controls:0.70%
cases:2.65%
controls:0.11%
cases:0.45%
controls:0.00%
cases:0.84%
controls:0.08%
cases:3.20%
controls:0.81%
cases:8.00%
controls:2.49%
27
177
1292
12987
29
92
1292
13087
35
14
1286
13165
6
0
1315
13179
11
11
1300
13154
41
104
1239
12762
93
290
1069
11345
furosemide; oral, parenteral
C03CA01 [21601518]
1.3e+00
1.4e+00
1.6e+00
—
1.5e+00
1.7e+00
1.8e+00
cases:12.66%
controls:3.87%
cases:12.04%
controls:3.15%
cases:4.09%
controls:0.85%
—
—
cases:4.27%
controls:0.96%
cases:15.55%
controls:3.25%
cases:25.30%
controls:5.37%
167
510
1152
12654
159
415
1162
12764
54
112
1267
13067
—
56
126
1255
13039
199
418
1081
12448
294
625
868
11010
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
5.9e-01
1.0e+00
2.3e+00
—
2.5e+00
1.6e+00
1.8e+00
cases:2.12%
controls:1.19%
cases:1.97%
controls:0.71%
cases:1.36%
controls:0.14%
—
—
cases:0.76%
controls:0.06%
cases:3.75%
controls:0.75%
cases:11.10%
controls:2.05%
28
156
1291
13008
26
94
1295
13085
18
18
1303
13161
—
10
8
1301
13157
48
97
1232
12769
129
239
1033
11396
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
5.1e-01
1.2e+00
2.5e+00
1.0e+50
2.5e+00
1.5e+00
1.6e+00
cases:0.68%
controls:0.41%
cases:1.06%
controls:0.33%
cases:0.45%
controls:0.04%
cases:0.38%
controls:0.00%
cases:0.76%
controls:0.06%
cases:1.48%
controls:0.35%
cases:3.18%
controls:0.68%
9
54
1310
13110
14
43
1307
13136
6
5
1315
13174
5
0
1316
13179
10
8
1301
13157
19
45
1261
12821
37
79
1125
11556
candesartan; oral
C09CA06 [21601829]
9.1e-01
1.1e+00
9.2e-01
3.0e+00
9.0e-01
1.3e+00
1.1e+00
cases:8.34%
controls:3.55%
cases:8.10%
controls:2.99%
cases:2.04%
controls:0.83%
cases:0.76%
controls:0.04%
cases:2.36%
controls:0.97%
cases:10.47%
controls:3.18%
cases:13.60%
controls:4.85%
110
467
1209
12697
107
394
1214
12785
27
109
1294
13070
10
5
1311
13174
31
128
1280
13037
134
409
1146
12457
158
564
1004
11071
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
6.9e-01
9.3e-01
2.2e+00
—
2.2e+00
1.5e+00
1.6e+00
cases:2.58%
controls:1.31%
cases:2.04%
controls:0.82%
cases:1.36%
controls:0.16%
—
—
cases:0.69%
controls:0.08%
cases:3.59%
controls:0.79%
cases:11.02%
controls:2.52%
34
172
1285
12992
27
108
1294
13071
18
21
1303
13158
—
9
10
1302
13155
46
102
1234
12764
128
293
1034
11342
Medical doctor
Z2221 [2001311556]
8.3e-01
1.4e+00
1.8e+00
—
1.7e+00
1.9e+00
1.3e+00
cases:8.19%
controls:3.74%
cases:5.07%
controls:1.27%
cases:1.14%
controls:0.18%
—
—
cases:0.92%
controls:0.17%
cases:7.34%
controls:1.13%
cases:10.67%
controls:3.06%
108
492
1211
12672
67
168
1254
13011
15
24
1306
13155
—
12
23
1299
13142
94
145
1186
12721
124
356
1038
11279
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
4.0e-01
1.1e+00
3.1e+00
1.0e+50
2.1e+00
1.3e+00
1.3e+00
cases:1.90%
controls:1.28%
cases:2.27%
controls:0.74%
cases:2.73%
controls:0.12%
cases:0.45%
controls:0.00%
cases:0.84%
controls:0.10%
cases:3.13%
controls:0.85%
cases:8.35%
controls:2.50%
25
169
1294
12995
30
97
1291
13082
36
16
1285
13163
6
0
1315
13179
11
13
1300
13152
40
110
1240
12756
97
291
1065
11344
Leukocytes [#/volume] in Urine
30405-5 [3018095]
2.7e-01
1.0e+00
3.1e+00
—
2.1e+00
1.6e+00
1.3e+00
cases:4.93%
controls:3.80%
cases:5.60%
controls:2.07%
cases:5.75%
controls:0.28%
—
—
cases:2.06%
controls:0.26%
cases:9.53%
controls:2.18%
cases:18.50%
controls:6.09%
65
500
1254
12664
74
273
1247
12906
76
37
1245
13142
—
27
34
1284
13131
122
281
1158
12585
215
709
947
10926
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
7.0e-01
1.0e+00
2.0e+00
—
2.8e+00
1.4e+00
1.1e+00
cases:9.02%
controls:4.69%
cases:3.71%
controls:1.37%
cases:1.14%
controls:0.16%
—
—
cases:2.14%
controls:0.13%
cases:4.92%
controls:1.31%
cases:14.29%
controls:5.13%
119
618
1200
12546
49
181
1272
12998
15
21
1306
13158
—
28
17
1283
13148
63
169
1217
12697
166
597
996
11038
Preparatory care for dialysis
Z49.0 [45571361]
3.8e+00
—
—
1.0e+50
1.0e+50
—
5.1e+00
cases:1.97%
controls:0.05%
—
—
—
—
cases:0.45%
controls:0.00%
cases:0.61%
controls:0.00%
—
—
cases:6.71%
controls:0.04%
26
6
1293
13158
—
—
6
0
1315
13179
8
0
1303
13165
—
78
5
1084
11630
More than one and less than three hours
ZXE10 [2001311401]
6.0e-01
1.1e+00
2.1e+00
—
1.9e+00
1.6e+00
1.6e+00
cases:7.35%
controls:4.16%
cases:3.48%
controls:1.14%
cases:0.83%
controls:0.11%
—
—
cases:0.76%
controls:0.11%
cases:4.92%
controls:1.05%
cases:16.01%
controls:3.88%
97
548
1222
12616
46
150
1275
13029
11
14
1310
13165
—
10
15
1301
13150
63
135
1217
12731
186
452
976
11183
Diastolic blood pressure
8462-4 [3012888]
3.6e+00
—
—
—
1.0e+50
—
5.2e+00
cases:2.20%
controls:0.06%
—
—
—
—
—
—
cases:0.53%
controls:0.00%
—
—
cases:9.90%
controls:0.06%
29
8
1290
13156
—
—
—
7
0
1304
13165
—
115
7
1047
11628
Systolic blood pressure
8480-6 [3004249]
3.6e+00
—
—
—
1.0e+50
—
5.2e+00
cases:2.20%
controls:0.06%
—
—
—
—
—
—
cases:0.53%
controls:0.00%
—
—
cases:9.90%
controls:0.06%
29
8
1290
13156
—
—
—
7
0
1304
13165
—
115
7
1047
11628
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
1.2e+00
2.0e+00
—
—
—
2.9e+00
2.8e+00
cases:1.14%
controls:0.36%
cases:1.59%
controls:0.23%
—
—
—
—
—
—
cases:2.66%
controls:0.15%
cases:6.63%
controls:0.45%
15
47
1304
13117
21
30
1300
13149
—
—
—
34
19
1246
12847
77
52
1085
11583
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
6.2e-01
9.9e-01
2.1e+00
—
2.4e+00
1.5e+00
1.7e+00
cases:2.35%
controls:1.28%
cases:1.97%
controls:0.74%
cases:1.29%
controls:0.16%
—
—
cases:0.69%
controls:0.06%
cases:3.44%
controls:0.76%
cases:10.84%
controls:2.21%
31
168
1288
12996
26
98
1295
13081
17
21
1304
13158
—
9
8
1302
13157
44
98
1236
12768
126
257
1036
11378
enalapril; oral, parenteral
C09AA02 [21601786]
1.4e+00
1.4e+00
1.2e+00
—
1.6e+00
1.5e+00
1.5e+00
cases:14.10%
controls:4.00%
cases:10.67%
controls:2.85%
cases:2.65%
controls:0.82%
—
—
cases:4.27%
controls:0.87%
cases:12.34%
controls:2.94%
cases:16.44%
controls:4.25%
186
527
1133
12637
141
376
1180
12803
35
108
1286
13071
—
56
115
1255
13050
158
378
1122
12488
191
494
971
11141
allopurinol; oral, parenteral
M04AA01 [21604131]
1.1e+00
1.4e+00
1.1e+00
—
1.6e+00
1.6e+00
1.7e+00
cases:5.91%
controls:1.97%
cases:5.53%
controls:1.41%
cases:1.14%
controls:0.38%
—
—
cases:1.83%
controls:0.36%
cases:6.80%
controls:1.47%
cases:11.45%
controls:2.21%
78
259
1241
12905
73
186
1248
12993
15
50
1306
13129
—
24
48
1287
13117
87
189
1193
12677
133
257
1029
11378
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
2.7e-01
1.0e+00
2.8e+00
—
1.7e+00
1.7e+00
1.4e+00
cases:4.02%
controls:3.09%
cases:3.48%
controls:1.31%
cases:2.35%
controls:0.15%
—
—
cases:0.99%
controls:0.17%
cases:6.33%
controls:1.17%
cases:14.54%
controls:4.13%
53
407
1266
12757
46
173
1275
13006
31
20
1290
13159
—
13
23
1298
13142
81
151
1199
12715
169
481
993
11154
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
2.6e-01
8.7e-01
3.1e+00
—
1.7e+00
1.6e+00
1.4e+00
cases:6.52%
controls:5.11%
cases:6.66%
controls:2.91%
cases:7.27%
controls:0.36%
—
—
cases:1.83%
controls:0.34%
cases:11.17%
controls:2.59%
cases:23.24%
controls:6.83%
86
673
1233
12491
88
383
1233
12796
96
48
1225
13131
—
24
45
1287
13120
143
333
1137
12533
270
795
892
10840
labetalol; oral, parenteral
C07AG01 [21601699]
2.1e+00
2.3e+00
—
—
—
2.2e+00
1.9e+00
cases:1.14%
controls:0.14%
cases:0.53%
controls:0.05%
—
—
—
—
—
—
cases:0.63%
controls:0.07%
cases:1.12%
controls:0.16%
15
19
1304
13145
7
7
1314
13172
—
—
—
8
9
1272
12857
13
19
1149
11616
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
2.6e-01
8.8e-01
3.0e+00
—
1.8e+00
1.5e+00
1.3e+00
cases:7.20%
controls:5.64%
cases:7.42%
controls:3.22%
cases:7.80%
controls:0.42%
—
—
cases:2.29%
controls:0.39%
cases:12.42%
controls:2.99%
cases:24.27%
controls:7.98%
95
743
1224
12421
98
425
1223
12754
103
55
1218
13124
—
30
52
1281
13113
159
385
1121
12481
282
928
880
10707
Protein [Mass/volume] in Urine
2888-6 [3037121]
6.4e-01
1.3e+00
3.6e+00
—
—
2.7e+00
2.1e+00
cases:0.83%
controls:0.44%
cases:0.68%
controls:0.18%
cases:1.44%
controls:0.04%
—
—
—
—
cases:2.19%
controls:0.16%
cases:3.70%
controls:0.45%
11
58
1308
13106
9
24
1312
13155
19
5
1302
13174
—
—
28
20
1252
12846
43
52
1119
11583
Insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E10.2 [2000503132]
2.2e+00
2.2e+00
—
—
—
2.3e+00
1.6e+00
cases:1.06%
controls:0.11%
cases:0.83%
controls:0.09%
—
—
—
—
—
—
cases:1.02%
controls:0.10%
cases:1.03%
controls:0.21%
14
15
1305
13149
11
12
1310
13167
—
—
—
13
13
1267
12853
12
24
1150
11611
FISTULA - Fistula
FISTULA-1 [2002330212]
3.4e+00
—
—
—
—
—
4.9e+00
cases:1.36%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:8.61%
controls:0.07%
18
6
1301
13158
—
—
—
—
—
100
8
1062
11627
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
4.4e-01
9.2e-01
3.0e+00
—
1.7e+00
1.2e+00
1.1e+00
cases:5.76%
controls:3.79%
cases:6.28%
controls:2.60%
cases:5.30%
controls:0.28%
—
—
cases:1.37%
controls:0.26%
cases:8.59%
controls:2.87%
cases:18.76%
controls:7.12%
76
499
1243
12665
83
342
1238
12837
70
37
1251
13142
—
18
34
1293
13131
110
369
1170
12497
218
828
944
10807
One hour or less
ZXE00 [2001311394]
6.0e-01
1.0e+00
1.7e+00
1.0e+50
2.4e+00
1.4e+00
1.2e+00
cases:8.57%
controls:4.87%
cases:4.01%
controls:1.52%
cases:1.14%
controls:0.21%
cases:0.68%
controls:0.00%
cases:1.45%
controls:0.14%
cases:4.92%
controls:1.26%
cases:14.97%
controls:5.04%
113
641
1206
12523
53
200
1268
12979
15
28
1306
13151
9
0
1312
13179
19
18
1292
13147
63
162
1217
12704
174
586
988
11049
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
7.8e-02
5.1e-01
1.8e+00
3.6e+00
8.1e-01
7.5e-01
7.3e-01
cases:11.60%
controls:10.82%
cases:10.83%
controls:6.81%
cases:7.27%
controls:1.22%
cases:2.12%
controls:0.06%
cases:2.59%
controls:1.17%
cases:13.20%
controls:6.70%
cases:27.88%
controls:15.69%
153
1425
1166
11739
143
897
1178
12282
96
161
1225
13018
28
8
1293
13171
34
154
1277
13011
169
862
1111
12004
324
1825
838
9810
Scheduled procedure
ZXD10 [2001311387]
6.8e-01
1.0e+00
1.5e+00
—
2.0e+00
1.6e+00
1.4e+00
cases:9.17%
controls:4.86%
cases:3.94%
controls:1.43%
cases:0.76%
controls:0.17%
—
—
cases:0.76%
controls:0.11%
cases:5.31%
controls:1.17%
cases:16.18%
controls:4.62%
121
640
1198
12524
52
188
1269
12991
10
22
1311
13157
—
10
14
1301
13151
68
151
1212
12715
188
538
974
11097
Albumin [Mass/volume] in Urine
1754-1 [3012516]
4.1e-01
9.0e-01
3.0e+00
—
1.9e+00
1.1e+00
1.1e+00
cases:5.16%
controls:3.47%
cases:5.98%
controls:2.51%
cases:5.37%
controls:0.27%
—
—
cases:1.53%
controls:0.23%
cases:7.73%
controls:2.67%
cases:17.56%
controls:6.92%
68
457
1251
12707
79
331
1242
12848
71
36
1250
13143
—
20
30
1291
13135
99
344
1181
12522
204
805
958
10830
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.5e-01
4.2e-01
1.8e+00
3.2e+00
1.4e+00
6.6e-01
5.1e-01
cases:15.31%
controls:13.47%
cases:15.90%
controls:11.00%
cases:11.88%
controls:2.22%
cases:3.33%
controls:0.14%
cases:7.25%
controls:1.96%
cases:19.30%
controls:11.00%
cases:31.41%
controls:21.51%
202
1773
1117
11391
210
1450
1111
11729
157
293
1164
12886
44
18
1277
13161
95
258
1216
12907
247
1415
1033
11451
365
2503
797
9132
Abdominal ultrasound examination
JN3AE [2001305555]
7.7e-01
2.1e+00
—
1.0e+50
—
2.6e+00
2.5e+00
cases:2.27%
controls:1.07%
cases:3.03%
controls:0.39%
—
—
cases:1.51%
controls:0.00%
—
—
cases:3.44%
controls:0.26%
cases:11.36%
controls:1.05%
30
141
1289
13023
40
51
1281
13128
—
20
0
1301
13179
—
44
34
1236
12832
132
122
1030
11513
Chronic disorders of vitamin D metabolism
123 [2001600122]
3.4e+00
—
1.0e+50
—
—
—
4.5e+00
cases:4.55%
controls:0.15%
—
—
cases:0.91%
controls:0.00%
—
—
—
—
—
—
cases:9.72%
controls:0.12%
60
20
1259
13144
—
12
0
1309
13179
—
—
—
113
14
1049
11621
Severe anaemia associated with chronic renal failure
138 [2001600134]
3.3e+00
—
—
—
1.0e+50
—
4.5e+00
cases:3.34%
controls:0.12%
—
—
—
—
—
—
cases:1.30%
controls:0.00%
—
—
cases:10.67%
controls:0.13%
44
16
1275
13148
—
—
—
17
0
1294
13165
—
124
15
1038
11620
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.1e-01
4.2e-01
1.8e+00
3.2e+00
1.4e+00
5.7e-01
4.4e-01
cases:19.79%
controls:18.10%
cases:20.14%
controls:14.21%
cases:13.55%
controls:2.47%
cases:4.09%
controls:0.17%
cases:9.00%
controls:2.35%
cases:22.58%
controls:14.17%
cases:38.98%
controls:29.06%
261
2383
1058
10781
266
1873
1055
11306
179
326
1142
12853
54
23
1267
13156
118
309
1193
12856
289
1823
991
11043
453
3381
709
8254
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
2.3e-01
7.1e-01
2.8e+00
—
1.5e+00
1.5e+00
1.4e+00
cases:6.07%
controls:4.87%
cases:5.30%
controls:2.68%
cases:6.59%
controls:0.42%
—
—
cases:1.60%
controls:0.38%
cases:11.02%
controls:2.72%
cases:21.94%
controls:6.71%
80
641
1239
12523
70
353
1251
12826
87
55
1234
13124
—
21
50
1290
13115
141
350
1139
12516
255
781
907
10854
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
7.1e-02
4.7e-01
1.8e+00
3.5e+00
1.1e+00
5.8e-01
4.6e-01
cases:17.97%
controls:16.94%
cases:16.81%
controls:11.25%
cases:10.60%
controls:1.97%
cases:4.16%
controls:0.14%
cases:5.95%
controls:2.10%
cases:18.91%
controls:11.57%
cases:35.63%
controls:25.91%
237
2230
1082
10934
222
1482
1099
11697
140
260
1181
12919
55
18
1266
13161
78
276
1233
12889
242
1489
1038
11377
414
3015
748
8620
Parathyrin.intact [Moles/volume] in Serum or Plasma
14866-8 [3010566]
9.8e-01
2.0e+00
—
—
—
3.1e+00
2.7e+00
cases:0.61%
controls:0.23%
cases:0.61%
controls:0.08%
—
—
—
—
—
—
cases:1.56%
controls:0.07%
cases:3.44%
controls:0.24%
8
30
1311
13134
8
11
1313
13168
—
—
—
20
9
1260
12857
40
28
1122
11607
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.1e-01
4.3e-01
1.8e+00
3.1e+00
1.4e+00
5.6e-01
4.4e-01
cases:19.94%
controls:18.24%
cases:20.44%
controls:14.34%
cases:13.93%
controls:2.50%
cases:4.09%
controls:0.19%
cases:9.31%
controls:2.44%
cases:22.81%
controls:14.43%
cases:39.24%
controls:29.34%
263
2401
1056
10763
270
1890
1051
11289
184
330
1137
12849
54
25
1267
13154
122
321
1189
12844
292
1856
988
11010
456
3414
706
8221
Cells panel - Urine sediment
58434-2 [40761535]
3.6e-01
1.4e+00
3.0e+00
—
—
1.9e+00
1.5e+00
cases:1.29%
controls:0.90%
cases:1.36%
controls:0.33%
cases:1.59%
controls:0.08%
—
—
—
—
cases:1.95%
controls:0.31%
cases:5.34%
controls:1.19%
17
119
1302
13045
18
44
1303
13135
21
11
1300
13168
—
—
25
40
1255
12826
62
138
1100
11497
General Practice Dentistry
1223G0001X [38003675]
1.5e+00
1.7e+00
—
—
—
2.3e+00
2.3e+00
cases:1.82%
controls:0.41%
cases:1.06%
controls:0.20%
—
—
—
—
—
—
cases:1.72%
controls:0.18%
cases:4.91%
controls:0.53%
24
54
1295
13110
14
26
1307
13153
—
—
—
22
23
1258
12843
57
62
1105
11573
Difficulties in perfomrming procedure
ZXD30 [2001311389]
5.1e-01
2.4e+00
—
—
—
2.7e+00
2.6e+00
cases:0.53%
controls:0.32%
cases:0.61%
controls:0.05%
—
—
—
—
—
—
cases:1.02%
controls:0.07%
cases:2.58%
controls:0.20%
7
42
1312
13122
8
7
1313
13172
—
—
—
13
9
1267
12857
30
23
1132
11612
Chronic kidney disease
N18 [45582391]
3.3e+00
—
—
—
1.0e+50
—
4.4e+00
cases:3.03%
controls:0.11%
—
—
—
—
—
—
cases:1.75%
controls:0.00%
—
—
cases:12.82%
controls:0.18%
40
15
1279
13149
—
—
—
23
0
1288
13165
—
149
21
1013
11614
Renal osteodystrophy
N25.0 [45567833]
3.1e+00
—
—
—
—
—
4.6e+00
cases:1.21%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:3.96%
controls:0.04%
16
7
1303
13157
—
—
—
—
—
46
5
1116
11630
Immunoglobulin A (IgA) nephropathy
N08.2*D89.80 [2000503126]
2.5e+00
2.6e+00
—
—
—
2.1e+00
2.5e+00
cases:0.76%
controls:0.06%
cases:0.53%
controls:0.04%
—
—
—
—
—
—
cases:0.39%
controls:0.05%
cases:0.95%
controls:0.08%
10
8
1309
13156
7
5
1314
13174
—
—
—
5
6
1275
12860
11
9
1151
11626
Pharmacy visit
OMOP4822462 [581458]
6.4e-01
9.5e-01
5.5e-01
1.9e+00
8.8e-01
1.3e+00
1.3e+00
cases:95.91%
controls:92.53%
cases:91.22%
controls:80.07%
cases:52.76%
controls:39.29%
cases:11.43%
controls:1.81%
cases:61.71%
controls:39.95%
cases:93.52%
controls:80.12%
cases:98.36%
controls:93.98%
1265
12180
54
984
1205
10553
116
2626
697
5178
624
8001
151
239
1170
12940
809
5259
502
7906
1197
10308
83
2558
1143
10934
19
701
TREATMENT - Hemodialysis, center
TREATMENT-21 [2002330236]
3.4e+00
—
—
—
—
—
4.1e+00
cases:1.36%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:3.10%
controls:0.05%
18
6
1301
13158
—
—
—
—
—
36
6
1126
11629
Albumin/Creatinine [Ratio] in Urine
32294-1 [3020682]
4.3e-01
8.7e-01
2.9e+00
—
1.7e+00
1.1e+00
1.0e+00
cases:5.69%
controls:3.79%
cases:6.28%
controls:2.73%
cases:5.83%
controls:0.33%
—
—
cases:1.45%
controls:0.28%
cases:8.13%
controls:2.95%
cases:18.24%
controls:7.55%
75
499
1244
12665
83
360
1238
12819
77
43
1244
13136
—
19
37
1292
13128
104
379
1176
12487
212
879
950
10756
Gas panel - Capillary blood
24337-8 [3022313]
2.7e-01
8.6e-01
3.2e+00
—
—
2.5e+00
1.7e+00
cases:0.68%
controls:0.52%
cases:0.68%
controls:0.29%
cases:0.91%
controls:0.04%
—
—
—
—
cases:2.19%
controls:0.18%
cases:3.61%
controls:0.66%
9
69
1310
13095
9
38
1312
13141
12
5
1309
13174
—
—
28
23
1252
12843
42
77
1120
11558
Other disorders resulting from impaired renal tubular function
N25.8 [45582397]
2.8e+00
—
—
—
—
—
4.6e+00
cases:1.14%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:6.45%
controls:0.07%
15
9
1304
13155
—
—
—
—
—
75
8
1087
11627
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
4.2e-01
1.1e+00
2.8e+00
—
1.9e+00
9.0e-01
6.1e-01
cases:3.71%
controls:2.46%
cases:4.47%
controls:1.49%
cases:2.88%
controls:0.18%
—
—
cases:0.99%
controls:0.15%
cases:4.06%
controls:1.69%
cases:9.29%
controls:5.29%
49
324
1270
12840
59
196
1262
12983
38
24
1283
13155
—
13
20
1298
13145
52
218
1228
12648
108
616
1054
11019
Vascular Surgery
77 [38004496]
7.0e-01
1.5e+00
1.4e+00
—
2.0e+00
1.6e+00
1.5e+00
cases:3.41%
controls:1.73%
cases:2.65%
controls:0.60%
cases:0.38%
controls:0.09%
—
—
cases:0.69%
controls:0.09%
cases:3.20%
controls:0.66%
cases:9.12%
controls:2.28%
45
228
1274
12936
35
79
1286
13100
5
12
1316
13167
—
9
12
1302
13153
41
85
1239
12781
106
265
1056
11370
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
2.8e-01
1.1e+00
2.5e+00
—
1.7e+00
1.2e+00
7.3e-01
cases:3.11%
controls:2.36%
cases:4.09%
controls:1.34%
cases:2.57%
controls:0.22%
—
—
cases:0.76%
controls:0.14%
cases:4.61%
controls:1.46%
cases:9.21%
controls:4.68%
41
311
1278
12853
54
177
1267
13002
34
29
1287
13150
—
10
18
1301
13147
59
188
1221
12678
107
544
1055
11091
Type 2 diabetes mellitus, with renal complications
E11.2 [45605400]
1.8e+00
2.1e+00
—
—
—
1.9e+00
1.4e+00
cases:1.29%
controls:0.22%
cases:1.06%
controls:0.13%
—
—
—
—
—
—
cases:0.86%
controls:0.12%
cases:1.64%
controls:0.40%
17
29
1302
13135
14
17
1307
13162
—
—
—
11
16
1269
12850
19
47
1143
11588
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.2e-01
3.8e-01
1.8e+00
3.0e+00
1.3e+00
5.3e-01
3.6e-01
cases:21.53%
controls:19.65%
cases:22.33%
controls:16.46%
cases:16.28%
controls:3.22%
cases:4.31%
controls:0.24%
cases:9.99%
controls:3.06%
cases:25.47%
controls:16.75%
cases:40.53%
controls:32.23%
284
2587
1035
10577
295
2169
1026
11010
215
425
1106
12754
57
31
1264
13148
131
403
1180
12762
326
2155
954
10711
471
3750
691
7885
pH of Serum or Plasma
2753-2 [3018418]
4.4e-01
1.0e+00
3.0e+00
—
9.2e-01
1.7e+00
1.5e+00
cases:4.55%
controls:2.97%
cases:4.77%
controls:1.76%
cases:4.69%
controls:0.24%
—
—
cases:0.69%
controls:0.27%
cases:7.73%
controls:1.54%
cases:16.61%
controls:4.21%
60
391
1259
12773
63
232
1258
12947
62
32
1259
13147
—
9
36
1302
13129
99
198
1181
12668
193
490
969
11145
Pediatric Medicine
37 [38004477]
-8.4e-02
1.7e-01
4.8e-01
4.3e+00
1.5e+00
7.8e-01
7.1e-01
cases:2.73%
controls:2.96%
cases:2.12%
controls:1.79%
cases:0.83%
controls:0.52%
cases:2.65%
controls:0.04%
cases:1.53%
controls:0.36%
cases:3.36%
controls:1.56%
cases:4.04%
controls:2.04%
36
390
1283
12774
28
236
1293
12943
11
68
1310
13111
35
5
1286
13174
20
47
1291
13118
43
201
1237
12665
47
237
1115
11398
Urology
34 [38004474]
3.7e-01
6.1e-01
1.6e+00
—
2.1e+00
1.4e+00
1.3e+00
cases:5.91%
controls:4.16%
cases:4.01%
controls:2.22%
cases:1.59%
controls:0.31%
—
—
cases:3.13%
controls:0.38%
cases:8.67%
controls:2.33%
cases:17.64%
controls:5.55%
78
548
1241
12616
53
293
1268
12886
21
41
1300
13138
—
41
50
1270
13115
111
300
1169
12566
205
646
957
10989
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
5.1e-01
1.9e+00
—
—
—
2.3e+00
2.8e+00
cases:0.38%
controls:0.23%
cases:0.53%
controls:0.08%
—
—
—
—
—
—
cases:0.55%
controls:0.05%
cases:4.48%
controls:0.28%
5
30
1314
13134
7
10
1314
13169
—
—
—
7
7
1273
12859
52
33
1110
11602
potassium chloride; oral
A12BA01 [21600877]
9.6e-01
1.5e+00
1.1e+00
—
1.6e+00
1.7e+00
1.3e+00
cases:2.73%
controls:1.06%
cases:2.50%
controls:0.58%
cases:0.53%
controls:0.17%
—
—
cases:0.69%
controls:0.14%
cases:3.13%
controls:0.61%
cases:5.08%
controls:1.46%
36
140
1283
13024
33
77
1288
13102
7
23
1314
13156
—
9
18
1302
13147
40
78
1240
12788
59
170
1103
11465
Microorganisms panel - Urine sediment
58435-9 [40761536]
3.1e-01
9.7e-01
3.1e+00
—
—
1.7e+00
1.2e+00
cases:1.44%
controls:1.06%
cases:1.29%
controls:0.49%
cases:1.14%
controls:0.05%
—
—
—
—
cases:2.27%
controls:0.41%
cases:3.87%
controls:1.18%
19
140
1300
13024
17
65
1304
13114
15
7
1306
13172
—
—
29
53
1251
12813
45
137
1117
11498
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
2.0e-01
1.2e+00
—
—
2.7e+00
2.3e+00
1.9e+00
cases:0.76%
controls:0.62%
cases:0.91%
controls:0.28%
—
—
—
—
cases:0.69%
controls:0.05%
cases:2.27%
controls:0.23%
cases:5.59%
controls:0.85%
10
82
1309
13082
12
37
1309
13142
—
—
9
6
1302
13159
29
29
1251
12837
65
99
1097
11536
Transplant complication
127 [2001600125]
2.3e+00
—
1.0e+50
—
—
—
4.6e+00
cases:0.76%
controls:0.08%
—
—
cases:0.53%
controls:0.00%
—
—
—
—
—
—
cases:8.09%
controls:0.09%
10
10
1309
13154
—
7
0
1314
13179
—
—
—
94
10
1068
11625
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
1.5e+00
1.8e+00
—
1.0e+50
-1.0e+50
1.8e+00
1.9e+00
cases:1.90%
controls:0.43%
cases:0.98%
controls:0.17%
—
—
cases:1.14%
controls:0.00%
cases:0.00%
controls:0.04%
cases:1.17%
controls:0.20%
cases:4.13%
controls:0.67%
25
57
1294
13107
13
22
1308
13157
—
15
0
1306
13179
0
5
1311
13160
15
26
1265
12840
48
78
1114
11557
nilvadipine; oral
C08CA10 [21601756]
1.5e+00
1.5e+00
—
—
2.0e+00
1.7e+00
1.6e+00
cases:0.99%
controls:0.22%
cases:0.68%
controls:0.16%
—
—
—
—
cases:0.46%
controls:0.06%
cases:0.94%
controls:0.17%
cases:1.12%
controls:0.22%
13
29
1306
13135
9
21
1312
13158
—
—
6
8
1305
13157
12
22
1268
12844
13
26
1149
11609
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
7.7e-01
1.2e+00
—
—
2.5e+00
1.2e+00
1.1e+00
cases:2.88%
controls:1.35%
cases:1.82%
controls:0.53%
—
—
—
—
cases:0.53%
controls:0.05%
cases:1.41%
controls:0.44%
cases:5.68%
controls:2.05%
38
178
1281
12986
24
70
1297
13109
—
—
7
6
1304
13159
18
56
1262
12810
66
238
1096
11397
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
7.0e-01
1.3e+00
—
—
2.3e+00
1.1e+00
1.3e+00
cases:3.03%
controls:1.53%
cases:1.59%
controls:0.45%
—
—
—
—
cases:0.46%
controls:0.05%
cases:1.33%
controls:0.45%
cases:7.14%
controls:2.12%
40
202
1279
12962
21
59
1300
13120
—
—
6
6
1305
13159
17
58
1263
12808
83
247
1079
11388
Urinary tract ultrasound examination
KH1AE [2001306329]
1.0e+00
2.1e+00
—
1.0e+50
—
2.5e+00
2.0e+00
cases:0.83%
controls:0.30%
cases:0.83%
controls:0.10%
—
—
cases:1.14%
controls:0.00%
—
—
cases:1.72%
controls:0.15%
cases:3.87%
controls:0.53%
11
39
1308
13125
11
13
1310
13166
—
15
0
1306
13179
—
22
19
1258
12847
45
62
1117
11573
pH of Specimen
17433-4 [3019225]
-1.5e-02
7.0e-01
3.3e+00
—
—
1.8e+00
1.5e+00
cases:1.14%
controls:1.15%
cases:1.06%
controls:0.53%
cases:1.44%
controls:0.05%
—
—
—
—
cases:2.19%
controls:0.38%
cases:4.65%
controls:1.09%
15
152
1304
13012
14
70
1307
13109
19
7
1302
13172
—
—
28
49
1252
12817
54
127
1108
11508
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
4.6e-01
8.9e-01
2.5e+00
—
1.2e+00
9.8e-01
5.5e-01
cases:7.35%
controls:4.79%
cases:5.98%
controls:2.53%
cases:3.63%
controls:0.31%
—
—
cases:1.22%
controls:0.38%
cases:6.56%
controls:2.56%
cases:13.43%
controls:8.21%
97
631
1222
12533
79
334
1242
12845
48
41
1273
13138
—
16
50
1295
13115
84
330
1196
12536
156
955
1006
10680
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
1.5e-01
4.1e-01
1.8e+00
2.5e+00
7.4e-01
5.7e-01
5.3e-01
cases:17.97%
controls:15.81%
cases:14.00%
controls:9.75%
cases:6.96%
controls:1.21%
cases:0.45%
controls:0.04%
cases:2.14%
controls:1.03%
cases:16.64%
controls:10.17%
cases:37.95%
controls:26.50%
237
2081
1082
11083
185
1285
1136
11894
92
160
1229
13019
6
5
1315
13174
28
135
1283
13030
213
1308
1067
11558
441
3083
721
8552
Kidney symptom/complaint
U14 [2002001145]
—
—
—
—
—
2.6e+00
3.9e+00
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.05%
cases:2.07%
controls:0.04%
—
—
—
—
—
8
6
1272
12860
24
5
1138
11630
lercanidipine; oral
C08CA13 [21601759]
1.0e+00
1.2e+00
8.7e-01
—
1.5e+00
1.3e+00
1.4e+00
cases:4.62%
controls:1.73%
cases:4.31%
controls:1.40%
cases:1.06%
controls:0.45%
—
—
cases:2.21%
controls:0.49%
cases:5.63%
controls:1.55%
cases:9.81%
controls:2.50%
61
228
1258
12936
57
185
1264
12994
14
59
1307
13120
—
29
64
1282
13101
72
200
1208
12666
114
291
1048
11344
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
1.6e-01
3.8e-01
1.8e+00
2.5e+00
7.8e-01
5.3e-01
5.0e-01
cases:17.66%
controls:15.52%
cases:13.25%
controls:9.45%
cases:6.66%
controls:1.18%
cases:0.45%
controls:0.04%
cases:2.14%
controls:0.99%
cases:15.63%
controls:9.85%
cases:36.75%
controls:26.06%
233
2043
1086
11121
175
1245
1146
11934
88
155
1233
13024
6
5
1315
13174
28
130
1283
13035
200
1267
1080
11599
427
3032
735
8603
Cyst of kidney
N28.1 [45558144]
3.4e+00
—
—
—
—
—
3.1e+00
cases:1.52%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:2.32%
controls:0.11%
20
7
1299
13157
—
—
—
—
—
27
13
1135
11622
Acute tubulo-interstitial nephritis
N10 [45543856]
8.2e-01
1.6e+00
—
1.0e+50
—
2.2e+00
1.8e+00
cases:1.82%
controls:0.81%
cases:1.44%
controls:0.30%
—
—
cases:1.29%
controls:0.00%
—
—
cases:2.50%
controls:0.29%
cases:7.06%
controls:1.26%
24
107
1295
13057
19
39
1302
13140
—
17
0
1304
13179
—
32
37
1248
12829
82
147
1080
11488
Outpatient Hospital
22 [8756]
2.7e-01
6.8e-01
1.4e+00
—
1.9e+00
1.2e+00
9.2e-01
cases:27.75%
controls:22.69%
cases:12.94%
controls:6.99%
cases:3.03%
controls:0.78%
—
—
cases:4.27%
controls:0.68%
cases:18.36%
controls:6.51%
cases:38.55%
controls:20.02%
366
2987
953
10177
171
921
1150
12258
40
103
1281
13076
—
56
90
1255
13075
235
837
1045
12029
448
2329
714
9306
Other and unspecified abdominal pain
R10.4 [45568113]
2.9e-01
7.5e-01
2.3e+00
—
1.7e+00
7.1e-01
8.1e-01
cases:5.23%
controls:3.96%
cases:2.95%
controls:1.42%
cases:1.29%
controls:0.13%
—
—
cases:0.84%
controls:0.15%
cases:2.81%
controls:1.41%
cases:10.76%
controls:5.11%
69
521
1250
12643
39
187
1282
12992
17
17
1304
13162
—
11
20
1300
13145
36
181
1244
12685
125
594
1037
11041
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
2.9e-02
3.2e-01
1.4e+00
3.2e+00
6.2e-01
3.9e-01
2.9e-01
cases:19.11%
controls:18.66%
cases:18.62%
controls:14.30%
cases:9.92%
controls:2.56%
cases:2.50%
controls:0.11%
cases:4.27%
controls:2.35%
cases:20.00%
controls:14.48%
cases:37.18%
controls:30.63%
252
2457
1067
10707
246
1884
1075
11295
131
338
1190
12841
33
14
1288
13165
56
309
1255
12856
256
1863
1024
11003
432
3564
730
8071
metoprolol; oral, parenteral
C07AB02 [21601684]
8.2e-01
9.8e-01
9.4e-01
—
1.2e+00
1.1e+00
1.1e+00
cases:9.78%
controls:4.55%
cases:8.63%
controls:3.44%
cases:2.73%
controls:1.08%
—
—
cases:3.20%
controls:0.94%
cases:10.00%
controls:3.50%
cases:13.17%
controls:4.80%
129
599
1190
12565
114
453
1207
12726
36
142
1285
13037
—
42
124
1269
13041
128
450
1152
12416
153
558
1009
11077
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.4e-03
2.8e-01
1.4e+00
2.9e+00
9.1e-01
3.6e-01
2.8e-01
cases:14.33%
controls:14.31%
cases:14.61%
controls:11.49%
cases:9.46%
controls:2.47%
cases:2.95%
controls:0.16%
cases:5.57%
controls:2.32%
cases:16.25%
controls:11.92%
cases:28.06%
controls:22.75%
189
1884
1130
11280
193
1514
1128
11665
125
326
1196
12853
39
21
1282
13158
73
305
1238
12860
208
1533
1072
11333
326
2647
836
8988
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
4.5e-01
7.1e-01
2.7e+00
1.0e+50
2.0e+00
1.8e+00
1.7e+00
cases:1.21%
controls:0.77%
cases:0.91%
controls:0.45%
cases:0.68%
controls:0.05%
cases:0.45%
controls:0.00%
cases:0.38%
controls:0.05%
cases:2.27%
controls:0.38%
cases:6.97%
controls:1.40%
16
102
1303
13062
12
59
1309
13120
9
6
1312
13173
6
0
1315
13179
5
7
1306
13158
29
49
1251
12817
81
163
1081
11472
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.6e-02
3.0e-01
1.4e+00
2.9e+00
8.6e-01
3.8e-01
2.3e-01
cases:22.21%
controls:21.94%
cases:23.54%
controls:18.64%
cases:14.91%
controls:4.04%
cases:4.77%
controls:0.27%
cases:8.47%
controls:3.78%
cases:25.70%
controls:19.20%
cases:40.96%
controls:35.53%
293
2888
1026
10276
311
2456
1010
10723
197
532
1124
12647
63
35
1258
13144
111
498
1200
12667
329
2470
951
10396
476
4134
686
7501
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
1.5e-01
5.8e-01
2.2e+00
—
1.3e+00
1.0e+00
9.4e-01
cases:5.23%
controls:4.55%
cases:4.84%
controls:2.77%
cases:2.80%
controls:0.30%
—
—
cases:0.99%
controls:0.27%
cases:7.03%
controls:2.67%
cases:17.47%
controls:7.63%
69
599
1250
12565
64
365
1257
12814
37
40
1284
13139
—
13
35
1298
13130
90
343
1190
12523
203
888
959
10747
MCH [Entitic mass]
28539-5 [3035941]
1.4e-02
3.0e-01
1.4e+00
2.9e+00
8.6e-01
3.7e-01
2.3e-01
cases:22.14%
controls:21.90%
cases:23.54%
controls:18.62%
cases:14.91%
controls:4.02%
cases:4.69%
controls:0.27%
cases:8.47%
controls:3.76%
cases:25.47%
controls:19.16%
cases:40.96%
controls:35.49%
292
2883
1027
10281
311
2454
1010
10725
197
530
1124
12649
62
35
1259
13144
111
495
1200
12670
326
2465
954
10401
476
4129
686
7506
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.0e-02
2.9e-01
1.4e+00
2.9e+00
8.5e-01
3.7e-01
2.3e-01
cases:22.29%
controls:21.95%
cases:23.54%
controls:18.68%
cases:14.99%
controls:4.03%
cases:4.69%
controls:0.27%
cases:8.47%
controls:3.81%
cases:25.63%
controls:19.18%
cases:41.05%
controls:35.57%
294
2889
1025
10275
311
2462
1010
10717
198
531
1123
12648
62
35
1259
13144
111
501
1200
12664
328
2468
952
10398
477
4138
685
7497
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.2e-02
2.9e-01
1.4e+00
2.9e+00
8.6e-01
3.7e-01
2.3e-01
cases:22.14%
controls:21.94%
cases:23.54%
controls:18.67%
cases:14.91%
controls:4.02%
cases:4.69%
controls:0.27%
cases:8.47%
controls:3.78%
cases:25.55%
controls:19.16%
cases:40.96%
controls:35.53%
292
2888
1027
10276
311
2460
1010
10719
197
530
1124
12649
62
35
1259
13144
111
498
1200
12667
327
2465
953
10401
476
4134
686
7501
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.2e-02
2.9e-01
1.4e+00
2.9e+00
8.6e-01
3.7e-01
2.3e-01
cases:22.14%
controls:21.92%
cases:23.54%
controls:18.68%
cases:14.91%
controls:4.03%
cases:4.69%
controls:0.27%
cases:8.47%
controls:3.78%
cases:25.63%
controls:19.18%
cases:40.96%
controls:35.54%
292
2886
1027
10278
311
2462
1010
10717
197
531
1124
12648
62
35
1259
13144
111
498
1200
12667
328
2468
952
10398
476
4135
686
7500
Office Visit
OMOP4822458 [581477]
1.3e-01
8.4e-01
1.2e+00
—
1.9e+00
1.2e+00
9.8e-01
cases:8.19%
controls:7.29%
cases:5.68%
controls:2.53%
cases:0.91%
controls:0.27%
—
—
cases:2.14%
controls:0.33%
cases:7.27%
controls:2.33%
cases:18.76%
controls:7.94%
108
959
1211
12205
75
333
1246
12846
12
36
1309
13143
—
28
44
1283
13121
93
300
1187
12566
218
924
944
10711
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
8.5e-03
2.9e-01
1.4e+00
2.9e+00
8.6e-01
3.7e-01
2.3e-01
cases:22.14%
controls:21.99%
cases:23.54%
controls:18.69%
cases:14.99%
controls:4.06%
cases:4.69%
controls:0.27%
cases:8.47%
controls:3.78%
cases:25.63%
controls:19.21%
cases:40.96%
controls:35.58%
292
2895
1027
10269
311
2463
1010
10716
198
535
1123
12644
62
35
1259
13144
111
498
1200
12667
328
2471
952
10395
476
4140
686
7495
Platelets [#/volume] in Blood
26515-7 [3007461]
1.4e-02
2.9e-01
1.4e+00
2.9e+00
8.6e-01
3.6e-01
2.3e-01
cases:22.14%
controls:21.90%
cases:23.47%
controls:18.64%
cases:14.84%
controls:4.01%
cases:4.69%
controls:0.27%
cases:8.47%
controls:3.78%
cases:25.39%
controls:19.13%
cases:40.96%
controls:35.45%
292
2883
1027
10281
310
2457
1011
10722
196
529
1125
12650
62
35
1259
13144
111
497
1200
12668
325
2461
955
10405
476
4125
686
7510
CT of urinary organs
KH1AD [2001306328]
1.1e+00
1.9e+00
—
1.0e+50
—
2.2e+00
1.9e+00
cases:0.53%
controls:0.17%
cases:0.53%
controls:0.08%
—
—
cases:0.38%
controls:0.00%
—
—
cases:0.55%
controls:0.06%
cases:1.55%
controls:0.22%
7
23
1312
13141
7
10
1314
13169
—
5
0
1316
13179
—
7
8
1273
12858
18
26
1144
11609
Case Management Agency
251B00000X [38004193]
2.5e-01
2.4e-01
4.9e-01
3.6e+00
5.1e-01
4.0e-01
5.5e-01
cases:50.95%
controls:44.72%
cases:44.44%
controls:38.56%
cases:22.56%
controls:15.21%
cases:25.51%
controls:0.92%
cases:23.19%
controls:15.39%
cases:51.41%
controls:41.57%
cases:72.63%
controls:60.39%
672
5887
647
7277
587
5082
734
8097
298
2004
1023
11175
337
121
984
13058
304
2026
1007
11139
658
5349
622
7517
844
7026
318
4609
calcium (different salts in combination); oral
A12AA20 [21600872]
4.1e-01
4.0e-01
5.0e-01
2.6e+00
9.4e-01
9.0e-01
1.1e+00
cases:7.88%
controls:5.36%
cases:6.36%
controls:4.37%
cases:1.89%
controls:1.15%
cases:0.53%
controls:0.04%
cases:2.75%
controls:1.09%
cases:10.16%
controls:4.41%
cases:19.45%
controls:7.18%
104
706
1215
12458
84
576
1237
12603
25
152
1296
13027
7
5
1314
13174
36
143
1275
13022
130
567
1150
12299
226
835
936
10800
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
4.0e-01
5.3e-01
1.5e+00
1.0e+50
2.3e+00
1.0e+00
1.2e+00
cases:4.09%
controls:2.78%
cases:2.50%
controls:1.49%
cases:0.91%
controls:0.20%
cases:0.53%
controls:0.00%
cases:1.07%
controls:0.11%
cases:3.28%
controls:1.23%
cases:10.15%
controls:3.45%
54
366
1265
12798
33
196
1288
12983
12
26
1309
13153
7
0
1314
13179
14
14
1297
13151
42
158
1238
12708
118
401
1044
11234
CBC panel - Blood by Automated count
58410-2 [40761511]
1.5e-02
2.1e-01
1.5e+00
2.8e+00
8.6e-01
3.9e-01
3.4e-01
cases:18.65%
controls:18.43%
cases:15.22%
controls:12.65%
cases:9.46%
controls:2.31%
cases:2.42%
controls:0.14%
cases:4.88%
controls:2.13%
cases:17.42%
controls:12.50%
cases:35.97%
controls:28.58%
246
2426
1073
10738
201
1667
1120
11512
125
305
1196
12874
32
19
1289
13160
64
280
1247
12885
223
1608
1057
11258
418
3325
744
8310
Thorax X-ray examination
GD1AA [2001303617]
2.6e-01
1.1e+00
1.4e+00
—
2.1e+00
1.3e+00
1.4e+00
cases:6.60%
controls:5.14%
cases:5.75%
controls:2.00%
cases:0.76%
controls:0.20%
—
—
cases:1.07%
controls:0.13%
cases:6.88%
controls:1.91%
cases:20.40%
controls:6.20%
87
677
1232
12487
76
264
1245
12915
10
26
1311
13153
—
14
17
1297
13148
88
246
1192
12620
237
721
925
10914
Unspecified haematuria
R31 [45553726]
9.8e-01
1.5e+00
—
1.0e+50
—
1.6e+00
1.7e+00
cases:1.52%
controls:0.58%
cases:1.29%
controls:0.28%
—
—
cases:0.98%
controls:0.00%
—
—
cases:1.33%
controls:0.28%
cases:4.65%
controls:0.85%
20
76
1299
13088
17
37
1304
13142
—
13
0
1308
13179
—
17
36
1263
12830
54
99
1108
11536
Removal of fixed intravenous catheter
TPH90 [2001309607]
—
—
—
—
—
2.9e+00
2.8e+00
—
—
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.05%
cases:1.20%
controls:0.08%
—
—
—
—
—
13
7
1267
12859
14
9
1148
11626
ramipril; oral
C09AA05 [21601789]
4.3e-01
5.8e-01
5.8e-01
2.5e+00
9.0e-01
6.8e-01
5.9e-01
cases:6.97%
controls:4.64%
cases:6.43%
controls:3.72%
cases:1.82%
controls:1.02%
cases:0.45%
controls:0.04%
cases:2.90%
controls:1.20%
cases:7.27%
controls:3.83%
cases:9.47%
controls:5.50%
92
611
1227
12553
85
490
1236
12689
24
135
1297
13044
6
5
1315
13174
38
158
1273
13007
93
493
1187
12373
110
640
1052
10995
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
1.0e+00
1.3e+00
—
—
—
2.5e+00
2.1e+00
cases:1.21%
controls:0.45%
cases:0.53%
controls:0.15%
—
—
—
—
—
—
cases:0.94%
controls:0.08%
cases:3.44%
controls:0.43%
16
59
1303
13105
7
20
1314
13159
—
—
—
12
10
1268
12856
40
50
1122
11585
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
5.1e-01
8.1e-01
2.8e+00
—
1.2e+00
9.2e-01
5.7e-01
cases:5.38%
controls:3.30%
cases:3.94%
controls:1.78%
cases:2.42%
controls:0.15%
—
—
cases:0.84%
controls:0.27%
cases:4.38%
controls:1.79%
cases:9.21%
controls:5.42%
71
434
1248
12730
52
235
1269
12944
32
20
1289
13159
—
11
35
1300
13130
56
230
1224
12636
107
631
1055
11004
Supraclavicular plexus blockade
WX202 [2001310778]
—
2.8e+00
—
—
—
—
2.8e+00
—
—
cases:0.61%
controls:0.04%
—
—
—
—
—
—
—
—
cases:1.29%
controls:0.08%
—
8
5
1313
13174
—
—
—
—
15
9
1147
11626
Right side
ZXA00 [2001311346]
4.8e-01
9.6e-01
1.6e+00
—
2.2e+00
1.0e+00
1.4e+00
cases:4.17%
controls:2.61%
cases:2.04%
controls:0.79%
cases:0.38%
controls:0.08%
—
—
cases:0.53%
controls:0.06%
cases:2.03%
controls:0.73%
cases:10.59%
controls:2.93%
55
344
1264
12820
27
104
1294
13075
5
10
1316
13169
—
7
8
1304
13157
26
94
1254
12772
123
341
1039
11294
trimethoprim; oral, parenteral
J01EA01 [21602931]
3.6e-01
1.1e+00
1.7e+00
—
1.4e+00
6.8e-01
6.0e-01
cases:5.76%
controls:4.09%
cases:3.79%
controls:1.27%
cases:0.91%
controls:0.16%
—
—
cases:0.76%
controls:0.19%
cases:2.89%
controls:1.49%
cases:7.66%
controls:4.35%
76
538
1243
12626
50
168
1271
13011
12
21
1309
13158
—
10
25
1301
13140
37
192
1243
12674
89
506
1073
11129
Infectious Disease
44 [38004484]
4.5e-01
8.2e-01
—
1.0e+50
2.7e+00
1.5e+00
1.3e+00
cases:1.74%
controls:1.12%
cases:1.06%
controls:0.47%
—
—
cases:0.91%
controls:0.00%
cases:0.69%
controls:0.05%
cases:1.72%
controls:0.40%
cases:4.39%
controls:1.19%
23
147
1296
13017
14
62
1307
13117
—
12
0
1309
13179
9
6
1302
13159
22
51
1258
12815
51
139
1111
11496
hydrochlorothiazide; oral
C03AA03 [21601466]
9.9e-01
1.1e+00
1.2e+00
—
1.2e+00
1.0e+00
1.1e+00
cases:4.25%
controls:1.62%
cases:2.88%
controls:0.94%
cases:0.68%
controls:0.21%
—
—
cases:0.92%
controls:0.27%
cases:2.66%
controls:0.99%
cases:5.42%
controls:1.84%
56
213
1263
12951
38
124
1283
13055
9
28
1312
13151
—
12
35
1299
13130
34
127
1246
12739
63
214
1099
11421
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
3.1e-01
1.3e+00
—
—
—
2.5e+00
2.9e+00
cases:0.76%
controls:0.55%
cases:0.61%
controls:0.16%
—
—
—
—
—
—
cases:1.17%
controls:0.09%
cases:8.00%
controls:0.46%
10
73
1309
13091
8
21
1313
13158
—
—
—
15
12
1265
12854
93
53
1069
11582
Bacteria identified in Blood by Culture
600-7 [3023368]
-3.0e-01
4.6e-01
1.8e+00
1.0e+50
2.0e+00
8.0e-01
8.4e-01
cases:1.90%
controls:2.53%
cases:1.89%
controls:1.21%
cases:0.98%
controls:0.16%
cases:1.21%
controls:0.00%
cases:0.84%
controls:0.11%
cases:2.58%
controls:1.17%
cases:8.43%
controls:3.83%
25
333
1294
12831
25
159
1296
13020
13
21
1308
13158
16
0
1305
13179
11
15
1300
13150
33
151
1247
12715
98
446
1064
11189
Triglyceride [Moles/volume] in Serum or Plasma
14927-8 [3025839]
7.8e-01
8.4e-01
1.8e+00
—
1.3e+00
9.8e-01
1.0e+00
cases:3.64%
controls:1.70%
cases:3.18%
controls:1.40%
cases:1.14%
controls:0.18%
—
—
cases:0.69%
controls:0.19%
cases:4.38%
controls:1.69%
cases:13.60%
controls:5.30%
48
224
1271
12940
42
185
1279
12994
15
24
1306
13155
—
9
25
1302
13140
56
218
1224
12648
158
617
1004
11018
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.0e+00
1.5e+00
—
—
—
2.5e+00
2.9e+00
cases:0.99%
controls:0.35%
cases:0.53%
controls:0.12%
—
—
—
—
—
—
cases:1.25%
controls:0.10%
cases:5.68%
controls:0.32%
13
46
1306
13118
7
16
1314
13163
—
—
—
16
13
1264
12853
66
37
1096
11598
Physiotherapy
R4110 [2001310233]
5.8e-01
9.8e-01
1.7e+00
1.0e+50
1.5e+00
1.0e+00
1.2e+00
cases:5.31%
controls:3.05%
cases:3.10%
controls:1.19%
cases:0.83%
controls:0.15%
cases:0.38%
controls:0.00%
cases:0.53%
controls:0.12%
cases:3.28%
controls:1.24%
cases:9.90%
controls:3.25%
70
401
1249
12763
41
157
1280
13022
11
20
1310
13159
5
0
1316
13179
7
16
1304
13149
42
159
1238
12707
115
378
1047
11257
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
8.8e-01
8.4e-01
2.3e+00
—
—
1.8e+00
1.3e+00
cases:1.29%
controls:0.54%
cases:0.91%
controls:0.39%
cases:0.45%
controls:0.05%
—
—
—
—
cases:1.48%
controls:0.25%
cases:3.70%
controls:1.07%
17
71
1302
13093
12
52
1309
13127
6
6
1315
13173
—
—
19
32
1261
12834
43
124
1119
11511
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
8.2e-01
1.9e+00
—
—
—
1.9e+00
1.6e+00
cases:0.91%
controls:0.40%
cases:0.83%
controls:0.13%
—
—
—
—
—
—
cases:0.86%
controls:0.12%
cases:2.41%
controls:0.52%
12
53
1307
13111
11
17
1310
13162
—
—
—
11
16
1269
12850
28
60
1134
11575
tacrolimus; oral, parenteral
L04AD02 [21603925]
1.3e+00
1.4e+00
—
—
—
2.1e+00
3.2e+00
cases:0.38%
controls:0.11%
cases:0.45%
controls:0.11%
—
—
—
—
—
—
cases:0.86%
controls:0.10%
cases:4.48%
controls:0.19%
5
14
1314
13150
6
15
1315
13164
—
—
—
11
13
1269
12853
52
22
1110
11613
valsartan; oral
C09CA03 [21601826]
7.7e-01
7.7e-01
9.7e-01
—
1.6e+00
1.2e+00
1.1e+00
cases:3.03%
controls:1.43%
cases:2.20%
controls:1.02%
cases:0.76%
controls:0.29%
—
—
cases:1.22%
controls:0.26%
cases:3.36%
controls:1.07%
cases:4.91%
controls:1.72%
40
188
1279
12976
29
135
1292
13044
10
38
1311
13141
—
16
34
1295
13131
43
138
1237
12728
57
200
1105
11435
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
3.5e-01
5.6e-01
1.7e+00
—
1.5e+00
7.9e-01
8.8e-01
cases:6.97%
controls:5.01%
cases:5.00%
controls:2.92%
cases:2.42%
controls:0.46%
—
—
cases:1.22%
controls:0.29%
cases:6.48%
controls:3.06%
cases:16.95%
controls:7.80%
92
659
1227
12505
66
385
1255
12794
32
61
1289
13118
—
16
38
1295
13127
83
394
1197
12472
197
907
965
10728
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
3.8e-02
2.5e-01
1.4e+00
2.8e+00
7.7e-01
2.8e-01
1.6e-01
cases:16.98%
controls:16.45%
cases:16.20%
controls:13.04%
cases:9.99%
controls:2.60%
cases:2.80%
controls:0.17%
cases:5.19%
controls:2.48%
cases:17.03%
controls:13.42%
cases:30.46%
controls:27.10%
224
2166
1095
10998
214
1719
1107
11460
132
342
1189
12837
37
22
1284
13157
68
326
1243
12839
218
1727
1062
11139
354
3153
808
8482
Written specialist consultation based on a referral from a dentist or a physician
WZC10 [2001310887]
1.3e+00
—
—
—
—
2.0e+00
1.9e+00
cases:1.06%
controls:0.28%
—
—
—
—
—
—
—
—
cases:0.86%
controls:0.12%
cases:2.24%
controls:0.33%
14
37
1305
13127
—
—
—
—
11
15
1269
12851
26
38
1136
11597
Oral Surgery
19 [38004464]
-2.2e-01
1.8e+00
—
—
—
1.6e+00
1.9e+00
cases:0.61%
controls:0.75%
cases:1.29%
controls:0.22%
—
—
—
—
—
—
cases:0.86%
controls:0.17%
cases:4.13%
controls:0.65%
8
99
1311
13065
17
29
1304
13150
—
—
—
11
22
1269
12844
48
76
1114
11559
Urgent procedure
ZXD05 [2001311386]
3.9e-01
1.2e+00
1.5e+00
1.0e+50
2.0e+00
9.5e-01
1.1e+00
cases:5.00%
controls:3.46%
cases:2.73%
controls:0.86%
cases:0.68%
controls:0.16%
cases:0.83%
controls:0.00%
cases:0.69%
controls:0.09%
cases:2.66%
controls:1.04%
cases:10.59%
controls:3.73%
66
455
1253
12709
36
113
1285
13066
9
21
1312
13158
11
0
1310
13179
9
12
1302
13153
34
134
1246
12732
123
434
1039
11201
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
2.0e-01
9.5e-01
2.1e+00
—
—
1.1e+00
1.0e+00
cases:3.56%
controls:2.93%
cases:2.50%
controls:0.98%
cases:0.61%
controls:0.08%
—
—
—
—
cases:2.58%
controls:0.83%
cases:8.61%
controls:3.23%
47
386
1272
12778
33
129
1288
13050
8
10
1313
13169
—
—
33
107
1247
12759
100
376
1062
11259
TREATMENT - Kidney transplant
TREATMENT-51 [2002330239]
—
—
—
1.0e+50
—
—
5.2e+00
—
—
—
—
—
—
cases:0.68%
controls:0.00%
—
—
—
—
cases:8.61%
controls:0.05%
—
—
—
9
0
1312
13179
—
—
100
6
1062
11629
Laboratory Visit
OMOP4822461 [32036]
1.9e-02
2.1e-01
1.2e+00
2.8e+00
8.8e-01
2.7e-01
1.2e-01
cases:25.02%
controls:24.66%
cases:27.40%
controls:23.38%
cases:21.04%
controls:7.26%
cases:6.51%
controls:0.42%
cases:15.48%
controls:7.07%
cases:30.08%
controls:24.75%
cases:42.51%
controls:39.66%
330
3246
989
9918
362
3081
959
10098
278
957
1043
12222
86
55
1235
13124
203
931
1108
12234
385
3184
895
9682
494
4615
668
7020
enalapril and diuretics
C09BA02 [21601804]
1.2e+00
1.1e+00
1.0e+00
—
1.2e+00
9.6e-01
7.9e-01
cases:5.31%
controls:1.72%
cases:3.79%
controls:1.31%
cases:0.98%
controls:0.35%
—
—
cases:1.22%
controls:0.38%
cases:3.44%
controls:1.34%
cases:4.13%
controls:1.92%
70
226
1249
12938
50
173
1271
13006
13
46
1308
13133
—
16
50
1295
13115
44
173
1236
12693
48
223
1114
11412
Cerebral aneurysm, nonruptured
I67.1 [45538401]
9.2e-01
—
—
—
—
2.6e+00
2.5e+00
cases:0.45%
controls:0.18%
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.09%
cases:2.24%
controls:0.18%
6
24
1313
13140
—
—
—
—
15
11
1265
12855
26
21
1136
11614
General Surgery
2 [38004447]
1.8e-01
6.9e-01
9.4e-01
—
1.6e+00
9.2e-01
9.8e-01
cases:20.47%
controls:17.62%
cases:10.37%
controls:5.46%
cases:2.20%
controls:0.87%
—
—
cases:3.05%
controls:0.62%
cases:12.97%
controls:5.60%
cases:34.51%
controls:16.50%
270
2320
1049
10844
137
720
1184
12459
29
114
1292
13065
—
40
82
1271
13083
166
721
1114
12145
401
1920
761
9715
CICLOSPORIN - yes
CICLOSPORIN-1 [2002330221]
—
—
—
—
—
—
5.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.63%
controls:0.04%
—
—
—
—
—
—
77
5
1085
11630
INR in Blood by Coagulation assay
34714-6 [3032080]
1.5e-01
3.6e-01
6.3e-01
3.0e+00
8.4e-01
5.2e-01
7.2e-01
cases:6.07%
controls:5.28%
cases:4.47%
controls:3.17%
cases:1.82%
controls:0.98%
cases:0.91%
controls:0.05%
cases:2.29%
controls:1.00%
cases:5.23%
controls:3.19%
cases:15.06%
controls:7.98%
80
695
1239
12469
59
418
1262
12761
24
129
1297
13050
12
6
1309
13173
30
132
1281
13033
67
411
1213
12455
175
928
987
10707
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
2.1e-01
1.2e+00
2.3e+00
—
—
1.3e+00
1.4e+00
cases:0.83%
controls:0.68%
cases:0.91%
controls:0.29%
cases:0.53%
controls:0.05%
—
—
—
—
cases:0.94%
controls:0.25%
cases:4.13%
controls:1.02%
11
89
1308
13075
12
38
1309
13141
7
7
1314
13172
—
—
12
32
1268
12834
48
119
1114
11516
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
6.6e-01
1.8e+00
—
—
—
2.3e+00
2.7e+00
cases:0.45%
controls:0.24%
cases:0.45%
controls:0.08%
—
—
—
—
—
—
cases:0.55%
controls:0.05%
cases:4.56%
controls:0.31%
6
31
1313
13133
6
10
1315
13169
—
—
—
7
7
1273
12859
53
36
1109
11599
Allogenic transplantation of kidney from cadaver donor
KAS10 [2001305738]
—
—
—
—
—
—
5.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.40%
controls:0.05%
—
—
—
—
—
—
86
6
1076
11629
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
6.3e-01
1.8e+00
—
—
—
2.3e+00
2.7e+00
cases:0.45%
controls:0.24%
cases:0.45%
controls:0.08%
—
—
—
—
—
—
cases:0.55%
controls:0.05%
cases:4.48%
controls:0.31%
6
32
1313
13132
6
10
1315
13169
—
—
—
7
7
1273
12859
52
36
1110
11599
linagliptin; oral
A10BH05 [40251691]
1.2e+00
1.2e+00
1.3e+00
—
1.2e+00
1.3e+00
1.3e+00
cases:0.91%
controls:0.27%
cases:0.98%
controls:0.30%
cases:0.38%
controls:0.11%
—
—
cases:0.38%
controls:0.11%
cases:1.17%
controls:0.31%
cases:2.24%
controls:0.63%
12
36
1307
13128
13
40
1308
13139
5
14
1316
13165
—
5
15
1306
13150
15
40
1265
12826
26
73
1136
11562
Standard cardiac ultrasound examination
FM1AE [2001303278]
7.9e-01
1.2e+00
—
—
1.1e+00
1.5e+00
1.5e+00
cases:4.47%
controls:2.08%
cases:2.35%
controls:0.71%
—
—
—
—
cases:0.38%
controls:0.12%
cases:2.97%
controls:0.65%
cases:8.61%
controls:2.16%
59
274
1260
12890
31
93
1290
13086
—
—
5
16
1306
13149
38
84
1242
12782
100
251
1062
11384
Cardiology
6 [38004451]
2.4e-01
6.1e-01
1.1e+00
—
1.3e+00
9.0e-01
1.1e+00
cases:8.72%
controls:6.96%
cases:5.98%
controls:3.34%
cases:1.21%
controls:0.42%
—
—
cases:1.75%
controls:0.48%
cases:7.58%
controls:3.24%
cases:20.22%
controls:7.92%
115
916
1204
12248
79
440
1242
12739
16
55
1305
13124
—
23
63
1288
13102
97
417
1183
12449
235
922
927
10713
Polycystic ovarian syndrome
E28.2 [45533028]
2.1e+00
2.0e+00
—
—
—
2.9e+00
—
cases:0.83%
controls:0.11%
cases:0.38%
controls:0.05%
—
—
—
—
—
—
cases:0.70%
controls:0.04%
—
—
11
14
1308
13150
5
7
1316
13172
—
—
—
9
5
1271
12861
—
Abdominal CT examination
JN3AD [2001305554]
1.1e+00
9.4e-01
—
1.0e+50
2.1e+00
2.1e+00
1.8e+00
cases:1.29%
controls:0.43%
cases:0.76%
controls:0.30%
—
—
cases:1.14%
controls:0.00%
cases:0.38%
controls:0.05%
cases:1.72%
controls:0.22%
cases:5.77%
controls:1.04%
17
56
1302
13108
10
39
1311
13140
—
15
0
1306
13179
5
6
1306
13159
22
28
1258
12838
67
121
1095
11514
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2.2e-01
9.2e-01
2.8e+00
—
—
1.2e+00
9.8e-01
cases:0.91%
controls:0.73%
cases:0.76%
controls:0.30%
cases:0.61%
controls:0.04%
—
—
—
—
cases:1.09%
controls:0.33%
cases:2.50%
controls:0.95%
12
96
1307
13068
10
40
1311
13139
8
5
1313
13174
—
—
14
43
1266
12823
29
111
1133
11524
T1D - yes
T1D-1 [2002330228]
—
2.5e+00
—
—
—
—
2.4e+00
—
—
cases:0.45%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.06%
—
6
5
1315
13174
—
—
—
—
8
7
1154
11628
Cystoscopy
UKC02 [2001306005]
2.8e-01
7.5e-01
1.6e+00
1.0e+50
2.5e+00
1.1e+00
1.3e+00
cases:1.59%
controls:1.21%
cases:1.14%
controls:0.54%
cases:0.38%
controls:0.08%
cases:0.68%
controls:0.00%
cases:0.53%
controls:0.05%
cases:1.95%
controls:0.64%
cases:5.68%
controls:1.60%
21
159
1298
13005
15
71
1306
13108
5
10
1316
13169
9
0
1312
13179
7
6
1304
13159
25
82
1255
12784
66
186
1096
11449
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
8.3e-01
1.8e+00
—
—
—
1.7e+00
1.4e+00
cases:0.61%
controls:0.27%
cases:0.53%
controls:0.09%
—
—
—
—
—
—
cases:0.78%
controls:0.14%
cases:1.03%
controls:0.26%
8
35
1311
13129
7
12
1314
13167
—
—
—
10
18
1270
12848
12
30
1150
11605
Abdominal X-ray examination without contrast
JN3AA [2001305553]
9.8e-01
—
—
—
—
2.4e+00
2.4e+00
cases:0.61%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.06%
cases:1.55%
controls:0.14%
8
30
1311
13134
—
—
—
—
9
8
1271
12858
18
16
1144
11619
Telehealth
OMOP5556618 [722455]
5.4e-02
2.2e-01
4.0e-01
3.4e+00
7.7e-01
4.4e-01
2.7e-01
cases:16.00%
controls:15.28%
cases:8.71%
controls:7.09%
cases:1.89%
controls:1.28%
cases:1.74%
controls:0.06%
cases:2.52%
controls:1.18%
cases:10.16%
controls:6.78%
cases:21.77%
controls:17.51%
211
2012
1108
11152
115
935
1206
12244
25
169
1296
13010
23
8
1298
13171
33
155
1278
13010
130
872
1150
11994
253
2037
909
9598
Dietary counselling and surveillance
Z71.3 [45552101]
3.4e-01
—
—
—
—
2.5e+00
2.3e+00
cases:0.53%
controls:0.38%
—
—
—
—
—
—
—
—
cases:1.33%
controls:0.11%
cases:3.79%
controls:0.39%
7
50
1312
13114
—
—
—
—
17
14
1263
12852
44
45
1118
11590
Other healthcare associate professional
Z3229 [2001311561]
9.4e-01
1.5e+00
—
—
—
1.1e+00
1.2e+00
cases:2.35%
controls:0.93%
cases:1.29%
controls:0.30%
—
—
—
—
—
—
cases:1.09%
controls:0.35%
cases:2.67%
controls:0.78%
31
123
1288
13041
17
40
1304
13139
—
—
—
14
45
1266
12821
31
91
1131
11544
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
8.6e-01
1.8e+00
—
—
—
1.7e+00
1.2e+00
cases:0.61%
controls:0.26%
cases:0.61%
controls:0.10%
—
—
—
—
—
—
cases:0.86%
controls:0.16%
cases:1.03%
controls:0.30%
8
34
1311
13130
8
13
1313
13166
—
—
—
11
20
1269
12846
12
35
1150
11600
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
8.3e-01
1.8e+00
—
—
—
1.7e+00
1.2e+00
cases:0.61%
controls:0.27%
cases:0.61%
controls:0.10%
—
—
—
—
—
—
cases:0.86%
controls:0.16%
cases:1.03%
controls:0.30%
8
35
1311
13129
8
13
1313
13166
—
—
—
11
20
1269
12846
12
35
1150
11600
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
—
—
—
1.0e+50
—
2.3e+00
2.5e+00
—
—
—
—
—
—
cases:0.38%
controls:0.00%
—
—
cases:0.47%
controls:0.05%
cases:1.29%
controls:0.11%
—
—
—
5
0
1316
13179
—
6
6
1274
12860
15
13
1147
11622
Failure and rejection of transplanted organs and tissues
T86 [45561099]
—
1.0e+50
1.0e+50
—
—
—
4.7e+00
—
—
cases:0.38%
controls:0.00%
cases:0.53%
controls:0.00%
—
—
—
—
—
—
cases:4.73%
controls:0.04%
—
5
0
1316
13179
7
0
1314
13179
—
—
—
55
5
1107
11630
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
3.9e-01
6.9e-01
2.2e+00
—
1.1e+00
1.1e+00
6.8e-01
cases:4.93%
controls:3.40%
cases:3.56%
controls:1.82%
cases:2.27%
controls:0.25%
—
—
cases:0.84%
controls:0.27%
cases:5.47%
controls:1.81%
cases:10.33%
controls:5.49%
65
448
1254
12716
47
240
1274
12939
30
33
1291
13146
—
11
36
1300
13129
70
233
1210
12633
120
639
1042
10996
Sedation and analgesia
WX002 [2001310758]
7.1e-01
1.4e+00
—
—
—
1.3e+00
1.4e+00
cases:3.18%
controls:1.59%
cases:1.74%
controls:0.46%
—
—
—
—
—
—
cases:1.56%
controls:0.45%
cases:6.11%
controls:1.56%
42
209
1277
12955
23
60
1298
13119
—
—
—
20
58
1260
12808
71
181
1091
11454
RR_MEDICAL_TREATMENT - yes
RR_MEDICAL_TREATMENT-1 [2002330205]
—
1.0e+50
1.0e+50
—
—
—
4.7e+00
—
—
cases:0.38%
controls:0.00%
cases:0.45%
controls:0.00%
—
—
—
—
—
—
cases:5.34%
controls:0.05%
—
5
0
1316
13179
6
0
1315
13179
—
—
—
62
6
1100
11629
Specific gravity of Urine by Refractometry
5810-7 [3019150]
4.8e-01
8.0e-01
2.2e+00
—
7.3e-01
7.6e-01
4.5e-01
cases:4.40%
controls:2.76%
cases:3.26%
controls:1.49%
cases:1.82%
controls:0.21%
—
—
cases:0.46%
controls:0.22%
cases:3.52%
controls:1.67%
cases:7.75%
controls:5.11%
58
363
1261
12801
43
197
1278
12982
24
28
1297
13151
—
6
29
1305
13136
45
215
1235
12651
90
594
1072
11041
Upper gastrointestinal surgery
106 [44777669]
1.9e-01
7.2e-01
1.1e+00
—
1.1e+00
7.7e-01
9.6e-01
cases:7.43%
controls:6.22%
cases:4.84%
controls:2.41%
cases:1.06%
controls:0.37%
—
—
cases:0.99%
controls:0.33%
cases:5.16%
controls:2.45%
cases:17.90%
controls:7.68%
98
819
1221
12345
64
318
1257
12861
14
49
1307
13130
—
13
44
1298
13121
66
315
1214
12551
208
894
954
10741
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
3.1e-01
8.8e-01
2.2e+00
—
—
1.1e+00
1.3e+00
cases:1.29%
controls:0.95%
cases:1.29%
controls:0.54%
cases:0.61%
controls:0.07%
—
—
—
—
cases:1.56%
controls:0.52%
cases:4.73%
controls:1.32%
17
125
1302
13039
17
71
1304
13108
8
9
1313
13170
—
—
20
67
1260
12799
55
154
1107
11481
Implantation of vascular injection port
TPX10 [2001309608]
1.3e+00
—
—
—
—
2.2e+00
2.4e+00
cases:0.38%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.05%
cases:1.46%
controls:0.14%
5
13
1314
13151
—
—
—
—
6
7
1274
12859
17
16
1145
11619
metoprolol and felodipine
C07FB02 [21601742]
1.2e+00
1.1e+00
—
—
1.4e+00
1.2e+00
1.1e+00
cases:1.44%
controls:0.46%
cases:1.14%
controls:0.38%
—
—
—
—
cases:0.38%
controls:0.10%
cases:1.17%
controls:0.37%
cases:1.46%
controls:0.51%
19
60
1300
13104
15
50
1306
13129
—
—
5
13
1306
13152
15
47
1265
12819
17
59
1145
11576
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
7.1e-02
2.2e-01
1.4e+00
—
2.4e+00
8.5e-01
1.2e+00
cases:2.88%
controls:2.69%
cases:1.29%
controls:1.04%
cases:0.53%
controls:0.13%
—
—
cases:0.69%
controls:0.06%
cases:2.27%
controls:0.98%
cases:8.26%
controls:2.71%
38
354
1281
12810
17
137
1304
13042
7
17
1314
13162
—
9
8
1302
13157
29
126
1251
12740
96
315
1066
11320
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
9.1e-02
5.2e-01
—
—
2.3e+00
8.6e-01
1.3e+00
cases:2.27%
controls:2.08%
cases:1.21%
controls:0.72%
—
—
—
—
cases:0.53%
controls:0.05%
cases:1.64%
controls:0.70%
cases:7.83%
controls:2.32%
30
274
1289
12890
16
95
1305
13084
—
—
7
7
1304
13158
21
90
1259
12776
91
270
1071
11365
HLA Ab [Presence] in Serum
44534-6 [3042733]
—
—
—
—
—
—
4.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.53%
controls:0.04%
—
—
—
—
—
—
41
5
1121
11630
Ultrasound examination transplanted kidney
KA2AE [2001305644]
—
—
—
—
—
—
4.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.42%
controls:0.07%
—
—
—
—
—
—
63
8
1099
11627
General anesthesia, balanced
WX408 [2001310808]
6.0e-01
8.3e-01
—
—
—
1.4e+00
1.6e+00
cases:4.78%
controls:2.67%
cases:1.59%
controls:0.70%
—
—
—
—
—
—
cases:2.73%
controls:0.68%
cases:9.81%
controls:2.22%
63
351
1256
12813
21
92
1300
13087
—
—
—
35
87
1245
12779
114
258
1048
11377
Repair of umbilical hernia using prosthetic material
JAF30 [2001304444]
2.2e+00
—
—
—
—
—
2.2e+00
cases:0.53%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.95%
controls:0.10%
7
8
1312
13156
—
—
—
—
—
11
12
1151
11623
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
—
—
—
—
—
2.0e+00
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.08%
cases:3.18%
controls:0.29%
—
—
—
—
—
7
10
1273
12856
37
34
1125
11601
Calculus of kidney
N20.0 [45567830]
1.2e+00
—
—
—
—
2.5e+00
1.8e+00
cases:0.45%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.04%
cases:0.86%
controls:0.14%
6
19
1313
13145
—
—
—
—
6
5
1274
12861
10
16
1152
11619
Blood transfusion
WW500 [2001310603]
1.3e+00
2.4e+00
—
—
—
—
1.9e+00
cases:0.61%
controls:0.16%
cases:0.61%
controls:0.05%
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.21%
8
21
1311
13143
8
7
1313
13172
—
—
—
—
16
25
1146
11610
Bacterial infection, unspecified
A49.9 [45590816]
1.0e+00
8.4e-01
—
1.0e+50
—
1.8e+00
1.5e+00
cases:1.44%
controls:0.52%
cases:0.68%
controls:0.30%
—
—
cases:0.68%
controls:0.00%
—
—
cases:1.56%
controls:0.27%
cases:4.22%
controls:0.97%
19
68
1300
13096
9
39
1312
13140
—
9
0
1312
13179
—
20
35
1260
12831
49
113
1113
11522
Base excess in Blood by calculation
11555-0 [3012501]
1.0e+00
1.8e+00
—
—
—
1.8e+00
2.5e+00
cases:0.53%
controls:0.19%
cases:0.45%
controls:0.08%
—
—
—
—
—
—
cases:0.63%
controls:0.10%
cases:1.20%
controls:0.10%
7
25
1312
13139
6
10
1315
13169
—
—
—
8
13
1272
12853
14
12
1148
11623
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
1.0e+00
1.8e+00
—
—
—
1.8e+00
2.5e+00
cases:0.53%
controls:0.19%
cases:0.45%
controls:0.08%
—
—
—
—
—
—
cases:0.63%
controls:0.10%
cases:1.20%
controls:0.10%
7
25
1312
13139
6
10
1315
13169
—
—
—
8
13
1272
12853
14
12
1148
11623
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
1.0e+00
1.8e+00
—
—
—
1.8e+00
2.5e+00
cases:0.53%
controls:0.19%
cases:0.45%
controls:0.08%
—
—
—
—
—
—
cases:0.63%
controls:0.10%
cases:1.20%
controls:0.10%
7
25
1312
13139
6
10
1315
13169
—
—
—
8
13
1272
12853
14
12
1148
11623
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
-9.8e-02
8.9e-01
—
—
—
2.3e+00
1.9e+00
cases:0.45%
controls:0.50%
cases:0.61%
controls:0.25%
—
—
—
—
—
—
cases:1.64%
controls:0.16%
cases:3.27%
controls:0.48%
6
66
1313
13098
8
33
1313
13146
—
—
—
21
21
1259
12845
38
56
1124
11579
Glomerular disorders in diabetes mellitus microalbuminuria
N08.39 [2000503131]
2.1e+00
—
—
—
—
—
2.2e+00
cases:0.53%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.08%
7
9
1312
13155
—
—
—
—
—
8
9
1154
11626
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
—
-1.0e+50
—
—
—
2.4e+00
1.8e+00
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:0.70%
controls:0.06%
cases:1.98%
controls:0.34%
—
0
13
1321
13166
—
—
—
9
8
1271
12858
23
39
1139
11596
Gas panel - Central venous blood
97535-9 [1616796]
8.7e-01
1.7e+00
—
—
—
2.1e+00
2.1e+00
cases:0.38%
controls:0.16%
cases:0.38%
controls:0.07%
—
—
—
—
—
—
cases:0.78%
controls:0.09%
cases:1.98%
controls:0.25%
5
21
1314
13143
5
9
1316
13170
—
—
—
10
12
1270
12854
23
29
1139
11606
More than three and less than five hours
ZXE20 [2001311408]
7.7e-01
1.1e+00
—
—
—
1.7e+00
1.7e+00
cases:2.05%
controls:0.96%
cases:0.83%
controls:0.29%
—
—
—
—
—
—
cases:1.33%
controls:0.25%
cases:6.11%
controls:1.13%
27
126
1292
13038
11
38
1310
13141
—
—
—
17
32
1263
12834
71
132
1091
11503
Other and unspecified hydronephrosis
N13.3 [45553432]
—
2.1e+00
—
—
—
2.4e+00
1.7e+00
—
—
cases:0.38%
controls:0.05%
—
—
—
—
—
—
cases:0.63%
controls:0.05%
cases:0.77%
controls:0.14%
—
5
6
1316
13173
—
—
—
8
7
1272
12859
9
16
1153
11619
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
6.4e-02
2.4e-01
7.4e-01
2.9e+00
-3.5e-03
2.6e-01
5.3e-01
cases:7.51%
controls:7.07%
cases:5.83%
controls:4.62%
cases:2.04%
controls:0.99%
cases:0.83%
controls:0.05%
cases:0.99%
controls:1.00%
cases:6.02%
controls:4.69%
cases:16.35%
controls:10.34%
99
931
1220
12233
77
609
1244
12570
27
130
1294
13049
11
6
1310
13173
13
131
1298
13034
77
604
1203
12262
190
1203
972
10432
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
9.8e-02
5.8e-01
1.9e+00
—
8.2e-01
8.2e-01
9.0e-01
cases:3.79%
controls:3.45%
cases:3.18%
controls:1.81%
cases:1.89%
controls:0.30%
—
—
cases:0.53%
controls:0.24%
cases:3.75%
controls:1.68%
cases:10.93%
controls:4.76%
50
454
1269
12710
42
238
1279
12941
25
39
1296
13140
—
7
31
1304
13134
48
216
1232
12650
127
554
1035
11081
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
9.6e-02
5.1e-01
1.3e+00
—
1.2e+00
6.1e-01
5.4e-01
cases:6.37%
controls:5.82%
cases:5.37%
controls:3.29%
cases:2.27%
controls:0.61%
—
—
cases:1.68%
controls:0.52%
cases:5.78%
controls:3.23%
cases:14.37%
controls:8.95%
84
766
1235
12398
71
433
1250
12746
30
81
1291
13098
—
22
68
1289
13097
74
415
1206
12451
167
1041
995
10594
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
8.2e-01
8.2e-01
—
—
—
1.7e+00
2.4e+00
cases:1.44%
controls:0.64%
cases:0.53%
controls:0.24%
—
—
—
—
—
—
cases:1.09%
controls:0.19%
cases:6.02%
controls:0.58%
19
84
1300
13080
7
31
1314
13148
—
—
—
14
25
1266
12841
70
67
1092
11568
Atherosclerotic heart disease
I25.1 [45596196]
2.5e-01
5.0e-01
4.0e-01
3.6e+00
6.8e-01
5.4e-01
4.9e-01
cases:4.02%
controls:3.16%
cases:2.65%
controls:1.62%
cases:0.45%
controls:0.30%
cases:1.36%
controls:0.04%
cases:0.69%
controls:0.35%
cases:2.81%
controls:1.66%
cases:6.28%
controls:3.94%
53
416
1266
12748
35
213
1286
12966
6
40
1315
13139
18
5
1303
13174
9
46
1302
13119
36
214
1244
12652
73
459
1089
11176
Nutritional therapy
R4190 [2001310243]
—
1.3e+00
—
—
—
2.1e+00
2.0e+00
—
—
cases:0.53%
controls:0.14%
—
—
—
—
—
—
cases:0.78%
controls:0.10%
cases:2.15%
controls:0.29%
—
7
19
1314
13160
—
—
—
10
13
1270
12853
25
34
1137
11601
Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]
7.3e-01
8.1e-01
3.1e+00
—
—
9.5e-01
9.4e-01
cases:0.99%
controls:0.48%
cases:0.68%
controls:0.30%
cases:0.83%
controls:0.04%
—
—
—
—
cases:1.09%
controls:0.43%
cases:3.61%
controls:1.44%
13
63
1306
13101
9
40
1312
13139
11
5
1310
13174
—
—
14
55
1266
12811
42
168
1120
11467
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
2.7e-01
7.4e-01
-1.0e+50
—
1.8e+00
1.2e+00
9.9e-01
cases:2.88%
controls:2.22%
cases:1.89%
controls:0.91%
cases:0.00%
controls:0.08%
—
—
cases:0.76%
controls:0.12%
cases:2.97%
controls:0.93%
cases:7.06%
controls:2.73%
38
292
1281
12872
25
120
1296
13059
0
10
1321
13169
—
10
16
1301
13149
38
120
1242
12746
82
318
1080
11317
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
1.1e-01
3.9e-01
9.5e-01
2.5e+00
2.1e-01
3.2e-01
5.2e-01
cases:6.97%
controls:6.32%
cases:5.68%
controls:3.91%
cases:1.82%
controls:0.71%
cases:0.45%
controls:0.04%
cases:0.92%
controls:0.74%
cases:5.39%
controls:3.97%
cases:15.23%
controls:9.65%
92
832
1227
12332
75
515
1246
12664
24
94
1297
13085
6
5
1315
13174
12
98
1299
13067
69
511
1211
12355
177
1123
985
10512
Periodontitis pronounced
K05.31 [2000502729]
5.8e-01
1.7e+00
—
—
—
1.3e+00
9.2e-01
cases:1.14%
controls:0.64%
cases:1.29%
controls:0.24%
—
—
—
—
—
—
cases:1.25%
controls:0.34%
cases:2.75%
controls:1.12%
15
84
1304
13080
17
32
1304
13147
—
—
—
16
44
1264
12822
32
130
1130
11505
Oxygen saturation in Capillary blood
2709-4 [3021901]
—
—
—
—
-1.0e+50
2.2e+00
1.7e+00
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.55%
controls:0.06%
cases:1.89%
controls:0.34%
—
—
—
—
0
5
1311
13160
7
8
1273
12858
22
40
1140
11595
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
—
—
—
—
—
—
3.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.07%
controls:0.04%
—
—
—
—
—
—
24
5
1138
11630
Pediatric Nephrology
OMOP4822026 [45756813]
—
—
—
1.0e+50
1.0e+50
—
3.9e+00
—
—
—
—
—
—
cases:0.68%
controls:0.00%
cases:0.46%
controls:0.00%
—
—
cases:2.41%
controls:0.05%
—
—
—
9
0
1312
13179
6
0
1305
13165
—
28
6
1134
11629
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
1.2e+00
1.8e+00
—
—
—
2.2e+00
1.6e+00
cases:0.38%
controls:0.11%
cases:0.45%
controls:0.08%
—
—
—
—
—
—
cases:0.94%
controls:0.10%
cases:2.50%
controls:0.52%
5
15
1314
13149
6
10
1315
13169
—
—
—
12
13
1268
12853
29
60
1133
11575
losartan; oral
C09CA01 [21601824]
7.0e-01
6.1e-01
6.6e-01
—
8.4e-01
6.9e-01
9.9e-01
cases:7.20%
controls:3.71%
cases:6.13%
controls:3.44%
cases:1.97%
controls:1.02%
—
—
cases:2.14%
controls:0.93%
cases:7.11%
controls:3.68%
cases:13.77%
controls:5.61%
95
489
1224
12675
81
453
1240
12726
26
135
1295
13044
—
28
123
1283
13042
91
474
1189
12392
160
653
1002
10982
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
8.9e-02
6.7e-01
1.8e+00
1.0e+50
1.3e+00
6.3e-01
6.6e-01
cases:3.71%
controls:3.41%
cases:2.73%
controls:1.41%
cases:1.29%
controls:0.20%
cases:1.06%
controls:0.00%
cases:0.76%
controls:0.21%
cases:2.73%
controls:1.48%
cases:9.90%
controls:5.36%
49
449
1270
12715
36
186
1285
12993
17
27
1304
13152
14
0
1307
13179
10
28
1301
13137
35
190
1245
12676
115
624
1047
11011
Atherosclerosis of arteries of extremities
I70.2 [45538421]
5.1e-01
1.3e+00
—
—
1.8e+00
9.8e-01
7.4e-01
cases:1.44%
controls:0.87%
cases:1.59%
controls:0.45%
—
—
—
—
cases:0.61%
controls:0.11%
cases:1.17%
controls:0.44%
cases:2.24%
controls:1.08%
19
114
1300
13050
21
59
1300
13120
—
—
8
14
1303
13151
15
57
1265
12809
26
126
1136
11509
betaxolol; oral
C07AB05 [21601687]
1.2e+00
1.3e+00
—
—
—
1.2e+00
1.1e+00
cases:1.36%
controls:0.40%
cases:1.06%
controls:0.30%
—
—
—
—
—
—
cases:1.09%
controls:0.32%
cases:1.03%
controls:0.36%
18
53
1301
13111
14
39
1307
13140
—
—
—
14
41
1266
12825
12
42
1150
11593
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
6.4e-02
2.5e-01
1.6e+00
—
9.3e-01
6.3e-01
6.1e-01
cases:7.66%
controls:7.22%
cases:4.62%
controls:3.63%
cases:1.67%
controls:0.36%
—
—
cases:1.30%
controls:0.52%
cases:6.25%
controls:3.44%
cases:17.47%
controls:10.31%
101
950
1218
12214
61
479
1260
12700
22
47
1299
13132
—
17
68
1294
13097
80
443
1200
12423
203
1199
959
10436
TACROLIMUS - yes
TACROLIMUS-1 [2002330222]
—
—
—
—
—
—
3.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.75%
controls:0.07%
—
—
—
—
—
—
32
8
1130
11627
Intravenous
ZX120 [2001311495]
4.8e-01
1.0e+00
—
—
1.9e+00
1.7e+00
2.0e+00
cases:1.14%
controls:0.71%
cases:0.76%
controls:0.28%
—
—
—
—
cases:0.46%
controls:0.07%
cases:1.17%
controls:0.21%
cases:4.39%
controls:0.64%
15
93
1304
13071
10
37
1311
13142
—
—
6
9
1305
13156
15
27
1265
12839
51
75
1111
11560
Gastroenterology
10 [38004455]
3.9e-01
8.2e-01
1.3e+00
—
1.0e+00
7.2e-01
8.3e-01
cases:5.23%
controls:3.59%
cases:3.56%
controls:1.59%
cases:1.06%
controls:0.29%
—
—
cases:0.69%
controls:0.24%
cases:3.28%
controls:1.62%
cases:9.72%
controls:4.50%
69
473
1250
12691
47
210
1274
12969
14
38
1307
13141
—
9
32
1302
13133
42
208
1238
12658
113
524
1049
11111
Supplier / Service Provider
OMOP5117446 [33004]
-1.2e+00
-1.0e+00
-2.4e-03
—
—
2.7e+00
3.1e+00
cases:9.70%
controls:26.02%
cases:3.10%
controls:7.97%
cases:0.76%
controls:0.76%
—
—
—
—
cases:3.59%
controls:0.25%
cases:14.29%
controls:0.71%
128
3425
1191
9739
41
1051
1280
12128
10
100
1311
13079
—
—
46
32
1234
12834
166
83
996
11552
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
4.4e-01
7.6e-01
—
1.0e+50
—
2.4e+00
1.2e+00
cases:0.99%
controls:0.64%
cases:0.45%
controls:0.21%
—
—
cases:1.21%
controls:0.00%
—
—
cases:1.88%
controls:0.18%
cases:1.98%
controls:0.58%
13
84
1306
13080
6
28
1315
13151
—
16
0
1305
13179
—
24
23
1256
12843
23
67
1139
11568
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
—
1.1e+00
—
—
2.1e+00
1.9e+00
1.7e+00
—
—
cases:0.38%
controls:0.12%
—
—
—
—
cases:0.38%
controls:0.05%
cases:0.86%
controls:0.13%
cases:2.50%
controls:0.46%
—
5
16
1316
13163
—
—
5
6
1306
13159
11
17
1269
12849
29
53
1133
11582
Magnesium Ionized [Moles/volume] in Serum or Plasma
2600-5 [3021197]
—
—
—
—
—
—
3.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.72%
controls:0.05%
—
—
—
—
—
—
20
6
1142
11629
Gout
M10 [45533711]
—
—
—
—
—
2.0e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.09%
cases:1.46%
controls:0.34%
—
—
—
—
—
9
12
1271
12854
17
39
1145
11596
Kidney Pathology biopsy report
65757-7 [40768446]
—
—
—
—
—
—
3.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.07%
—
—
—
—
—
—
26
8
1136
11627
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.2e+00
8.8e-01
—
—
—
1.4e+00
8.8e-01
cases:2.20%
controls:0.70%
cases:0.53%
controls:0.22%
—
—
—
—
—
—
cases:1.02%
controls:0.24%
cases:1.98%
controls:0.83%
29
92
1290
13072
7
29
1314
13150
—
—
—
13
31
1267
12835
23
97
1139
11538
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
-3.7e-02
7.7e-01
1.6e+00
—
1.1e+00
6.8e-01
4.1e-01
cases:3.71%
controls:3.85%
cases:3.86%
controls:1.82%
cases:0.91%
controls:0.18%
—
—
cases:0.53%
controls:0.18%
cases:3.52%
controls:1.82%
cases:8.78%
controls:5.98%
49
507
1270
12657
51
240
1270
12939
12
24
1309
13155
—
7
24
1304
13141
45
234
1235
12632
102
696
1060
10939
cefalexin; oral
J01DB01 [21602870]
3.0e-01
2.4e-01
7.6e-01
—
1.3e+00
5.2e-01
5.7e-01
cases:33.74%
controls:27.34%
cases:10.30%
controls:8.26%
cases:2.27%
controls:1.08%
—
—
cases:3.36%
controls:0.95%
cases:13.59%
controls:8.59%
cases:39.59%
controls:26.99%
445
3599
874
9565
136
1088
1185
12091
30
142
1291
13037
—
44
125
1267
13040
174
1105
1106
11761
460
3140
702
8495
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
1.2e-01
2.6e-01
2.0e-01
1.9e+00
7.2e-01
4.4e-01
3.8e-01
cases:25.63%
controls:23.41%
cases:15.82%
controls:12.60%
cases:3.10%
controls:2.55%
cases:0.68%
controls:0.11%
cases:4.35%
controls:2.17%
cases:18.52%
controls:12.75%
cases:38.90%
controls:30.39%
338
3082
981
10082
209
1661
1112
11518
41
336
1280
12843
9
14
1312
13165
57
286
1254
12879
237
1640
1043
11226
452
3536
710
8099
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
1.6e-02
4.0e-01
9.5e-01
—
1.9e+00
6.8e-01
8.1e-01
cases:5.23%
controls:5.15%
cases:3.03%
controls:2.04%
cases:0.61%
controls:0.24%
—
—
cases:1.22%
controls:0.18%
cases:3.75%
controls:1.94%
cases:13.34%
controls:6.40%
69
678
1250
12486
40
269
1281
12910
8
31
1313
13148
—
16
24
1295
13141
48
250
1232
12616
155
745
1007
10890
Neurology
13 [38004458]
1.3e-01
3.4e-01
5.0e-01
2.9e+00
5.6e-01
5.0e-01
3.0e-01
cases:8.42%
controls:7.47%
cases:4.39%
controls:3.17%
cases:0.91%
controls:0.55%
cases:0.68%
controls:0.04%
cases:1.22%
controls:0.70%
cases:6.02%
controls:3.74%
cases:11.45%
controls:8.77%
111
984
1208
12180
58
418
1263
12761
12
73
1309
13106
9
5
1312
13174
16
92
1295
13073
77
481
1203
12385
133
1020
1029
10615
Ultrasound examination of upper extremity veins
PH1AE [2001309445]
—
—
—
—
—
—
3.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.46%
controls:0.05%
—
—
—
—
—
—
17
6
1145
11629
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician
208G00000X [38004023]
1.0e+00
—
—
—
—
2.1e+00
1.3e+00
cases:0.99%
controls:0.35%
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.08%
cases:1.38%
controls:0.40%
13
46
1306
13118
—
—
—
—
8
10
1272
12856
16
46
1146
11589
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
4.7e-02
3.7e-01
1.5e+00
—
7.2e-01
3.9e-01
3.3e-01
cases:14.18%
controls:13.61%
cases:13.17%
controls:9.52%
cases:6.28%
controls:1.41%
—
—
cases:2.21%
controls:1.09%
cases:13.67%
controls:9.71%
cases:29.95%
controls:23.44%
187
1792
1132
11372
174
1254
1147
11925
83
186
1238
12993
—
29
144
1282
13021
175
1249
1105
11617
348
2727
814
8908
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
1.0e-01
4.2e-01
1.7e+00
—
8.7e-01
3.8e-01
2.1e-01
cases:16.91%
controls:15.49%
cases:13.63%
controls:9.40%
cases:5.60%
controls:1.12%
—
—
cases:2.29%
controls:0.97%
cases:13.20%
controls:9.40%
cases:28.83%
controls:24.75%
223
2039
1096
11125
180
1239
1141
11940
74
147
1247
13032
—
30
128
1281
13037
169
1210
1111
11656
335
2880
827
8755
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
-9.0e-02
5.5e-01
—
—
2.1e+00
6.0e-01
1.2e+00
cases:2.20%
controls:2.40%
cases:1.59%
controls:0.93%
—
—
—
—
cases:0.84%
controls:0.11%
cases:1.72%
controls:0.95%
cases:9.21%
controls:2.87%
29
316
1290
12848
21
122
1300
13057
—
—
11
14
1300
13151
22
122
1258
12744
107
334
1055
11301
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
2.2e-01
4.6e-01
2.1e+00
—
—
4.6e-01
1.1e+00
cases:2.50%
controls:2.01%
cases:0.98%
controls:0.62%
cases:0.45%
controls:0.05%
—
—
—
—
cases:0.86%
controls:0.54%
cases:5.85%
controls:2.02%
33
265
1286
12899
13
82
1308
13097
6
7
1315
13172
—
—
11
70
1269
12796
68
235
1094
11400
Left side
ZXA05 [2001311347]
4.9e-01
1.1e+00
1.3e+00
—
—
1.2e+00
1.0e+00
cases:3.79%
controls:2.35%
cases:2.12%
controls:0.74%
cases:0.38%
controls:0.10%
—
—
—
—
cases:2.19%
controls:0.70%
cases:7.40%
controls:2.82%
50
310
1269
12854
28
97
1293
13082
5
13
1316
13166
—
—
28
90
1252
12776
86
328
1076
11307
ranitidine bismuth citrate; oral
A02BA07 [21600088]
4.6e-01
1.0e+00
—
—
1.5e+00
1.2e+00
9.8e-01
cases:3.34%
controls:2.14%
cases:2.04%
controls:0.74%
—
—
—
—
cases:0.53%
controls:0.12%
cases:1.95%
controls:0.58%
cases:3.70%
controls:1.43%
44
282
1275
12882
27
98
1294
13081
—
—
7
16
1304
13149
25
75
1255
12791
43
166
1119
11469
ranitidine; oral, parenteral
A02BA02 [21600083]
4.6e-01
1.0e+00
—
—
1.5e+00
1.2e+00
9.8e-01
cases:3.34%
controls:2.14%
cases:2.04%
controls:0.74%
—
—
—
—
cases:0.53%
controls:0.12%
cases:1.95%
controls:0.58%
cases:3.70%
controls:1.43%
44
282
1275
12882
27
98
1294
13081
—
—
7
16
1304
13149
25
75
1255
12791
43
166
1119
11469
Axillary plexus blockaced
WX204 [2001310780]
1.6e+00
—
—
—
—
2.1e+00
1.7e+00
cases:0.68%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.39%
controls:0.05%
cases:1.46%
controls:0.28%
9
19
1310
13145
—
—
—
—
5
6
1275
12860
17
33
1145
11602
Intravenous general anesthesia
WX404 [2001310807]
4.8e-01
9.5e-01
—
—
—
1.0e+00
1.2e+00
cases:2.96%
controls:1.85%
cases:1.51%
controls:0.59%
—
—
—
—
—
—
cases:1.33%
controls:0.48%
cases:4.91%
controls:1.50%
39
243
1280
12921
20
78
1301
13101
—
—
—
17
62
1263
12804
57
175
1105
11460
Drug-induced cataract
H26.3 [45562213]
—
—
—
—
—
—
3.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.04%
—
—
—
—
—
—
12
5
1150
11630
Inpatient Visit
IP [9201]
2.2e-01
3.6e-02
—
—
1.7e+00
7.2e-01
7.3e-01
cases:5.76%
controls:4.68%
cases:1.44%
controls:1.39%
—
—
—
—
cases:0.76%
controls:0.14%
cases:2.58%
controls:1.27%
cases:8.18%
controls:4.11%
76
616
1243
12548
19
183
1302
12996
—
—
10
18
1301
13147
33
164
1247
12702
95
478
1067
11157
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
—
—
—
—
—
1.9e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.09%
cases:1.20%
controls:0.34%
—
—
—
—
—
7
11
1273
12855
14
39
1148
11596
codeine and paracetamol
N02AJ06 [1123647]
4.1e-01
6.8e-01
1.1e+00
—
9.4e-01
5.3e-01
4.3e-01
cases:14.10%
controls:9.81%
cases:7.49%
controls:3.96%
cases:1.89%
controls:0.64%
—
—
cases:1.22%
controls:0.48%
cases:6.41%
controls:3.89%
cases:17.30%
controls:11.97%
186
1292
1133
11872
99
522
1222
12657
25
85
1296
13094
—
16
63
1295
13102
82
500
1198
12366
201
1393
961
10242
Emergency Room and Inpatient Visit
ERIP [262]
3.4e-03
4.7e-01
1.6e+00
1.0e+50
1.5e+00
6.0e-01
3.7e-01
cases:2.88%
controls:2.87%
cases:2.42%
controls:1.53%
cases:0.83%
controls:0.17%
cases:1.36%
controls:0.00%
cases:0.92%
controls:0.20%
cases:2.81%
controls:1.57%
cases:6.88%
controls:4.88%
38
378
1281
12786
32
201
1289
12978
11
23
1310
13156
18
0
1303
13179
12
26
1299
13139
36
202
1244
12664
80
568
1082
11067
T2D - yes
T2D-2 [2002330230]
3.1e+00
—
—
—
—
—
—
cases:0.83%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
11
5
1308
13159
—
—
—
—
—
—
Hypertensive renal disease with renal failure
I12.0 [45596187]
—
1.0e+50
—
—
—
—
3.1e+00
—
—
cases:0.45%
controls:0.00%
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.05%
—
6
0
1315
13179
—
—
—
—
13
6
1149
11629
varenicline; oral
N07BA03 [21604819]
4.5e-01
—
—
—
—
2.0e+00
1.1e+00
cases:0.61%
controls:0.39%
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.09%
cases:1.46%
controls:0.50%
8
51
1311
13113
—
—
—
—
8
11
1272
12855
17
58
1145
11577
losartan and diuretics
C09DA01 [21601834]
7.3e-01
8.0e-01
3.6e-01
—
5.9e-01
7.6e-01
7.7e-01
cases:3.56%
controls:1.75%
cases:3.26%
controls:1.49%
cases:0.61%
controls:0.42%
—
—
cases:0.92%
controls:0.51%
cases:3.28%
controls:1.55%
cases:4.99%
controls:2.38%
47
230
1272
12934
43
197
1278
12982
8
56
1313
13123
—
12
67
1299
13098
42
200
1238
12666
58
277
1104
11358
Bacteria identified in Urine by Culture
630-4 [3026008]
1.7e-01
3.3e-01
1.7e+00
—
1.1e+00
7.7e-01
6.3e-01
cases:3.49%
controls:2.97%
cases:1.97%
controls:1.43%
cases:1.06%
controls:0.20%
—
—
cases:0.69%
controls:0.24%
cases:3.20%
controls:1.52%
cases:8.43%
controls:4.66%
46
391
1273
12773
26
188
1295
12991
14
27
1307
13152
—
9
31
1302
13134
41
195
1239
12671
98
542
1064
11093
dalteparin; parenteral
B01AB04 [21600975]
9.7e-01
—
—
—
—
1.7e+00
1.4e+00
cases:0.76%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.15%
cases:1.38%
controls:0.35%
10
38
1309
13126
—
—
—
—
10
19
1270
12847
16
41
1146
11594
Acute renal failure, unspecified
N17.9 [45567829]
1.7e+00
1.5e+00
—
1.0e+50
—
1.7e+00
1.4e+00
cases:0.76%
controls:0.14%
cases:0.53%
controls:0.12%
—
—
cases:0.38%
controls:0.00%
—
—
cases:0.55%
controls:0.10%
cases:1.12%
controls:0.28%
10
19
1309
13145
7
16
1314
13163
—
5
0
1316
13179
—
7
13
1273
12853
13
33
1149
11602
Emergency Medicine
93 [38004510]
1.1e-01
4.4e-01
1.3e+00
—
1.0e+00
1.6e-01
2.8e-01
cases:8.95%
controls:8.07%
cases:6.13%
controls:4.04%
cases:2.12%
controls:0.58%
—
—
cases:1.83%
controls:0.67%
cases:5.47%
controls:4.69%
cases:16.70%
controls:13.17%
118
1062
1201
12102
81
532
1240
12647
28
77
1293
13102
—
24
88
1287
13077
70
603
1210
12263
194
1532
968
10103
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
—
—
—
—
—
1.9e+00
3.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.07%
cases:2.93%
controls:0.15%
—
—
—
—
—
6
9
1274
12857
34
17
1128
11618
simvastatin; oral
C10AA01 [21601856]
8.2e-02
1.7e-01
1.6e-01
2.2e+00
2.2e-01
3.9e-01
4.0e-01
cases:11.68%
controls:10.86%
cases:9.61%
controls:8.24%
cases:2.50%
controls:2.14%
cases:0.98%
controls:0.11%
cases:2.75%
controls:2.23%
cases:11.95%
controls:8.46%
cases:17.30%
controls:12.30%
154
1429
1165
11735
127
1086
1194
12093
33
282
1288
12897
13
14
1308
13165
36
293
1275
12872
153
1088
1127
11778
201
1431
961
10204
Chronic kidney disease, stage 5
N18.5 [45582394]
—
—
—
—
—
—
3.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.05%
—
—
—
—
—
—
12
6
1150
11629

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
239
55
52.39
307.65
32.7
30.1
99.74
143.93
ug/l
3.50
207
42
210
43
57.47
307.65
6.2
4.1
—
—
—
0
0
926
1736
14.29
307.65
28.1
6.2
1.14
1.06
mmol/l
11.12
918
1620
325
281
14.84
307.65
2.7
1.4
—
—
—
0
0
317
262
15.43
307.65
2.7
1.5
164.35
143.89
au/ml
1.47
127
77
493
423
17.62
307.65
10.0
6.1
1.97
1.43
mg/l
18.97
485
388
847
1145
17.68
307.65
26.4
8.1
13.05
9.28
mmol/l
32.26
840
1103
796
912
19.37
307.65
14.0
4.1
158.88
82.34
ng/l
35.06
758
809
240
46
63.00
307.65
2.3
1.8
—
—
—
0
0
320
61
68.08
307.65
42.8
47.7
6.77
7.16
ug/l
0.93
292
55
242
157
18.50
286.53
2.3
2.5
19.67
38.80
iu/ml
0.73
19
21
694
1757
6.96
285.12
10.3
2.6
23.00
23.00
%
0.00
684
1656
305
302
12.70
281.98
2.0
1.3
268.53
246.62
u/ml
0.44
234
174
469
848
7.88
267.49
15.9
4.9
22.91
24.12
mmol/l
14.87
469
840
700
1907
6.44
262.16
10.1
2.6
2.04
2.32
g/l
39.58
688
1783
574
1355
6.56
249.12
15.7
4.5
7.36
7.38
ph
13.55
420
792
563
1314
6.56
247.06
15.9
4.6
-0.02
1.76
mmol/l
23.44
518
1121
572
1357
6.51
246.64
15.6
4.5
5.73
5.81
kpa
1.23
567
1322
711
2060
6.08
245.81
10.0
2.6
11.94
13.33
umol/l
8.15
700
1926
825
2747
6.01
242.21
8.6
2.7
2.51
5.65
e6/l
14.03
792
2505
132
31
47.00
223.46
1.1
1.2
—
—
—
0
0
137
45
33.71
211.85
1.0
1.0
—
—
—
0
0
136
44
34.19
211.27
1.0
1.1
—
—
—
0
0
966
3999
5.77
209.91
11.5
3.4
12.45
78.37
e6/l
3.57
873
3062
321
499
8.09
206.54
1.9
1.3
—
—
—
0
0
876
3474
5.20
197.02
10.8
3.3
0.10
0.41
e6/l
11.82
760
2552
921
3837
5.25
193.47
9.2
3.5
69.51
50.84
mg/l
1.91
809
2503
927
3912
5.21
190.68
10.3
4.2
15.07
8.95
mg/mmol
3.79
806
2486
882
3590
5.07
189.80
23.2
4.1
7.38
7.40
ph
21.23
760
2563
806
3080
4.91
187.70
7.0
2.8
401.59
343.15
umol/l
43.25
777
2734
320
550
7.28
186.78
2.0
2.0
1.47
1.44
g/l
0.19
301
489
210
218
11.19
185.42
11.5
3.1
14.74
8.17
pmol/l
9.34
210
218
959
4233
5.19
184.01
9.2
3.5
6.05
7.89
mmol/l
41.87
922
3630
468
1179
5.50
182.35
11.1
4.1
6.08
4.59
kpa
21.18
463
1150
118
40
32.18
180.32
3.1
2.6
0.60
0.61
mmol/l
0.43
118
40
651
2174
4.79
178.84
6.9
3.0
0.49
1.06
e6/l
6.78
433
1165
991
4587
5.16
176.01
14.8
4.0
36.24
104.42
e6/l
2.90
881
3211
183
174
11.98
171.25
1.2
1.2
—
—
—
0
0
1051
5228
5.30
166.25
18.3
5.3
35.72
35.84
g/l
0.32
1027
4926
613
2090
4.49
160.77
6.3
3.9
0.79
0.82
mmol/l
5.20
601
1977
655
2370
4.37
157.92
8.9
2.9
468.49
539.94
mosm/kgh2o
21.21
625
2076
585
2009
4.33
150.18
7.4
3.2
1.36
2.11
e6/l
1.83
351
992
1047
5450
4.87
148.92
33.1
7.3
1.22
1.21
mmol/l
7.07
1026
5043
154
140
12.26
147.99
5.6
5.9
11.21
10.75
%
0.56
154
140
482
1485
4.46
142.19
4.2
1.6
—
—
—
0
0
78
16
51.62
135.23
4.0
3.1
42.38
14.04
mg/l
—
19
5
1086
6058
4.78
134.10
40.2
7.7
1.21
1.21
mmol/l
0.91
1021
5261
534
1899
3.96
127.03
3.5
2.4
29.32
29.49
s
0.25
527
1845
970
5200
3.94
121.61
8.9
3.4
6.25
6.21
ph
0.54
541
2949
536
2012
3.73
115.98
4.2
1.7
—
—
—
0
0
310
792
4.76
114.14
9.6
3.9
112.00
129.56
g/l
32.27
304
776
672
2952
3.50
113.03
9.6
3.7
0.67
0.19
—
6
26
427
1399
3.98
112.52
5.0
3.0
1.62
1.78
%
3.42
417
1272
694
3138
3.45
110.87
9.2
4.5
95.82
89.47
%
8.11
687
3082
362
1074
4.22
109.29
4.7
3.0
60.31
70.06
e9/l
6.20
242
778
380
1168
4.11
109.26
12.7
9.5
1.03
1.37
mmol/l
7.60
374
1147
345
990
4.32
108.93
6.2
2.5
0.15
0.46
e6/l
2.39
336
941
716
3341
3.39
107.84
9.4
4.3
—
—
—
0
0
220
439
5.78
107.62
5.4
3.0
22.41
24.84
mmol/l
16.97
220
433
1059
6379
3.88
103.10
10.7
3.7
0.00
0.00
estimate
0.50
240
1312
1066
6453
3.91
102.88
10.8
3.7
10.05
3.94
estimate
0.37
246
1334
958
5446
3.51
101.72
5.2
2.5
80.19
76.14
nmol/l
5.39
935
4947
1066
6490
3.87
101.10
10.9
3.8
0.01
0.25
estimate
0.49
242
1241
315
940
4.05
93.11
13.1
4.4
4.89
5.14
kpa
7.09
310
910
564
2452
3.21
92.51
4.2
1.9
—
—
—
0
0
309
920
4.04
91.51
13.1
4.5
7.40
7.42
ph
9.23
290
766
447
1765
3.27
85.20
2.5
2.1
—
—
—
0
0
784
4284
2.93
82.65
11.2
6.5
—
—
—
0
0
687
3527
2.90
80.97
7.2
2.9
0.20
0.03
—
10
64
197
456
4.88
80.47
9.0
4.5
299.78
333.75
mg/l
0.23
139
219
147
267
6.05
78.71
8.9
3.9
—
—
—
0
0
735
3957
2.84
78.39
4.2
2.5
—
—
—
0
0
106
139
8.18
76.88
2.5
2.7
0.94
1.16
g/24h
0.48
73
85
1165
8221
3.74
72.91
14.5
4.4
—
3.51
—
0
11
978
6310
2.91
70.42
8.3
6.9
10.82
11.74
umol/l
1.18
959
6033
1123
7818
3.39
70.35
10.6
4.5
40.32
924.84
e6/l
1.70
18
108
883
5426
2.76
69.58
21.8
14.3
1.22
1.24
inr
0.40
746
4520
697
3814
2.68
69.45
4.2
2.7
65.26
82.58
u/l
0.39
679
3561
930
5873
2.81
69.30
9.2
3.1
188.43
123.80
ug/l
18.37
911
5523
980
6399
2.85
67.64
11.8
6.5
0.04
0.04
e9/l
6.49
852
5499
978
6385
2.84
67.41
11.8
6.5
0.58
0.58
e9/l
0.13
851
5483
991
6521
2.86
67.13
11.8
6.6
1.65
1.97
e9/l
6.83
875
5733
992
6600
2.81
64.47
12.1
6.8
0.19
0.19
e9/l
0.87
876
5762
142
300
5.16
64.19
2.5
1.2
—
—
—
0
0
640
3493
2.56
62.20
4.9
3.1
—
—
—
0
0
911
5881
2.63
61.66
12.6
6.7
0.61
0.68
%
3.49
886
5536
910
5893
2.61
60.81
12.6
6.7
2.73
2.88
%
1.23
885
5546
913
5939
2.60
60.14
12.1
6.5
60.77
56.70
%
22.02
892
5699
909
5908
2.59
59.86
12.6
6.8
8.83
8.84
%
0.06
883
5564
922
6045
2.60
59.40
12.5
6.6
24.51
28.27
%
21.71
898
5763
1027
7104
2.76
59.05
13.8
9.8
4.31
4.07
e9/l
2.51
904
6179
1202
9064
3.61
58.72
20.5
8.3
80.82
80.82
u/l
0.00
1185
8619
64
66
10.12
55.75
1.2
1.0
1720.73
1490.47
miu/ml
0.70
64
66
873
5684
2.47
55.37
4.4
2.9
—
—
estimate
—
0
0
304
1208
2.95
54.53
4.1
2.5
41.89
79.95
u/l
0.47
283
1024
266
1004
3.05
52.14
2.9
1.5
—
—
—
0
0
1011
7143
2.57
52.00
15.0
5.5
6.51
6.65
mmol/l
1.86
992
6789
851
5572
2.39
51.84
23.3
11.3
0.00
0.00
e9/l
0.08
646
4545
683
4112
2.31
50.08
7.9
3.5
2.34
2.35
mmol/l
0.87
649
3760
142
371
4.15
48.98
1.9
3.8
77.22
64.68
mg/l
0.32
110
322
142
371
4.15
48.98
1.9
3.8
60.34
45.45
mg/l
0.72
110
323
254
972
2.98
48.33
2.6
2.9
64.09
66.79
g/l
6.49
242
903
134
339
4.27
48.23
5.2
3.3
2.13
1.91
index
0.22
82
187
132
336
4.24
47.11
1.9
3.6
1.37
3.34
ratio
1.11
68
193
597
3472
2.27
46.63
10.8
3.9
0.02
0.01
estimate
0.37
218
1222
321
1414
2.66
46.59
10.3
9.4
7.40
7.41
ph
1.16
146
782
317
1403
2.64
45.46
10.3
9.4
-0.84
0.95
mmol/l
10.82
266
1166
318
1420
2.61
44.71
10.3
9.3
5.14
5.13
kpa
0.06
307
1373
318
1420
2.61
44.71
10.3
9.3
11.81
12.52
kpa
1.50
309
1375
92
182
5.35
44.56
7.4
5.8
11.71
11.47
mg/l
0.17
85
169
564
3256
2.24
44.28
3.2
2.3
2.71
2.83
mg/l
0.70
496
2829
193
665
3.21
43.81
15.9
4.7
—
—
—
0
0
251
1006
2.83
43.56
1.6
1.4
—
—
—
0
0
220
821
3.00
43.51
12.0
12.0
91.91
94.15
%
3.74
220
816
152
454
3.64
43.23
2.1
2.8
—
—
—
0
0
618
3735
2.19
42.94
9.4
6.2
—
—
—
0
0
289
1276
2.60
41.28
10.8
9.8
93.87
95.79
%
3.38
281
1237
115
298
4.12
39.96
4.6
2.3
129.85
131.18
g/l
0.23
105
241
141
423
3.60
39.75
3.9
3.3
3.46
3.53
g/l
0.17
136
403
257
1099
2.65
39.00
3.9
2.1
0.02
0.02
estimate
0.09
58
220
98
234
4.43
37.88
8.3
4.2
1.86
2.54
mmol/l
1.42
55
153
266
1189
2.53
36.67
11.4
10.1
110.27
121.68
g/l
16.34
260
1163
102
266
4.06
35.08
5.9
2.3
135.21
110.61
ug/min
0.25
85
152
280
1315
2.42
34.51
2.6
1.8
—
—
—
0
0
574
3605
2.02
33.76
1.7
1.5
—
—
—
0
0
714
4847
1.98
33.51
10.0
3.6
0.03
0.02
estimate
0.10
227
1093
144
498
3.11
32.16
2.6
1.8
5.23
2.00
ug/l
1.03
137
446
355
1895
2.18
32.03
1.9
1.7
1273.55
1190.09
nmol/l
0.73
302
1456
156
568
2.97
31.83
17.9
4.9
23.60
24.78
mmol/l
6.88
151
538
57
100
5.90
31.33
2.5
2.6
1454.47
1039.18
mg
0.61
57
100
545
3448
1.96
30.63
2.1
1.7
19.75
20.20
nmol/l
0.27
504
2938
187
773
2.64
29.94
1.8
2.6
—
—
—
0
0
141
509
2.97
29.15
3.1
2.7
20.75
21.09
s
0.37
134
465
289
1487
2.19
28.21
2.4
1.7
—
—
—
0
0
207
927
2.45
27.93
16.0
3.8
1.23
1.23
mmol/l
0.03
200
798
246
1190
2.30
27.86
3.6
2.5
0.22
0.21
g/l
0.97
236
1113
147
561
2.81
27.41
4.2
2.2
0.00
1.47
estimate
0.51
42
173
279
1443
2.17
26.75
5.9
3.2
7.49
8.14
umol/l
0.19
258
1277
57
116
5.08
26.68
6.3
3.5
16.30
11.93
index
1.62
46
76
28
33
8.64
21.94
1.5
1.3
12.36
6.83
pmol/l
0.93
20
14
709
5238
1.73
21.62
2.5
2.1
96.11
95.24
pmol/l
0.20
422
2815
516
3506
1.76
21.08
8.1
3.2
0.00
0.04
estimate
0.84
224
1052
590
4187
1.72
20.46
4.9
3.5
32.69
32.84
u/l
0.02
579
3978
438
2865
1.78
20.25
9.9
3.8
1.02
1.55
kg/l
0.50
342
1900
25
7
36.34
19.87
2.7
5.3
—
—
—
0
0
534
3724
1.71
19.48
2.2
2.3
172.92
240.45
u/l
1.24
523
3543
36
65
5.66
19.20
1.3
4.8
3330.92
75.00
mg/l
0.49
36
49
70
219
3.31
18.37
3.7
3.6
3.84
4.31
e9/l
0.98
70
219
109
453
2.53
17.04
1.2
1.2
—
—
—
0
0
138
651
2.24
16.23
1.5
1.2
—
—
—
0
0
1287
11771
2.47
15.64
49.6
15.6
24.54
24.20
mg/l
0.15
1208
9636
29
52
5.68
15.59
1.6
1.7
4449.71
3851.43
titre
—
7
7
96
392
2.56
15.57
2.1
2.5
9.61
10.84
g/l
2.28
91
355
190
1032
1.98
15.40
6.3
4.7
1.01
0.60
%
1.41
86
314
105
453
2.43
15.15
2.0
2.5
3.49
3.73
g/l
1.11
100
418
105
453
2.43
15.15
2.0
2.5
3.79
4.20
g/l
6.18
100
418
105
453
2.43
15.15
2.0
2.5
7.36
7.30
g/l
0.13
100
418
487
3494
1.61
14.92
3.1
3.3
5158.40
1213.46
ng/l
10.31
443
2982
44
117
3.85
14.75
1.4
2.3
—
—
—
0
0
613
4652
1.57
14.73
2.6
2.1
—
—
—
0
0
1215
10922
1.97
14.58
10.7
6.2
38.21
39.05
mmol/mol
3.32
1193
10282
77
291
2.74
14.56
2.5
3.5
31.44
34.62
umol/l
0.36
68
266
257
1572
1.78
14.30
1.5
1.3
—
—
—
0
0
185
1027
1.93
14.01
6.7
4.9
0.11
0.11
%
0.01
83
288
1289
11879
2.38
13.94
62.0
18.5
139.56
139.67
mmol/l
0.89
1283
11653
91
382
2.48
13.93
1.5
1.4
295.73
289.66
ug/g
0.10
56
233
191
1074
1.90
13.91
6.7
4.8
0.94
0.93
%
0.02
90
335
1290
11900
2.37
13.78
64.8
18.6
4.10
3.97
mmol/l
34.52
1284
11649
17
5
34.39
13.51
5.2
5.2
500.41
392.60
umol/l
—
17
5
213
1252
1.83
13.48
2.8
2.2
355.93
374.32
nmol/l
0.74
208
1175
589
4497
1.54
13.37
5.0
3.7
41.79
60.61
ng/l
0.63
486
3131
66
241
2.83
13.33
1.3
1.7
—
—
—
0
0
75
294
2.64
13.22
3.7
3.2
58.59
57.49
%
0.36
75
294
184
1039
1.89
13.21
6.9
5.2
0.03
0.14
%
1.61
80
261
55
183
3.09
13.09
1.5
1.7
—
—
—
0
0
55
183
3.09
13.09
1.5
1.7
—
—
—
0
0
55
183
3.09
13.09
1.5
1.7
—
—
—
0
0
55
183
3.09
13.09
1.5
1.7
—
—
—
0
0
959
8189
1.57
12.68
5.7
3.5
53.63
48.50
u/l
0.90
935
7753
1203
10883
1.85
12.66
7.0
4.2
1.37
1.29
mmol/l
3.42
1167
10087
389
2743
1.58
12.36
2.2
1.9
2.42
1.22
mg/l
1.46
326
2103
42
129
3.33
11.42
4.5
4.5
—
—
—
0
0
168
964
1.85
11.42
14.0
3.8
—
—
—
0
0
333
2303
1.59
11.36
4.0
3.9
537.67
474.99
ng/l
0.15
282
1757
168
968
1.84
11.26
2.2
2.4
4.92
7.58
ug/l
2.92
156
870
241
1553
1.67
10.90
1.8
1.5
—
—
—
0
0
173
1020
1.80
10.74
2.7
3.0
9.88
10.75
g/l
1.98
168
945
82
379
2.24
10.14
1.6
1.2
—
—
—
0
0
1113
10015
1.59
10.03
54.9
19.3
13.93
13.56
%
15.79
1107
9893
36
111
3.30
9.76
1.4
1.1
—
—
—
0
0
1232
11410
1.77
9.50
8.2
5.0
1.39
1.44
mmol/l
4.12
1201
10652
619
5005
1.43
9.46
2.7
1.9
1.36
1.37
mmol/l
0.07
572
4256
1234
11466
1.75
8.97
8.3
5.1
4.32
4.61
mmol/l
24.00
1204
10772
51
205
2.55
8.63
1.3
1.2
4.43
4.74
u/ml
0.05
23
88
209
1377
1.61
8.54
1.4
1.7
—
—
—
0
0
172
1084
1.67
8.37
24.6
4.1
7.35
7.35
ph
0.05
161
774
55
234
2.41
8.26
1.7
1.4
54.22
63.86
mmol/l
1.05
50
190
1242
11616
1.72
8.08
8.7
5.7
2.43
2.70
mmol/l
27.51
1211
10878
30
95
3.21
7.84
2.7
3.3
108.04
35.45
mg/l
0.74
25
72
21
55
3.86
7.27
1.5
1.4
140.81
174.94
mmol/24h
1.40
21
55
1278
12101
1.80
7.26
40.2
13.9
—
—
—
0
0
19
33
5.82
7.23
1.7
2.2
5199.69
3993.53
e6/l
0.16
13
19
19
35
5.49
6.92
16.5
6.5
10.37
5.14
kpa
5.68
19
35
30
103
2.96
6.88
1.1
1.0
—
—
—
0
0
29
98
3.00
6.83
1.3
1.1
90.79
109.92
pmol/l
1.19
29
98
22
63
3.53
6.73
3.1
2.0
—
46.16
—
0
5
40
165
2.47
6.48
1.5
1.3
0.69
0.60
nmol/l
0.57
40
157
145
937
1.61
6.39
3.8
2.4
6.09
6.09
ph
0.00
92
626
41
173
2.41
6.33
2.0
1.6
24.63
31.30
ng/l
0.44
41
173
38
155
2.49
6.31
1.5
2.3
32.61
32.90
pg
0.19
38
155
120
747
1.66
6.13
10.8
7.3
23.03
24.46
mmol/l
4.09
114
716
49
227
2.20
6.12
1.1
1.1
—
—
—
0
0
76
415
1.88
6.08
1.6
1.3
132.55
235.05
miu/ml
1.44
25
189
36
148
2.47
5.89
1.5
1.3
0.21
0.18
nmol/l
0.40
31
120
228
1655
1.45
5.85
1.3
1.2
—
—
—
0
0
16
32
5.05
5.57
1.4
1.9
—
—
—
0
0
39
171
2.32
5.57
1.6
1.3
0.30
0.51
nmol/l
—
6
12
31
122
2.58
5.56
1.5
1.1
—
—
—
0
0
359
2845
1.35
5.49
8.8
4.9
—
—
—
0
0
34
141
2.45
5.48
1.7
1.4
1094.25
1730.24
e6/l
0.79
28
93
300
2312
1.38
5.46
3.8
3.0
2.45
2.45
mmol/l
0.14
262
2095
34
142
2.43
5.41
1.6
1.3
—
—
nmol/l
—
0
0
193
1393
1.45
5.09
1.3
1.4
—
—
—
0
0
84
1352
0.60
5.05
1.8
2.0
3.66
3.50
ratio
0.38
62
1060
32
136
2.39
4.92
1.1
1.1
—
—
—
0
0
29
118
2.49
4.89
1.8
1.4
—
—
—
0
0
34
149
2.31
4.89
2.5
2.3
—
—
—
0
0
9
10
9.05
4.78
1.6
2.7
114.89
164.90
ug/g
—
9
10
30
126
2.41
4.74
1.7
1.4
46531.14
21210.66
e6/l
0.33
21
68
25
96
2.63
4.74
2.8
1.4
—
—
—
0
0
79
473
1.71
4.71
2.7
3.6
1113.88
3257.57
u/ml
0.46
72
406
63
354
1.82
4.67
1.3
1.2
—
—
—
0
0
39
185
2.14
4.66
1.1
1.1
1.58
1.50
g/l
0.62
39
167
1283
12339
1.60
4.55
27.9
12.0
23.44
26.70
u/l
3.68
1277
12027
220
1661
1.39
4.49
2.2
2.6
136.67
117.25
ug/g
0.40
182
1344
12
23
5.25
4.46
3.3
2.3
—
—
—
0
0
35
162
2.19
4.46
1.7
1.5
24.32
32.32
g/l
3.56
30
146
65
375
1.77
4.43
1.3
1.3
61.67
90.83
titre
—
6
36
86
538
1.64
4.37
2.5
1.9
—
—
—
0
0
208
1563
1.39
4.37
2.8
3.4
5.50
5.10
e9/l
0.18
188
1369
228
1746
1.37
4.26
1.4
1.4
575.61
474.22
titre
0.24
41
360
303
2425
1.32
4.22
1.7
1.7
18638425.10
26501163.78
pmol/l
0.15
279
2049
37
180
2.08
4.18
1.3
1.2
—
—
—
0
0
88
566
1.59
4.02
7.9
3.4
1.02
1.02
ratio
0.96
77
523
44
232
1.93
4.00
1.2
1.1
—
—
—
0
0
9
14
6.46
3.98
25.0
3.4
113.11
99.71
g/l
—
9
14
28
126
2.25
3.85
2.1
2.2
1094.14
1316.64
e6/l
0.54
28
109
329
2704
1.28
3.71
1.6
1.5
2.07
2.37
g/l
2.97
211
1662
40
211
1.92
3.66
1.2
1.4
—
9.50
—
0
6
64
1012
0.61
3.61
1.6
1.7
3.06
3.44
mmol/l
1.71
38
719
17
62
2.76
3.59
1.1
1.7
—
—
—
0
0
28
130
2.18
3.59
1.5
1.4
—
—
—
0
0
78
502
1.59
3.58
6.0
5.6
0.86
0.87
%
0.01
72
471
78
1170
0.65
3.49
1.2
1.4
—
—
—
0
0
62
380
1.66
3.46
1.3
1.3
—
1216.25
—
0
8
83
548
1.55
3.42
6.3
5.3
1.42
1.56
%
1.27
78
518
7
10
7.03
3.36
1.6
1.3
278.43
403.70
umol/24h
—
7
10
84
561
1.53
3.30
2.5
2.3
—
—
—
0
0
26
126
2.08
3.03
1.1
1.2
—
—
—
0
0
7
12
5.86
3.02
1.0
1.1
—
—
—
0
0
14
51
2.76
2.99
1.8
2.1
163.07
66.13
ug/l
0.72
14
51
8
17
4.73
2.92
1.0
1.7
6.84
4.70
nmol/l
—
8
17
25
124
2.03
2.77
1.2
1.3
—
—
—
0
0
53
335
1.61
2.69
1.9
2.2
18.11
12.05
mg/l
2.67
45
310
25
126
2.00
2.66
1.8
2.1
42.34
39.69
%
0.38
25
126
11
35
3.16
2.64
1.4
1.1
16.40
16.46
umol/l
0.01
11
29
20
93
2.17
2.61
2.1
2.4
185.45
242.21
e6/l
0.83
20
78
5
7
7.16
2.55
4.4
2.0
4.50
4.21
mmol/l
—
5
7
54
350
1.57
2.49
7.0
6.9
0.99
1.29
mmol/l
3.10
43
308
26
137
1.92
2.46
1.5
1.3
—
—
—
0
0
152
1191
1.31
2.46
2.6
4.5
5.38
23.67
ug/l
1.69
118
979
24
123
1.97
2.46
1.3
1.3
3.06
2.82
g/l
0.22
19
92
24
123
1.97
2.46
1.3
1.3
0.49
0.40
g/l
0.48
19
90
24
123
1.97
2.46
1.3
1.3
6.38
7.08
g/l
0.47
19
93
31
174
1.80
2.43
7.3
2.9
10.22
8.08
umol/l
0.35
31
131
6
12
5.02
2.40
1.0
1.2
—
—
—
0
0
6
12
5.02
2.40
1.0
2.4
5.11
1.76
nmol/l
—
6
12
454
4024
1.19
2.39
5.0
5.4
2.02
2.48
ug/l
1.25
421
3649
5
8
6.27
2.37
1.0
1.0
—
—
—
0
0
9
28
3.23
2.31
2.1
1.4
6.61
9.01
mmol/l
—
9
28
114
867
1.34
2.28
2.9
3.2
467.87
182.14
ng/l
4.10
106
794
418
4695
0.84
2.25
4.5
3.1
—
—
—
0
0
74
525
1.43
2.24
1.5
1.8
8.08
7.68
iu/ml
0.03
17
123
19
93
2.06
2.22
2.1
2.3
471.84
580.16
e6/l
0.32
19
74
13
55
2.38
2.12
1.4
1.2
—
—
—
0
0
19
95
2.01
2.11
3.4
2.1
1.23
1.63
u/field
0.26
13
56
27
454
0.59
2.05
1.0
1.1
1.40
1.52
g/l
1.43
27
454
23
126
1.84
1.99
1.4
1.6
—
—
—
0
0
21
113
1.87
1.92
1.3
1.3
—
—
—
0
0
13
58
2.25
1.91
1.4
1.8
—
—
—
0
0
28
166
1.70
1.88
2.2
2.5
—
—
—
0
0
7
22
3.19
1.88
1.7
1.9
1.09
1.19
umol/l
—
7
15
46
309
1.51
1.87
1.7
1.6
41852.74
12522.71
e6/l
0.47
31
224
12
251
0.47
1.87
1.6
1.6
—
—
—
0
0
9
34
2.66
1.86
1.1
1.4
66.79
79.06
mu/l
—
9
27
41
610
0.66
1.86
1.8
1.7
—
—
—
0
0
11
47
2.35
1.78
1.8
1.7
29.27
29.83
%
0.04
11
47
71
524
1.37
1.77
1.1
1.2
—
—
—
0
0
969
9255
1.16
1.74
4.6
4.3
14.77
14.74
pmol/l
0.15
924
8527
5
14
3.58
1.61
1.4
1.2
—
—
—
0
0
1128
10923
1.18
1.61
5.4
5.3
2.07
1.92
mu/l
0.96
1088
10153
1147
11125
1.19
1.59
8.0
5.0
5.89
5.91
mmol/l
0.37
1110
10263
10
43
2.34
1.59
1.4
1.3
0.00
0.07
estimate
—
10
43
10
43
2.34
1.59
1.2
1.3
—
—
—
0
0
28
176
1.60
1.55
2.1
2.8
—
—
—
0
0
22
130
1.70
1.53
1.8
1.4
6.47
6.55
mmol/l
0.05
22
121
61
453
1.36
1.50
2.4
2.4
4176.18
5343.51
u/l
0.18
27
193
5
16
3.13
1.44
1.0
1.2
—
—
—
0
0
33
221
1.51
1.42
3.1
3.4
0.74
0.84
nmol/l
0.82
24
184
150
1264
1.21
1.38
1.4
1.5
—
—
—
0
0
6
23
2.62
1.37
1.5
1.2
—
—
—
0
0
22
135
1.64
1.36
5.2
3.1
23.14
21.75
nmol/l
0.17
22
128
22
135
1.64
1.36
1.1
1.2
—
—
—
0
0
5
17
2.95
1.36
1.6
1.2
—
—
—
0
0
92
738
1.26
1.33
3.2
3.7
4.15
4.59
pmol/l
2.81
84
656
60
455
1.33
1.32
1.7
1.6
17.10
10.62
u/ml
0.62
16
111
32
217
1.49
1.31
1.3
1.7
0.69
0.79
g/l
0.26
27
176
1302
12827
1.29
1.29
68.5
23.8
234.76
250.51
e9/l
15.16
1294
12584
334
3020
1.14
1.29
1.3
1.4
0.61
1.80
u/ml
4.27
74
798
48
353
1.37
1.29
1.4
1.7
—
—
—
0
0
12
62
1.94
1.28
2.1
3.1
1532.00
709.90
u/ml
0.85
12
62
38
270
1.42
1.24
7.7
4.3
—
—
—
0
0
20
123
1.64
1.24
3.8
2.4
—
—
—
0
0
13
70
1.87
1.24
1.5
1.3
168.15
144.63
nmol/l
0.73
13
70
1302
12834
1.28
1.23
68.4
23.8
4.25
4.52
e12/l
54.43
1292
12556
8
37
2.17
1.21
1.3
1.4
28.00
27.95
s
—
8
37
8
37
2.17
1.21
1.4
1.5
40.50
81.27
nmol/24h
—
8
37
1302
12837
1.27
1.20
68.5
23.8
6.66
6.75
e9/l
0.97
1294
12556
15
86
1.75
1.19
1.6
1.3
33.20
34.25
mmol/l
0.06
15
80
34
474
0.71
1.18
1.0
1.1
—
—
—
0
0
29
200
1.46
1.12
1.2
1.1
—
—
—
0
0
15
88
1.71
1.11
1.1
1.0
—
—
—
0
0
26
176
1.49
1.10
2.0
1.8
—
—
—
0
0
124
1059
1.19
1.03
1.2
1.2
—
—
—
0
0
5
22
2.28
1.03
1.0
1.3
75.00
67.45
ug/l
—
5
22
45
342
1.33
1.02
14.7
10.4
—
—
—
0
0
7
36
1.95
0.97
1.1
1.1
288.14
314.13
pmol/l
—
7
23
9
50
1.81
0.96
4.8
2.9
—
—
—
0
0
53
419
1.28
0.93
1.6
1.5
8.15
8.73
u/l
0.12
44
337
6
29
2.07
0.89
1.0
1.2
—
—
—
0
0
17
111
1.54
0.88
1.1
1.2
—
—
—
0
0
17
111
1.54
0.88
1.3
1.1
—
—
—
0
0
6
30
2.00
0.87
2.0
3.5
—
—
—
0
0
6
31
1.94
0.84
1.2
2.1
—
—
—
0
0
8
45
1.78
0.84
1.5
1.2
30.35
34.31
nmol/l
—
8
36
10
58
1.73
0.79
1.3
1.7
—
—
—
0
0
33
251
1.32
0.79
1.9
2.1
—
—
—
0
0
0
26
0.00
0.78
0.0
1.4
—
—
—
0
0
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
5
24
2.09
0.74
8.2
2.0
—
—
—
0
0
5
25
2.00
0.72
1.2
1.0
14.20
6.75
mg/g
—
5
25
25
333
0.75
0.72
1.1
1.1
3.36
2.79
u/ml
0.08
14
199
14
93
1.51
0.69
2.1
2.7
31.67
40.14
%
—
6
46
37
293
1.27
0.68
2.5
2.1
1.23
0.86
nmol/l
1.21
31
252
15
212
0.70
0.63
1.3
1.2
—
—
—
0
0
8
49
1.64
0.62
1.3
2.6
31.48
190.05
ug/l
—
8
41
5
30
1.67
0.61
1.6
2.0
—
—
—
0
0
0
20
0.00
0.60
0.0
1.8
—
3.20
—
0
20
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
7
114
0.61
0.58
1.0
1.2
—
—
—
0
0
27
342
0.79
0.57
1.2
1.5
567.04
509.40
mg/l
0.28
27
327
39
472
0.82
0.56
2.1
1.2
0.86
0.90
g/l
0.73
39
472
21
274
0.76
0.56
1.3
1.3
—
—
—
0
0
34
275
1.24
0.55
1.1
1.1
—
—
—
0
0
34
277
1.23
0.53
1.1
1.1
—
—
—
0
0
22
282
0.78
0.52
1.0
1.1
0.50
2.06
u/ml
1.97
14
163
109
1209
0.89
0.52
2.5
2.3
11.58
13.40
nmol/l
1.64
101
1099
24
303
0.79
0.51
1.2
1.5
3.81
3.68
mmol/l
0.18
24
289
342
3247
1.07
0.51
4.4
4.4
29.18
21.20
%
10.04
174
1498
70
613
1.15
0.50
1.7
1.7
0.20
0.33
mg/l
1.49
28
289
11
75
1.47
0.50
1.9
2.8
7.27
8.40
mmol/l
0.60
11
75
56
482
1.17
0.50
1.6
1.5
275.63
284.43
mu/l
0.13
49
442
7
45
1.56
0.49
3.3
3.2
—
—
—
0
0
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
8
121
0.66
0.45
2.4
2.7
—
—
—
0
0
14
103
1.36
0.45
1.0
1.1
—
—
—
0
0
211
2247
0.93
0.44
1.3
1.3
30.46
31.41
iu/ml
0.03
59
674
12
86
1.40
0.44
1.5
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
0.22
—
0
5
0
15
0.00
0.41
0.0
1.0
—
1.32
—
0
7
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
45.80
—
0
5
80
881
0.90
0.37
1.3
1.2
96.54
136.10
u/ml
0.50
29
355
14
107
1.31
0.37
1.1
1.2
5.21
4.01
u/ml
—
7
57
19
235
0.81
0.37
1.0
1.1
5.77
3.53
u/ml
—
10
128
17
134
1.27
0.37
1.3
1.6
75.30
57.81
%
—
10
91
9
71
1.27
0.36
1.9
2.9
14.21
16.67
%
—
9
71
25
296
0.84
0.33
1.0
1.1
3.85
6.73
u/ml
0.63
16
176
6
46
1.31
0.33
1.2
1.7
40.93
40.80
g/l
—
6
46
7
96
0.73
0.31
1.0
1.2
405.71
378.11
nmol/l
—
7
85
14
111
1.26
0.30
1.1
1.1
291.14
276.47
mg/l
0.25
14
101
8
64
1.25
0.27
1.5
1.5
—
—
—
0
0
25
289
0.86
0.26
1.0
1.1
4.04
1.15
u/ml
0.47
14
146
28
245
1.15
0.25
1.1
1.2
—
—
—
0
0
12
96
1.25
0.24
1.0
1.1
—
—
—
0
0
52
567
0.91
0.23
1.6
1.6
1011.86
974.31
mu/l
0.12
46
473
39
352
1.11
0.22
1.3
1.2
1.84
2.56
u/ml
—
5
24
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
38.25
—
0
12
25
220
1.14
0.21
1.2
1.1
46.75
85.83
iu/ml
—
8
48
6
49
1.23
0.20
2.0
1.1
—
—
—
0
0
6
50
1.20
0.19
1.0
1.0
—
—
—
0
0
27
302
0.89
0.19
1.3
1.8
1441.86
820.10
e6/l
0.21
21
229
58
541
1.08
0.18
1.8
1.8
—
—
—
0
0
25
277
0.90
0.16
1.3
1.7
—
—
—
0
0
27
297
0.91
0.15
1.3
1.7
6.15
44.45
e6/l
1.06
20
216
64
605
1.06
0.15
1.6
1.5
27.57
24.34
iu/l
0.24
52
517
81
849
0.95
0.14
2.3
2.4
33.49
18.91
au/ml
—
9
91
28
257
1.09
0.13
1.5
1.5
—
—
—
0
0
151
1465
1.03
0.13
1.6
1.6
—
—
—
0
0
61
579
1.06
0.13
1.8
1.8
—
—
—
0
0
11
94
1.17
0.13
1.4
1.1
2.00
1.50
u/ml
—
5
37
52
491
1.06
0.13
1.3
1.2
0.23
1.11
u/ml
—
6
28
61
580
1.05
0.12
1.9
1.8
—
—
—
0
0
61
581
1.05
0.12
1.9
1.8
—
—
—
0
0
79
823
0.96
0.12
1.3
1.2
—
—
—
0
0
61
584
1.05
0.10
1.9
1.8
—
—
—
0
0
248
2437
1.02
0.10
3.4
3.2
1.09
0.75
ug/l
2.02
184
1518
28
262
1.07
0.09
1.5
1.6
—
—
—
0
0
6
54
1.11
0.09
1.0
1.1
158.67
214.40
iu/ml
—
6
54
6
56
1.07
0.08
5.0
3.6
2.58
1.79
ug/l
—
6
51
21
226
0.93
0.08
3.5
3.8
33.98
26.91
mg/l
0.37
13
161
5
62
0.81
0.08
1.0
1.2
12.20
8.53
mm/h
—
5
62
7
67
1.05
0.08
1.4
1.2
—
—
—
0
0
20
215
0.93
0.07
1.0
1.1
21.01
5.24
u/ml
—
10
104
14
153
0.91
0.07
1.3
2.2
—
—
—
0
0
15
141
1.06
0.03
1.1
1.1
—
—
—
0
0
207
2086
0.99
0.03
1.2
1.3
8.64
11.46
u/ml
0.23
77
792
25
259
0.96
0.02
1.4
1.2
—
—
—
0
0
34
348
0.98
0.01
2.2
2.0
3.34
4.15
iu/l
—
10
145
61
618
0.99
0.01
1.0
1.1
—
—
—
0
0
15
154
0.97
0.00
1.4
2.0
—
—
—
0
0
20
201
0.99
0.00
1.0
1.0
0.28
0.34
u/ml
—
8
74
26
261
1.00
0.00
1.1
1.1
32.53
24.45
au/ml
—
6
67
6
64
0.94
0.00
3.2
2.4
—
—
—
0
0
41
410
1.00
-0.00
2.2
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
0.82
—
0
5
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
9
92
0.98
-0.00
1.1
1.1
400.22
246.68
mg/l
—
9
79
8
83
0.96
-0.00
1.6
1.5
97.00
80.82
umol/l
—
8
83
0
8
0.00
-0.00
0.0
1.6
—
365.13
—
0
8
9
97
0.93
-0.00
1.1
1.2
61.38
39.08
mg/l
—
9
78
0
7
0.00
-0.00
0.0
1.0
—
0.06
—
0
7
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
55
0.91
-0.00
2.0
2.5
52.14
50.28
umol/l
—
5
49
0
6
0.00
-0.00
0.0
1.2
—
0.03
—
0
6
0
7
0.00
-0.00
0.0
2.4
—
190.00
—
0
7
0
8
0.00
-0.00
0.0
1.1
—
56.01
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
10
100
1.00
-0.00
1.4
1.2
2.16
1.95
mmol/l
—
10
94
0
8
0.00
-0.00
0.0
2.9
—
0.52
—
0
8

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: Q17_CYSTIC_KIDNEY_DISEA_WIDE – Cystic kidney disease, including avohilmo

GWS hits: 19

This endpoint is excluded (different definition than used in FinnGen).